id	sid	tid	token	lemma	pos
iajs-3142	1	1	333	333	NUM
iajs-3142	1	2	this	this	DET
iajs-3142	1	3	work	work	NOUN
iajs-3142	1	4	is	be	AUX
iajs-3142	1	5	licensed	license	VERB
iajs-3142	1	6	under	under	ADP
iajs-3142	1	7	a	a	DET
iajs-3142	1	8	creative	creative	ADJ
iajs-3142	1	9	commons	common	NOUN
iajs-3142	1	10	attribution	attribution	NOUN
iajs-3142	1	11	4.0	4.0	NUM
iajs-3142	1	12	international	international	ADJ
iajs-3142	1	13	license	license	NOUN
iajs-3142	1	14	ihjpas	ihjpa	NOUN
iajs-3142	1	15	.	.	PUNCT
iajs-3142	2	1	37	37	NUM
iajs-3142	2	2	(	(	PUNCT
iajs-3142	2	3	1	1	NUM
iajs-3142	2	4	)	)	PUNCT
iajs-3142	2	5	2024	2024	NUM
iajs-3142	2	6	ibn	ibn	PROPN
iajs-3142	2	7	al	al	PROPN
iajs-3142	2	8	-	-	PUNCT
iajs-3142	2	9	haitham	haitham	PROPN
iajs-3142	2	10	journal	journal	PROPN
iajs-3142	2	11	for	for	ADP
iajs-3142	2	12	pure	pure	ADJ
iajs-3142	2	13	and	and	CCONJ
iajs-3142	2	14	applied	applied	ADJ
iajs-3142	2	15	sciences	sciences	PROPN
iajs-3142	2	16	journal	journal	PROPN
iajs-3142	2	17	homepage	homepage	NOUN
iajs-3142	2	18	:	:	PUNCT
iajs-3142	2	19	jih.uobaghdad.edu.iq	jih.uobaghdad.edu.iq	NOUN
iajs-3142	2	20	pissn	pissn	ADJ
iajs-3142	2	21	:	:	PUNCT
iajs-3142	2	22	1609	1609	NUM
iajs-3142	2	23	-	-	SYM
iajs-3142	2	24	4042	4042	NUM
iajs-3142	2	25	,	,	PUNCT
iajs-3142	2	26	eissn	eissn	NOUN
iajs-3142	2	27	:	:	PUNCT
iajs-3142	2	28	2521	2521	NUM
iajs-3142	2	29	-	-	SYM
iajs-3142	2	30	3407	3407	NUM
iajs-3142	2	31	1riyam	1riyam	NUM
iajs-3142	2	32	hussein	hussein	PROPN
iajs-3142	2	33	assaf	assaf	PROPN
iajs-3142	2	34	*	*	PUNCT
iajs-3142	2	35	2layla	2layla	NUM
iajs-3142	2	36	othman	othman	ADJ
iajs-3142	2	37	farhan	farhan	PROPN
iajs-3142	2	38	1,2department	1,2department	NUM
iajs-3142	2	39	of	of	ADP
iajs-3142	2	40	chemistry	chemistry	NOUN
iajs-3142	2	41	,	,	PUNCT
iajs-3142	2	42	college	college	NOUN
iajs-3142	2	43	of	of	ADP
iajs-3142	2	44	sciences	science	NOUN
iajs-3142	2	45	for	for	ADP
iajs-3142	2	46	women	woman	NOUN
iajs-3142	2	47	,	,	PUNCT
iajs-3142	2	48	university	university	NOUN
iajs-3142	2	49	of	of	ADP
iajs-3142	2	50	baghdad	baghdad	PROPN
iajs-3142	2	51	,	,	PUNCT
iajs-3142	2	52	baghdad	baghdad	PROPN
iajs-3142	2	53	,	,	PUNCT
iajs-3142	2	54	iraq	iraq	PROPN
iajs-3142	2	55	.	.	PUNCT
iajs-3142	3	1	*	*	PUNCT
iajs-3142	3	2	corresponding	correspond	VERB
iajs-3142	3	3	author	author	NOUN
iajs-3142	3	4	:	:	PUNCT
iajs-3142	3	5	rayam.hussein1205a@csw.uobaghdad.edu.iq	rayam.hussein1205a@csw.uobaghdad.edu.iq	ADJ
iajs-3142	3	6	abstract	abstract	ADV
iajs-3142	3	7	by	by	ADP
iajs-3142	3	8	measuring	measure	VERB
iajs-3142	3	9	adropin	adropin	NOUN
iajs-3142	3	10	,	,	PUNCT
iajs-3142	3	11	fasting	fast	VERB
iajs-3142	3	12	blood	blood	NOUN
iajs-3142	3	13	glucose	glucose	NOUN
iajs-3142	3	14	(	(	PUNCT
iajs-3142	3	15	fbg	fbg	PROPN
iajs-3142	3	16	)	)	PUNCT
iajs-3142	3	17	,	,	PUNCT
iajs-3142	3	18	cholesterol	cholesterol	NOUN
iajs-3142	3	19	,	,	PUNCT
iajs-3142	3	20	high	high	ADJ
iajs-3142	3	21	-	-	PUNCT
iajs-3142	3	22	density	density	NOUN
iajs-3142	3	23	lipoprotein	lipoprotein	ADJ
iajs-3142	3	24	(	(	PUNCT
iajs-3142	3	25	hdl	hdl	NOUN
iajs-3142	3	26	)	)	PUNCT
iajs-3142	3	27	,	,	PUNCT
iajs-3142	3	28	triglycerides	triglyceride	NOUN
iajs-3142	3	29	(	(	PUNCT
iajs-3142	3	30	tg	tg	NOUN
iajs-3142	3	31	)	)	PUNCT
iajs-3142	3	32	,	,	PUNCT
iajs-3142	3	33	low	low	ADJ
iajs-3142	3	34	-	-	PUNCT
iajs-3142	3	35	density	density	NOUN
iajs-3142	3	36	lipoprotein	lipoprotein	ADJ
iajs-3142	3	37	(	(	PUNCT
iajs-3142	3	38	ldl	ldl	NOUN
iajs-3142	3	39	)	)	PUNCT
iajs-3142	3	40	,	,	PUNCT
iajs-3142	3	41	and	and	CCONJ
iajs-3142	3	42	very	very	ADV
iajs-3142	3	43	low	low	ADJ
iajs-3142	3	44	-	-	PUNCT
iajs-3142	3	45	density	density	NOUN
iajs-3142	3	46	lipoprotein	lipoprotein	ADJ
iajs-3142	3	47	(	(	PUNCT
iajs-3142	3	48	vldl	vldl	NOUN
iajs-3142	3	49	)	)	PUNCT
iajs-3142	3	50	in	in	ADP
iajs-3142	3	51	the	the	DET
iajs-3142	3	52	sera	sera	NOUN
iajs-3142	3	53	of	of	ADP
iajs-3142	3	54	iraqi	iraqi	ADJ
iajs-3142	3	55	patients	patient	NOUN
iajs-3142	3	56	with	with	ADP
iajs-3142	3	57	mets	met	NOUN
iajs-3142	3	58	and	and	CCONJ
iajs-3142	3	59	type	type	NOUN
iajs-3142	3	60	2	2	NUM
iajs-3142	3	61	diabetes	diabetes	NOUN
iajs-3142	3	62	mellitus	mellitus	NOUN
iajs-3142	3	63	(	(	PUNCT
iajs-3142	3	64	t2	t2	NOUN
iajs-3142	3	65	dm	dm	PROPN
iajs-3142	3	66	)	)	PUNCT
iajs-3142	3	67	,	,	PUNCT
iajs-3142	3	68	the	the	DET
iajs-3142	3	69	current	current	ADJ
iajs-3142	3	70	study	study	NOUN
iajs-3142	3	71	was	be	AUX
iajs-3142	3	72	designed	design	VERB
iajs-3142	3	73	to	to	PART
iajs-3142	3	74	compare	compare	VERB
iajs-3142	3	75	some	some	DET
iajs-3142	3	76	crucial	crucial	ADJ
iajs-3142	3	77	markers	marker	NOUN
iajs-3142	3	78	in	in	ADP
iajs-3142	3	79	metabolic	metabolic	NOUN
iajs-3142	3	80	syndrome	syndrome	NOUN
iajs-3142	3	81	(	(	PUNCT
iajs-3142	3	82	mets	met	NOUN
iajs-3142	3	83	)	)	PUNCT
iajs-3142	3	84	sera	sera	NOUN
iajs-3142	3	85	and	and	CCONJ
iajs-3142	3	86	diabetic	diabetic	ADJ
iajs-3142	3	87	patients	patient	NOUN
iajs-3142	3	88	(	(	PUNCT
iajs-3142	3	89	t2	t2	NOUN
iajs-3142	3	90	dm	dm	PROPN
iajs-3142	3	91	)	)	PUNCT
iajs-3142	3	92	with	with	ADP
iajs-3142	3	93	control	control	NOUN
iajs-3142	3	94	.	.	PUNCT
iajs-3142	4	1	twenty	twenty	NUM
iajs-3142	4	2	female	female	ADJ
iajs-3142	4	3	subjects	subject	NOUN
iajs-3142	4	4	were	be	AUX
iajs-3142	4	5	divided	divide	VERB
iajs-3142	4	6	into	into	ADP
iajs-3142	4	7	three	three	NUM
iajs-3142	4	8	groups	group	NOUN
iajs-3142	4	9	:	:	PUNCT
iajs-3142	4	10	group	group	NOUN
iajs-3142	4	11	i=40	i=40	VERB
iajs-3142	4	12	with	with	ADP
iajs-3142	4	13	mets	met	NOUN
iajs-3142	4	14	and	and	CCONJ
iajs-3142	4	15	group	group	NOUN
iajs-3142	4	16	ii=40	ii=40	VERB
iajs-3142	4	17	with	with	ADP
iajs-3142	4	18	t2	t2	NOUN
iajs-3142	4	19	dm	dm	NOUN
iajs-3142	4	20	,	,	PUNCT
iajs-3142	4	21	and	and	CCONJ
iajs-3142	4	22	40	40	NUM
iajs-3142	4	23	healthy	healthy	ADJ
iajs-3142	4	24	subjects	subject	NOUN
iajs-3142	4	25	were	be	AUX
iajs-3142	4	26	employed	employ	VERB
iajs-3142	4	27	as	as	ADP
iajs-3142	4	28	a	a	DET
iajs-3142	4	29	control	control	NOUN
iajs-3142	4	30	group	group	NOUN
iajs-3142	4	31	.	.	PUNCT
iajs-3142	5	1	compared	compare	VERB
iajs-3142	5	2	to	to	ADP
iajs-3142	5	3	the	the	DET
iajs-3142	5	4	control	control	NOUN
iajs-3142	5	5	group	group	NOUN
iajs-3142	5	6	,	,	PUNCT
iajs-3142	5	7	adropin	adropin	NOUN
iajs-3142	5	8	levels	level	NOUN
iajs-3142	5	9	in	in	ADP
iajs-3142	5	10	the	the	DET
iajs-3142	5	11	mets	met	NOUN
iajs-3142	5	12	group	group	NOUN
iajs-3142	5	13	and	and	CCONJ
iajs-3142	5	14	t2	t2	PROPN
iajs-3142	5	15	dm	dm	PROPN
iajs-3142	5	16	group	group	NOUN
iajs-3142	5	17	decreased	decrease	VERB
iajs-3142	5	18	significantly	significantly	ADV
iajs-3142	5	19	(	(	PUNCT
iajs-3142	5	20	p	p	X
iajs-3142	5	21	<	<	X
iajs-3142	5	22	0.05	0.05	NUM
iajs-3142	5	23	)	)	PUNCT
iajs-3142	5	24	.	.	PUNCT
iajs-3142	6	1	in	in	ADP
iajs-3142	6	2	contrast	contrast	NOUN
iajs-3142	6	3	,	,	PUNCT
iajs-3142	6	4	none	none	NOUN
iajs-3142	6	5	of	of	ADP
iajs-3142	6	6	the	the	DET
iajs-3142	6	7	patient	patient	ADJ
iajs-3142	6	8	groups	group	NOUN
iajs-3142	6	9	(	(	PUNCT
iajs-3142	6	10	mets	met	NOUN
iajs-3142	6	11	and	and	CCONJ
iajs-3142	6	12	t2	t2	PROPN
iajs-3142	6	13	dm	dm	PROPN
iajs-3142	6	14	)	)	PUNCT
iajs-3142	6	15	showed	show	VERB
iajs-3142	6	16	any	any	DET
iajs-3142	6	17	change	change	NOUN
iajs-3142	6	18	compared	compare	VERB
iajs-3142	6	19	to	to	ADP
iajs-3142	6	20	themselves	themselves	PRON
iajs-3142	6	21	.	.	PUNCT
iajs-3142	7	1	in	in	ADP
iajs-3142	7	2	conclusion	conclusion	NOUN
iajs-3142	7	3	,	,	PUNCT
iajs-3142	7	4	according	accord	VERB
iajs-3142	7	5	to	to	ADP
iajs-3142	7	6	the	the	DET
iajs-3142	7	7	present	present	ADJ
iajs-3142	7	8	data	datum	NOUN
iajs-3142	7	9	,	,	PUNCT
iajs-3142	7	10	higher	high	ADJ
iajs-3142	7	11	levels	level	NOUN
iajs-3142	7	12	of	of	ADP
iajs-3142	7	13	fbg	fbg	PROPN
iajs-3142	7	14	,	,	PUNCT
iajs-3142	7	15	lipid	lipid	NOUN
iajs-3142	7	16	profile	profile	NOUN
iajs-3142	7	17	,	,	PUNCT
iajs-3142	7	18	and	and	CCONJ
iajs-3142	7	19	increased	increase	VERB
iajs-3142	7	20	blood	blood	NOUN
iajs-3142	7	21	pressure	pressure	NOUN
iajs-3142	7	22	(	(	PUNCT
iajs-3142	7	23	bp	bp	PROPN
iajs-3142	7	24	)	)	PUNCT
iajs-3142	7	25	were	be	AUX
iajs-3142	7	26	found	find	VERB
iajs-3142	7	27	in	in	ADP
iajs-3142	7	28	patients	patient	NOUN
iajs-3142	7	29	with	with	ADP
iajs-3142	7	30	mets	met	NOUN
iajs-3142	7	31	and	and	CCONJ
iajs-3142	7	32	t2	t2	NOUN
iajs-3142	7	33	dm	dm	PROPN
iajs-3142	7	34	.	.	PUNCT
iajs-3142	8	1	a	a	DET
iajs-3142	8	2	drop	drop	NOUN
iajs-3142	8	3	in	in	ADP
iajs-3142	8	4	level	level	NOUN
iajs-3142	8	5	could	could	AUX
iajs-3142	8	6	be	be	AUX
iajs-3142	8	7	considered	consider	VERB
iajs-3142	8	8	a	a	DET
iajs-3142	8	9	novel	novel	ADJ
iajs-3142	8	10	indicator	indicator	NOUN
iajs-3142	8	11	of	of	ADP
iajs-3142	8	12	mets	met	NOUN
iajs-3142	8	13	and	and	CCONJ
iajs-3142	8	14	t2	t2	NOUN
iajs-3142	8	15	dm	dm	PROPN
iajs-3142	8	16	.	.	PUNCT
iajs-3142	8	17	compared	compare	VERB
iajs-3142	8	18	to	to	ADP
iajs-3142	8	19	t2	t2	PROPN
iajs-3142	8	20	dm	dm	PROPN
iajs-3142	8	21	patients	patient	NOUN
iajs-3142	8	22	,	,	PUNCT
iajs-3142	8	23	adropin	adropin	NOUN
iajs-3142	8	24	levels	level	NOUN
iajs-3142	8	25	are	be	AUX
iajs-3142	8	26	thought	think	VERB
iajs-3142	8	27	to	to	PART
iajs-3142	8	28	have	have	VERB
iajs-3142	8	29	a	a	DET
iajs-3142	8	30	more	more	ADV
iajs-3142	8	31	sensitive	sensitive	ADJ
iajs-3142	8	32	diagnostic	diagnostic	ADJ
iajs-3142	8	33	function	function	NOUN
iajs-3142	8	34	than	than	ADP
iajs-3142	8	35	those	those	PRON
iajs-3142	8	36	with	with	ADP
iajs-3142	8	37	mets	met	NOUN
iajs-3142	8	38	and	and	CCONJ
iajs-3142	8	39	newly	newly	ADV
iajs-3142	8	40	diagnosed	diagnose	VERB
iajs-3142	8	41	dm	dm	NOUN
iajs-3142	8	42	.	.	PUNCT
iajs-3142	9	1	keywords	keyword	NOUN
iajs-3142	9	2	:	:	PUNCT
iajs-3142	9	3	adropin	adropin	ADJ
iajs-3142	9	4	,	,	PUNCT
iajs-3142	9	5	type	type	NOUN
iajs-3142	9	6	2	2	NUM
iajs-3142	9	7	diabetes	diabetes	NOUN
iajs-3142	9	8	mellitus	mellitus	NOUN
iajs-3142	9	9	,	,	PUNCT
iajs-3142	9	10	metabolic	metabolic	NOUN
iajs-3142	9	11	syndrome	syndrome	NOUN
iajs-3142	9	12	,	,	PUNCT
iajs-3142	9	13	body	body	NOUN
iajs-3142	9	14	mass	mass	PROPN
iajs-3142	9	15	index	index	NOUN
iajs-3142	9	16	,	,	PUNCT
iajs-3142	9	17	blood	blood	NOUN
iajs-3142	9	18	pressure	pressure	NOUN
iajs-3142	9	19	.	.	PUNCT
iajs-3142	10	1	1	1	X
iajs-3142	10	2	.	.	X
iajs-3142	10	3	introduction	introduction	NOUN
iajs-3142	10	4	metabolic	metabolic	NOUN
iajs-3142	10	5	syndrome	syndrome	PROPN
iajs-3142	10	6	(	(	PUNCT
iajs-3142	10	7	mets	met	NOUN
iajs-3142	10	8	)	)	PUNCT
iajs-3142	10	9	has	have	AUX
iajs-3142	10	10	increased	increase	VERB
iajs-3142	10	11	more	more	ADV
iajs-3142	10	12	widely	widely	ADV
iajs-3142	10	13	and	and	CCONJ
iajs-3142	10	14	is	be	AUX
iajs-3142	10	15	known	know	VERB
iajs-3142	10	16	to	to	PART
iajs-3142	10	17	dramatically	dramatically	ADV
iajs-3142	10	18	increase	increase	VERB
iajs-3142	10	19	the	the	DET
iajs-3142	10	20	risk	risk	NOUN
iajs-3142	10	21	of	of	ADP
iajs-3142	10	22	acquiring	acquire	VERB
iajs-3142	10	23	diabetes	diabetes	NOUN
iajs-3142	10	24	and	and	CCONJ
iajs-3142	10	25	cardiovascular	cardiovascular	ADJ
iajs-3142	10	26	disease	disease	NOUN
iajs-3142	10	27	.	.	PUNCT
iajs-3142	11	1	obesity	obesity	NOUN
iajs-3142	11	2	,	,	PUNCT
iajs-3142	11	3	atherogenic	atherogenic	ADJ
iajs-3142	11	4	dyslipidemia	dyslipidemia	NOUN
iajs-3142	11	5	,	,	PUNCT
iajs-3142	11	6	hypertension	hypertension	NOUN
iajs-3142	11	7	,	,	PUNCT
iajs-3142	11	8	and	and	CCONJ
iajs-3142	11	9	insulin	insulin	NOUN
iajs-3142	11	10	resistance	resistance	NOUN
iajs-3142	11	11	(	(	PUNCT
iajs-3142	11	12	ir	ir	NOUN
iajs-3142	11	13	)	)	PUNCT
iajs-3142	11	14	are	be	AUX
iajs-3142	11	15	a	a	DET
iajs-3142	11	16	group	group	NOUN
iajs-3142	11	17	of	of	ADP
iajs-3142	11	18	cardiac	cardiac	ADJ
iajs-3142	11	19	risk	risk	NOUN
iajs-3142	11	20	factors	factor	NOUN
iajs-3142	11	21	that	that	PRON
iajs-3142	11	22	collectively	collectively	ADV
iajs-3142	11	23	make	make	VERB
iajs-3142	11	24	up	up	ADP
iajs-3142	11	25	the	the	DET
iajs-3142	11	26	syndrome	syndrome	NOUN
iajs-3142	11	27	.	.	PUNCT
iajs-3142	12	1	in	in	ADP
iajs-3142	12	2	women	woman	NOUN
iajs-3142	12	3	,	,	PUNCT
iajs-3142	12	4	the	the	DET
iajs-3142	12	5	mets	met	NOUN
iajs-3142	12	6	has	have	VERB
iajs-3142	12	7	a	a	DET
iajs-3142	12	8	few	few	ADJ
iajs-3142	12	9	distinctive	distinctive	ADJ
iajs-3142	12	10	characteristics	characteristic	NOUN
iajs-3142	12	11	.	.	PUNCT
iajs-3142	13	1	dietary	dietary	ADJ
iajs-3142	13	2	and	and	CCONJ
iajs-3142	13	3	lifestyle	lifestyle	NOUN
iajs-3142	13	4	changes	change	NOUN
iajs-3142	13	5	are	be	AUX
iajs-3142	13	6	two	two	NUM
iajs-3142	13	7	of	of	ADP
iajs-3142	13	8	the	the	DET
iajs-3142	13	9	most	most	ADV
iajs-3142	13	10	important	important	ADJ
iajs-3142	13	11	aspects	aspect	NOUN
iajs-3142	13	12	of	of	ADP
iajs-3142	13	13	controlling	control	VERB
iajs-3142	13	14	the	the	DET
iajs-3142	13	15	mets	met	NOUN
iajs-3142	13	16	[	[	X
iajs-3142	13	17	1	1	NUM
iajs-3142	13	18	]	]	PUNCT
iajs-3142	13	19	.	.	PUNCT
iajs-3142	14	1	adropin	adropin	NOUN
iajs-3142	14	2	is	be	AUX
iajs-3142	14	3	a	a	DET
iajs-3142	14	4	peptide	peptide	ADJ
iajs-3142	14	5	hormone	hormone	NOUN
iajs-3142	14	6	composed	compose	VERB
iajs-3142	14	7	of	of	ADP
iajs-3142	14	8	76	76	NUM
iajs-3142	14	9	amino	amino	NOUN
iajs-3142	14	10	acids	acid	NOUN
iajs-3142	14	11	.	.	PUNCT
iajs-3142	15	1	it	it	PRON
iajs-3142	15	2	was	be	AUX
iajs-3142	15	3	first	first	ADV
iajs-3142	15	4	characterized	characterize	VERB
iajs-3142	15	5	as	as	ADP
iajs-3142	15	6	a	a	DET
iajs-3142	15	7	secreted	secreted	ADJ
iajs-3142	15	8	peptide	peptide	NOUN
iajs-3142	15	9	with	with	ADP
iajs-3142	15	10	residues	residue	NOUN
iajs-3142	15	11	1–33	1–33	NOUN
iajs-3142	15	12	encoding	encode	VERB
iajs-3142	15	13	a	a	DET
iajs-3142	15	14	secretory	secretory	ADJ
iajs-3142	15	15	signal	signal	NOUN
iajs-3142	15	16	peptide	peptide	NOUN
iajs-3142	15	17	sequence	sequence	NOUN
iajs-3142	15	18	[	[	X
iajs-3142	15	19	2	2	NUM
iajs-3142	15	20	]	]	PUNCT
iajs-3142	15	21	.	.	PUNCT
iajs-3142	16	1	this	this	DET
iajs-3142	16	2	protein	protein	NOUN
iajs-3142	16	3	has	have	VERB
iajs-3142	16	4	the	the	DET
iajs-3142	16	5	same	same	ADJ
iajs-3142	16	6	amino	amino	NOUN
iajs-3142	16	7	acid	acid	NOUN
iajs-3142	16	8	sequence	sequence	NOUN
iajs-3142	16	9	in	in	ADP
iajs-3142	16	10	humans	human	NOUN
iajs-3142	16	11	,	,	PUNCT
iajs-3142	16	12	mice	mouse	NOUN
iajs-3142	16	13	,	,	PUNCT
iajs-3142	16	14	and	and	CCONJ
iajs-3142	16	15	rats	rat	NOUN
iajs-3142	16	16	.	.	PUNCT
iajs-3142	17	1	recent	recent	ADJ
iajs-3142	17	2	results	result	NOUN
iajs-3142	17	3	[	[	X
iajs-3142	17	4	3,4	3,4	NUM
iajs-3142	17	5	]	]	PUNCT
iajs-3142	17	6	indicate	indicate	VERB
iajs-3142	17	7	a	a	DET
iajs-3142	17	8	role	role	NOUN
iajs-3142	17	9	in	in	ADP
iajs-3142	17	10	energy	energy	NOUN
iajs-3142	17	11	balance	balance	NOUN
iajs-3142	17	12	and	and	CCONJ
iajs-3142	17	13	the	the	DET
iajs-3142	17	14	regulation	regulation	NOUN
iajs-3142	17	15	of	of	ADP
iajs-3142	17	16	glucose	glucose	NOUN
iajs-3142	17	17	and	and	CCONJ
iajs-3142	17	18	fatty	fatty	NOUN
iajs-3142	17	19	acid	acid	NOUN
iajs-3142	17	20	metabolism	metabolism	NOUN
iajs-3142	17	21	,	,	PUNCT
iajs-3142	17	22	even	even	ADV
iajs-3142	17	23	if	if	SCONJ
iajs-3142	17	24	our	our	PRON
iajs-3142	17	25	understanding	understanding	NOUN
iajs-3142	17	26	of	of	ADP
iajs-3142	17	27	the	the	DET
iajs-3142	17	28	precise	precise	ADJ
iajs-3142	17	29	physiological	physiological	ADJ
iajs-3142	17	30	effects	effect	NOUN
iajs-3142	17	31	of	of	ADP
iajs-3142	17	32	this	this	DET
iajs-3142	17	33	poorly	poorly	ADV
iajs-3142	17	34	characterized	characterize	VERB
iajs-3142	17	35	peptide	peptide	NOUN
iajs-3142	17	36	is	be	AUX
iajs-3142	17	37	still	still	ADV
iajs-3142	17	38	developing	develop	VERB
iajs-3142	17	39	[	[	PUNCT
iajs-3142	17	40	5	5	NUM
iajs-3142	17	41	]	]	PUNCT
iajs-3142	17	42	.	.	PUNCT
iajs-3142	18	1	a	a	DET
iajs-3142	18	2	comparative	comparative	ADJ
iajs-3142	18	3	study	study	NOUN
iajs-3142	18	4	between	between	ADP
iajs-3142	18	5	the	the	DET
iajs-3142	18	6	levels	level	NOUN
iajs-3142	18	7	of	of	ADP
iajs-3142	18	8	adropin	adropin	NOUN
iajs-3142	18	9	in	in	ADP
iajs-3142	18	10	iraqi	iraqi	ADJ
iajs-3142	18	11	women	woman	NOUN
iajs-3142	18	12	with	with	ADP
iajs-3142	18	13	metabolic	metabolic	NOUN
iajs-3142	18	14	syndrome	syndrome	NOUN
iajs-3142	18	15	and	and	CCONJ
iajs-3142	18	16	diabetes	diabetes	NOUN
iajs-3142	18	17	received	receive	VERB
iajs-3142	18	18	14	14	NUM
iajs-3142	18	19	december	december	PROPN
iajs-3142	18	20	2022	2022	NUM
iajs-3142	18	21	,	,	PUNCT
iajs-3142	18	22	received	receive	VERB
iajs-3142	18	23	12	12	NUM
iajs-3142	18	24	february	february	NOUN
iajs-3142	18	25	2023	2023	NUM
iajs-3142	18	26	,	,	PUNCT
iajs-3142	18	27	accepted	accept	VERB
iajs-3142	18	28	20	20	NUM
iajs-3142	18	29	february	february	NOUN
iajs-3142	18	30	2023	2023	NUM
iajs-3142	18	31	,	,	PUNCT
iajs-3142	18	32	published	publish	VERB
iajs-3142	18	33	20	20	NUM
iajs-3142	18	34	january	january	PROPN
iajs-3142	18	35	2024	2024	NUM
iajs-3142	18	36	doi.org/10.30526/37.1.3142	doi.org/10.30526/37.1.3142	NOUN
iajs-3142	18	37	https://creativecommons.org/licenses/by/4.0/	https://creativecommons.org/licenses/by/4.0/	PROPN
iajs-3142	18	38	https://jih.uobaghdad.edu.iq/index.php/j/index#1609-4042	https://jih.uobaghdad.edu.iq/index.php/j/index#1609-4042	NOUN
iajs-3142	18	39	https://jih.uobaghdad.edu.iq/index.php/j/index#2521-3407	https://jih.uobaghdad.edu.iq/index.php/j/index#2521-3407	VERB
iajs-3142	18	40	mailto:rayam.hussein1205a@csw.uobaghdad.edu.iq	mailto:rayam.hussein1205a@csw.uobaghdad.edu.iq	ADJ
iajs-3142	18	41	https://orcid.org/0000-0003-4942-6291	https://orcid.org/0000-0003-4942-6291	NOUN
iajs-3142	18	42	mailto:riyamalazawi3@gmail.com	mailto:riyamalazawi3@gmail.com	PUNCT
iajs-3142	18	43	https://orcid.org/0000-0003-1886-7780	https://orcid.org/0000-0003-1886-7780	PROPN
iajs-3142	18	44	mailto:laylaof_chem@csw.uobaghdad.edu.iq	mailto:laylaof_chem@csw.uobaghdad.edu.iq	NOUN
iajs-3142	18	45	ihjpas	ihjpa	NOUN
iajs-3142	18	46	.	.	PUNCT
iajs-3142	19	1	37	37	NUM
iajs-3142	19	2	(	(	PUNCT
iajs-3142	19	3	1	1	NUM
iajs-3142	19	4	)	)	PUNCT
iajs-3142	19	5	2024	2024	NUM
iajs-3142	19	6	334	334	NUM
iajs-3142	19	7	the	the	DET
iajs-3142	19	8	gene	gene	NOUN
iajs-3142	19	9	encoding	encode	VERB
iajs-3142	19	10	this	this	DET
iajs-3142	19	11	protein	protein	NOUN
iajs-3142	19	12	,	,	PUNCT
iajs-3142	19	13	enho	enho	NOUN
iajs-3142	19	14	,	,	PUNCT
iajs-3142	19	15	is	be	AUX
iajs-3142	19	16	mainly	mainly	ADV
iajs-3142	19	17	expressed	express	VERB
iajs-3142	19	18	in	in	ADP
iajs-3142	19	19	the	the	DET
iajs-3142	19	20	liver	liver	NOUN
iajs-3142	19	21	and	and	CCONJ
iajs-3142	19	22	the	the	DET
iajs-3142	19	23	central	central	ADJ
iajs-3142	19	24	nervous	nervous	ADJ
iajs-3142	19	25	system	system	NOUN
iajs-3142	19	26	.	.	PUNCT
iajs-3142	20	1	adropin	adropin	NOUN
iajs-3142	20	2	,	,	PUNCT
iajs-3142	20	3	however	however	ADV
iajs-3142	20	4	,	,	PUNCT
iajs-3142	20	5	may	may	AUX
iajs-3142	20	6	be	be	AUX
iajs-3142	20	7	a	a	DET
iajs-3142	20	8	membrane	membrane	NOUN
iajs-3142	20	9	-	-	PUNCT
iajs-3142	20	10	bound	bind	VERB
iajs-3142	20	11	protein	protein	NOUN
iajs-3142	20	12	that	that	PRON
iajs-3142	20	13	controls	control	VERB
iajs-3142	20	14	cell	cell	NOUN
iajs-3142	20	15	-	-	PUNCT
iajs-3142	20	16	cell	cell	NOUN
iajs-3142	20	17	communication	communication	NOUN
iajs-3142	20	18	,	,	PUNCT
iajs-3142	20	19	as	as	SCONJ
iajs-3142	20	20	has	have	AUX
iajs-3142	20	21	been	be	AUX
iajs-3142	20	22	proposed	propose	VERB
iajs-3142	20	23	more	more	ADV
iajs-3142	20	24	recently	recently	ADV
iajs-3142	20	25	[	[	X
iajs-3142	20	26	6	6	NUM
iajs-3142	20	27	]	]	PUNCT
iajs-3142	20	28	.	.	PUNCT
iajs-3142	21	1	adropin	adropin	NOUN
iajs-3142	21	2	has	have	AUX
iajs-3142	21	3	also	also	ADV
iajs-3142	21	4	been	be	AUX
iajs-3142	21	5	found	find	VERB
iajs-3142	21	6	in	in	ADP
iajs-3142	21	7	several	several	ADJ
iajs-3142	21	8	physiological	physiological	ADJ
iajs-3142	21	9	fluids	fluid	NOUN
iajs-3142	21	10	and	and	CCONJ
iajs-3142	21	11	tissues	tissue	NOUN
iajs-3142	21	12	,	,	PUNCT
iajs-3142	21	13	including	include	VERB
iajs-3142	21	14	milk	milk	NOUN
iajs-3142	21	15	,	,	PUNCT
iajs-3142	21	16	colostrum	colostrum	NOUN
iajs-3142	21	17	,	,	PUNCT
iajs-3142	21	18	liver	liver	NOUN
iajs-3142	21	19	,	,	PUNCT
iajs-3142	21	20	kidney	kidney	NOUN
iajs-3142	21	21	,	,	PUNCT
iajs-3142	21	22	pancreas	pancrea	NOUN
iajs-3142	21	23	,	,	PUNCT
iajs-3142	21	24	small	small	ADJ
iajs-3142	21	25	intestine	intestine	NOUN
iajs-3142	21	26	,	,	PUNCT
iajs-3142	21	27	endothelial	endothelial	ADJ
iajs-3142	21	28	cells	cell	NOUN
iajs-3142	21	29	,	,	PUNCT
iajs-3142	21	30	brain	brain	NOUN
iajs-3142	21	31	,	,	PUNCT
iajs-3142	21	32	cerebellum	cerebellum	NOUN
iajs-3142	21	33	,	,	PUNCT
iajs-3142	21	34	liver	liver	NOUN
iajs-3142	21	35	,	,	PUNCT
iajs-3142	21	36	kidney	kidney	NOUN
iajs-3142	21	37	,	,	PUNCT
iajs-3142	21	38	and	and	CCONJ
iajs-3142	21	39	heart	heart	NOUN
iajs-3142	21	40	[	[	X
iajs-3142	21	41	7,8	7,8	NUM
iajs-3142	21	42	]	]	PUNCT
iajs-3142	21	43	.	.	PUNCT
iajs-3142	22	1	low	low	ADJ
iajs-3142	22	2	levels	level	NOUN
iajs-3142	22	3	of	of	ADP
iajs-3142	22	4	adropin	adropin	NOUN
iajs-3142	22	5	have	have	AUX
iajs-3142	22	6	been	be	AUX
iajs-3142	22	7	linked	link	VERB
iajs-3142	22	8	to	to	ADP
iajs-3142	22	9	a	a	DET
iajs-3142	22	10	risk	risk	NOUN
iajs-3142	22	11	of	of	ADP
iajs-3142	22	12	dyslipidemia	dyslipidemia	NOUN
iajs-3142	22	13	,	,	PUNCT
iajs-3142	22	14	ir	ir	NOUN
iajs-3142	22	15	,	,	PUNCT
iajs-3142	22	16	and	and	CCONJ
iajs-3142	22	17	other	other	ADJ
iajs-3142	22	18	mets	met	NOUN
iajs-3142	22	19	symptoms	symptom	NOUN
iajs-3142	22	20	[	[	X
iajs-3142	22	21	9	9	NUM
iajs-3142	22	22	]	]	PUNCT
iajs-3142	22	23	.	.	PUNCT
iajs-3142	23	1	age	age	NOUN
iajs-3142	23	2	and	and	CCONJ
iajs-3142	23	3	body	body	NOUN
iajs-3142	23	4	mass	mass	NOUN
iajs-3142	23	5	index	index	NOUN
iajs-3142	23	6	(	(	PUNCT
iajs-3142	23	7	bmi	bmi	PROPN
iajs-3142	23	8	)	)	PUNCT
iajs-3142	23	9	are	be	AUX
iajs-3142	23	10	antagonistic	antagonistic	ADJ
iajs-3142	23	11	to	to	ADP
iajs-3142	23	12	blood	blood	NOUN
iajs-3142	23	13	adropin	adropin	NOUN
iajs-3142	23	14	concentrations	concentration	NOUN
iajs-3142	23	15	[	[	X
iajs-3142	23	16	10	10	NUM
iajs-3142	23	17	]	]	PUNCT
iajs-3142	23	18	.	.	PUNCT
iajs-3142	24	1	adropin	adropin	ADJ
iajs-3142	24	2	levels	level	NOUN
iajs-3142	24	3	are	be	AUX
iajs-3142	24	4	controlled	control	VERB
iajs-3142	24	5	by	by	ADP
iajs-3142	24	6	dietary	dietary	ADJ
iajs-3142	24	7	macronutrients	macronutrient	NOUN
iajs-3142	24	8	during	during	ADP
iajs-3142	24	9	feeding	feed	VERB
iajs-3142	24	10	circumstances	circumstance	NOUN
iajs-3142	24	11	and	and	CCONJ
iajs-3142	24	12	rise	rise	VERB
iajs-3142	24	13	with	with	ADP
iajs-3142	24	14	dietary	dietary	ADJ
iajs-3142	24	15	fat	fat	ADJ
iajs-3142	24	16	content	content	NOUN
iajs-3142	24	17	[	[	X
iajs-3142	24	18	11	11	NUM
iajs-3142	24	19	]	]	PUNCT
iajs-3142	24	20	.	.	PUNCT
iajs-3142	25	1	adropin	adropin	NOUN
iajs-3142	25	2	is	be	AUX
iajs-3142	25	3	not	not	PART
iajs-3142	25	4	necessary	necessary	ADJ
iajs-3142	25	5	for	for	ADP
iajs-3142	25	6	controlling	control	VERB
iajs-3142	25	7	appetite	appetite	NOUN
iajs-3142	25	8	;	;	PUNCT
iajs-3142	25	9	its	its	PRON
iajs-3142	25	10	actions	action	NOUN
iajs-3142	25	11	impact	impact	VERB
iajs-3142	25	12	adiposity	adiposity	NOUN
iajs-3142	25	13	and	and	CCONJ
iajs-3142	25	14	help	help	VERB
iajs-3142	25	15	prevent	prevent	VERB
iajs-3142	25	16	ir	ir	PROPN
iajs-3142	25	17	,	,	PUNCT
iajs-3142	25	18	dyslipidemia	dyslipidemia	NOUN
iajs-3142	25	19	,	,	PUNCT
iajs-3142	25	20	and	and	CCONJ
iajs-3142	25	21	poor	poor	ADJ
iajs-3142	25	22	glucose	glucose	NOUN
iajs-3142	25	23	tolerance	tolerance	NOUN
iajs-3142	25	24	.	.	PUNCT
iajs-3142	26	1	this	this	DET
iajs-3142	26	2	study	study	NOUN
iajs-3142	26	3	aims	aim	VERB
iajs-3142	26	4	to	to	PART
iajs-3142	26	5	compare	compare	VERB
iajs-3142	26	6	adropin	adropin	ADJ
iajs-3142	26	7	levels	level	NOUN
iajs-3142	26	8	in	in	ADP
iajs-3142	26	9	diabetic	diabetic	ADJ
iajs-3142	26	10	females	female	NOUN
iajs-3142	26	11	with	with	ADP
iajs-3142	26	12	and	and	CCONJ
iajs-3142	26	13	without	without	ADP
iajs-3142	26	14	mets	met	NOUN
iajs-3142	26	15	and	and	CCONJ
iajs-3142	26	16	compare	compare	VERB
iajs-3142	26	17	them	they	PRON
iajs-3142	26	18	with	with	ADP
iajs-3142	26	19	the	the	DET
iajs-3142	26	20	control	control	NOUN
iajs-3142	26	21	group	group	NOUN
iajs-3142	26	22	[	[	X
iajs-3142	26	23	12	12	NUM
iajs-3142	26	24	]	]	PUNCT
iajs-3142	26	25	.	.	PUNCT
iajs-3142	27	1	2	2	X
iajs-3142	27	2	.	.	X
iajs-3142	27	3	materials	material	NOUN
iajs-3142	27	4	and	and	CCONJ
iajs-3142	27	5	methods	method	NOUN
iajs-3142	27	6	metabolic	metabolic	NOUN
iajs-3142	27	7	syndrome	syndrome	NOUN
iajs-3142	27	8	criteria	criterion	NOUN
iajs-3142	27	9	includes	include	VERB
iajs-3142	27	10	:	:	PUNCT
iajs-3142	27	11	1	1	NUM
iajs-3142	27	12	)	)	PUNCT
iajs-3142	27	13	triglyceride	triglyceride	ADP
iajs-3142	27	14	levels	level	NOUN
iajs-3142	27	15	above	above	ADP
iajs-3142	27	16	150	150	NUM
iajs-3142	27	17	mg	mg	PROPN
iajs-3142	27	18	/	/	SYM
iajs-3142	27	19	dl	dl	PROPN
iajs-3142	27	20	(	(	PUNCT
iajs-3142	27	21	or	or	CCONJ
iajs-3142	27	22	specific	specific	ADJ
iajs-3142	27	23	treatment	treatment	NOUN
iajs-3142	27	24	for	for	ADP
iajs-3142	27	25	this	this	DET
iajs-3142	27	26	lipid	lipid	NOUN
iajs-3142	27	27	abnormality	abnormality	NOUN
iajs-3142	27	28	)	)	PUNCT
iajs-3142	27	29	.	.	PUNCT
iajs-3142	28	1	2	2	X
iajs-3142	28	2	)	)	PUNCT
iajs-3142	28	3	decrease	decrease	NOUN
iajs-3142	28	4	in	in	ADP
iajs-3142	28	5	hdl	hdl	NOUN
iajs-3142	28	6	-	-	PUNCT
iajs-3142	28	7	cholesterol	cholesterol	NOUN
iajs-3142	28	8	levels	level	NOUN
iajs-3142	28	9	(	(	PUNCT
iajs-3142	28	10	40	40	NUM
iajs-3142	28	11	mg	mg	PROPN
iajs-3142	28	12	/	/	SYM
iajs-3142	28	13	dl	dl	PROPN
iajs-3142	28	14	in	in	ADP
iajs-3142	28	15	men	man	NOUN
iajs-3142	28	16	and	and	CCONJ
iajs-3142	28	17	50	50	NUM
iajs-3142	28	18	mg	mg	PROPN
iajs-3142	28	19	/	/	SYM
iajs-3142	28	20	dl	dl	PROPN
iajs-3142	28	21	in	in	ADP
iajs-3142	28	22	women	woman	NOUN
iajs-3142	28	23	)	)	PUNCT
iajs-3142	28	24	or	or	CCONJ
iajs-3142	28	25	treatment	treatment	NOUN
iajs-3142	28	26	for	for	ADP
iajs-3142	28	27	this	this	DET
iajs-3142	28	28	lipid	lipid	NOUN
iajs-3142	28	29	abnormality	abnormality	NOUN
iajs-3142	28	30	.	.	PUNCT
iajs-3142	29	1	3	3	X
iajs-3142	29	2	)	)	PUNCT
iajs-3142	29	3	high	high	ADJ
iajs-3142	29	4	bp	bp	PROPN
iajs-3142	29	5	;	;	PUNCT
iajs-3142	29	6	systolic	systolic	ADJ
iajs-3142	29	7	or	or	CCONJ
iajs-3142	29	8	diastolic	diastolic	ADJ
iajs-3142	29	9	readings	reading	NOUN
iajs-3142	29	10	of	of	ADP
iajs-3142	29	11	130	130	NUM
iajs-3142	29	12	or	or	CCONJ
iajs-3142	29	13	more	more	ADJ
iajs-3142	29	14	millimeters	millimeter	NOUN
iajs-3142	29	15	mercury	mercury	NOUN
iajs-3142	29	16	;	;	PUNCT
iajs-3142	29	17	or	or	CCONJ
iajs-3142	29	18	(	(	PUNCT
iajs-3142	29	19	having	having	AUX
iajs-3142	29	20	been	be	AUX
iajs-3142	29	21	diagnosed	diagnose	VERB
iajs-3142	29	22	with	with	ADP
iajs-3142	29	23	hypertension	hypertension	NOUN
iajs-3142	29	24	and	and	CCONJ
iajs-3142	29	25	were	be	AUX
iajs-3142	29	26	treated	treat	VERB
iajs-3142	29	27	)	)	PUNCT
iajs-3142	29	28	.	.	PUNCT
iajs-3142	30	1	4	4	X
iajs-3142	30	2	)	)	PUNCT
iajs-3142	30	3	higher	high	ADJ
iajs-3142	30	4	than	than	ADP
iajs-3142	30	5	normal	normal	ADJ
iajs-3142	30	6	fasting	fast	VERB
iajs-3142	30	7	blood	blood	NOUN
iajs-3142	30	8	glucose	glucose	NOUN
iajs-3142	30	9	(	(	PUNCT
iajs-3142	30	10	fbg	fbg	NOUN
iajs-3142	30	11	;	;	PUNCT
iajs-3142	30	12	110	110	NUM
iajs-3142	30	13	mg	mg	PROPN
iajs-3142	30	14	/	/	SYM
iajs-3142	30	15	dl	dl	PROPN
iajs-3142	30	16	)	)	PUNCT
iajs-3142	30	17	or	or	CCONJ
iajs-3142	30	18	have	have	AUX
iajs-3142	30	19	been	be	AUX
iajs-3142	30	20	given	give	VERB
iajs-3142	30	21	a	a	DET
iajs-3142	30	22	type	type	NOUN
iajs-3142	30	23	ii	ii	NOUN
iajs-3142	30	24	diabetes	diabetes	NOUN
iajs-3142	30	25	diagnosis	diagnosis	NOUN
iajs-3142	30	26	.	.	PUNCT
iajs-3142	31	1	patients	patient	NOUN
iajs-3142	31	2	with	with	ADP
iajs-3142	31	3	type	type	NOUN
iajs-3142	31	4	2	2	NUM
iajs-3142	31	5	diabetes	diabetes	NOUN
iajs-3142	31	6	mellitus	mellitus	NOUN
iajs-3142	31	7	(	(	PUNCT
iajs-3142	31	8	t2	t2	NOUN
iajs-3142	31	9	dm	dm	NOUN
iajs-3142	31	10	)	)	PUNCT
iajs-3142	31	11	using	use	VERB
iajs-3142	31	12	insulin	insulin	NOUN
iajs-3142	31	13	as	as	ADP
iajs-3142	31	14	hypoglycemic	hypoglycemic	ADJ
iajs-3142	31	15	therapy	therapy	NOUN
iajs-3142	31	16	,	,	PUNCT
iajs-3142	31	17	acromegaly	acromegaly	NOUN
iajs-3142	31	18	,	,	PUNCT
iajs-3142	31	19	and	and	CCONJ
iajs-3142	31	20	chronic	chronic	ADJ
iajs-3142	31	21	liver	liver	NOUN
iajs-3142	31	22	and	and	CCONJ
iajs-3142	31	23	renal	renal	ADJ
iajs-3142	31	24	disorders	disorder	NOUN
iajs-3142	31	25	were	be	AUX
iajs-3142	31	26	excluded	exclude	VERB
iajs-3142	31	27	from	from	ADP
iajs-3142	31	28	the	the	DET
iajs-3142	31	29	study	study	NOUN
iajs-3142	31	30	[	[	X
iajs-3142	31	31	6	6	NUM
iajs-3142	31	32	]	]	PUNCT
iajs-3142	31	33	.	.	PUNCT
iajs-3142	32	1	2.1	2.1	NUM
iajs-3142	32	2	blood	blood	NOUN
iajs-3142	32	3	sample	sample	NOUN
iajs-3142	32	4	collection	collection	NOUN
iajs-3142	32	5	after	after	ADP
iajs-3142	32	6	10–12	10–12	NUM
iajs-3142	32	7	hours	hour	NOUN
iajs-3142	32	8	,	,	PUNCT
iajs-3142	32	9	ten	ten	NUM
iajs-3142	32	10	milliliters	milliliter	NOUN
iajs-3142	32	11	of	of	ADP
iajs-3142	32	12	venous	venous	ADJ
iajs-3142	32	13	blood	blood	NOUN
iajs-3142	32	14	were	be	AUX
iajs-3142	32	15	collected	collect	VERB
iajs-3142	32	16	and	and	CCONJ
iajs-3142	32	17	divided	divide	VERB
iajs-3142	32	18	into	into	ADP
iajs-3142	32	19	two	two	NUM
iajs-3142	32	20	aliquots	aliquot	NOUN
iajs-3142	32	21	.	.	PUNCT
iajs-3142	33	1	the	the	DET
iajs-3142	33	2	samples	sample	NOUN
iajs-3142	33	3	were	be	AUX
iajs-3142	33	4	centrifuged	centrifuge	VERB
iajs-3142	33	5	at	at	ADP
iajs-3142	33	6	1500	1500	NUM
iajs-3142	33	7	g	g	NOUN
iajs-3142	33	8	for	for	ADP
iajs-3142	33	9	15	15	NUM
iajs-3142	33	10	minutes	minute	NOUN
iajs-3142	33	11	after	after	ADP
iajs-3142	33	12	an	an	DET
iajs-3142	33	13	incubation	incubation	NOUN
iajs-3142	33	14	period	period	NOUN
iajs-3142	33	15	of	of	ADP
iajs-3142	33	16	30	30	NUM
iajs-3142	33	17	minutes	minute	NOUN
iajs-3142	33	18	.	.	PUNCT
iajs-3142	34	1	a	a	DET
iajs-3142	34	2	part	part	NOUN
iajs-3142	34	3	of	of	ADP
iajs-3142	34	4	the	the	DET
iajs-3142	34	5	acquired	acquire	VERB
iajs-3142	34	6	serum	serum	NOUN
iajs-3142	34	7	was	be	AUX
iajs-3142	34	8	employed	employ	VERB
iajs-3142	34	9	to	to	PART
iajs-3142	34	10	estimate	estimate	VERB
iajs-3142	34	11	the	the	DET
iajs-3142	34	12	lipid	lipid	NOUN
iajs-3142	34	13	profile	profile	NOUN
iajs-3142	34	14	.	.	PUNCT
iajs-3142	35	1	the	the	DET
iajs-3142	35	2	following	follow	VERB
iajs-3142	35	3	analysis	analysis	NOUN
iajs-3142	35	4	used	use	VERB
iajs-3142	35	5	the	the	DET
iajs-3142	35	6	second	second	ADJ
iajs-3142	35	7	serum	serum	NOUN
iajs-3142	35	8	component	component	NOUN
iajs-3142	35	9	to	to	PART
iajs-3142	35	10	measure	measure	VERB
iajs-3142	35	11	fasting	fast	VERB
iajs-3142	35	12	serum	serum	NOUN
iajs-3142	35	13	insulin	insulin	NOUN
iajs-3142	35	14	.	.	PUNCT
iajs-3142	36	1	weight	weight	NOUN
iajs-3142	36	2	(	(	PUNCT
iajs-3142	36	3	in	in	ADP
iajs-3142	36	4	kilograms	kilogram	NOUN
iajs-3142	36	5	)	)	PUNCT
iajs-3142	36	6	,	,	PUNCT
iajs-3142	36	7	height	height	NOUN
iajs-3142	36	8	(	(	PUNCT
iajs-3142	36	9	in	in	ADP
iajs-3142	36	10	centimeters	centimeter	NOUN
iajs-3142	36	11	)	)	PUNCT
iajs-3142	36	12	,	,	PUNCT
iajs-3142	36	13	and	and	CCONJ
iajs-3142	36	14	waist	waist	NOUN
iajs-3142	36	15	circumference	circumference	NOUN
iajs-3142	36	16	(	(	PUNCT
iajs-3142	36	17	in	in	ADP
iajs-3142	36	18	centimeters	centimeter	NOUN
iajs-3142	36	19	)	)	PUNCT
iajs-3142	36	20	were	be	AUX
iajs-3142	36	21	assessed	assess	VERB
iajs-3142	36	22	for	for	ADP
iajs-3142	36	23	each	each	DET
iajs-3142	36	24	subject	subject	NOUN
iajs-3142	36	25	.	.	PUNCT
iajs-3142	37	1	body	body	NOUN
iajs-3142	37	2	mass	mass	PROPN
iajs-3142	37	3	index	index	NOUN
iajs-3142	37	4	(	(	PUNCT
iajs-3142	37	5	bmi	bmi	PROPN
iajs-3142	37	6	)	)	PUNCT
iajs-3142	37	7	was	be	AUX
iajs-3142	37	8	calculated	calculate	VERB
iajs-3142	37	9	by	by	ADP
iajs-3142	37	10	dividing	divide	VERB
iajs-3142	37	11	weight	weight	NOUN
iajs-3142	37	12	(	(	PUNCT
iajs-3142	37	13	in	in	ADP
iajs-3142	37	14	kilograms	kilogram	NOUN
iajs-3142	37	15	)	)	PUNCT
iajs-3142	37	16	by	by	ADP
iajs-3142	37	17	the	the	DET
iajs-3142	37	18	square	square	NOUN
iajs-3142	37	19	of	of	ADP
iajs-3142	37	20	height	height	NOUN
iajs-3142	37	21	(	(	PUNCT
iajs-3142	37	22	m2	m2	PROPN
iajs-3142	37	23	)	)	PUNCT
iajs-3142	37	24	or	or	CCONJ
iajs-3142	37	25	waist	waist	NOUN
iajs-3142	37	26	-	-	PUNCT
iajs-3142	37	27	to	to	ADP
iajs-3142	37	28	-	-	PUNCT
iajs-3142	37	29	hip	hip	NOUN
iajs-3142	37	30	ratio	ratio	NOUN
iajs-3142	37	31	(	(	PUNCT
iajs-3142	37	32	whr	whr	PROPN
iajs-3142	37	33	)	)	PUNCT
iajs-3142	37	34	.	.	PUNCT
iajs-3142	38	1	the	the	DET
iajs-3142	38	2	bmi	bmi	NOUN
iajs-3142	38	3	was	be	AUX
iajs-3142	38	4	calculated	calculate	VERB
iajs-3142	38	5	by	by	ADP
iajs-3142	38	6	dividing	divide	VERB
iajs-3142	38	7	weight	weight	NOUN
iajs-3142	38	8	(	(	PUNCT
iajs-3142	38	9	in	in	ADP
iajs-3142	38	10	kilograms	kilogram	NOUN
iajs-3142	38	11	)	)	PUNCT
iajs-3142	38	12	by	by	ADP
iajs-3142	38	13	the	the	DET
iajs-3142	38	14	square	square	NOUN
iajs-3142	38	15	of	of	ADP
iajs-3142	38	16	height	height	NOUN
iajs-3142	38	17	(	(	PUNCT
iajs-3142	38	18	m2	m2	PROPN
iajs-3142	38	19	)	)	PUNCT
iajs-3142	39	1	[	[	X
iajs-3142	39	2	13	13	NUM
iajs-3142	39	3	]	]	PUNCT
iajs-3142	39	4	.	.	PUNCT
iajs-3142	40	1	in	in	ADP
iajs-3142	40	2	a	a	DET
iajs-3142	40	3	seated	seated	ADJ
iajs-3142	40	4	position	position	NOUN
iajs-3142	40	5	,	,	PUNCT
iajs-3142	40	6	the	the	DET
iajs-3142	40	7	systolic	systolic	ADJ
iajs-3142	40	8	and	and	CCONJ
iajs-3142	40	9	diastolic	diastolic	ADJ
iajs-3142	40	10	blood	blood	NOUN
iajs-3142	40	11	pressures	pressure	NOUN
iajs-3142	40	12	(	(	PUNCT
iajs-3142	40	13	sbp	sbp	PROPN
iajs-3142	40	14	,	,	PUNCT
iajs-3142	40	15	dbp	dbp	PROPN
iajs-3142	40	16	)	)	PUNCT
iajs-3142	40	17	(	(	PUNCT
iajs-3142	40	18	measured	measure	VERB
iajs-3142	40	19	in	in	ADP
iajs-3142	40	20	mmhg	mmhg	PROPN
iajs-3142	40	21	)	)	PUNCT
iajs-3142	40	22	were	be	AUX
iajs-3142	40	23	taken	take	VERB
iajs-3142	40	24	using	use	VERB
iajs-3142	40	25	a	a	DET
iajs-3142	40	26	mercury	mercury	NOUN
iajs-3142	40	27	sphygmomanometer	sphygmomanometer	NOUN
iajs-3142	40	28	.	.	PUNCT
iajs-3142	41	1	from	from	ADP
iajs-3142	41	2	these	these	DET
iajs-3142	41	3	observations	observation	NOUN
iajs-3142	41	4	,	,	PUNCT
iajs-3142	41	5	the	the	DET
iajs-3142	41	6	mean	mean	ADJ
iajs-3142	41	7	arterial	arterial	ADJ
iajs-3142	41	8	pressure	pressure	NOUN
iajs-3142	41	9	(	(	PUNCT
iajs-3142	41	10	map	map	NOUN
iajs-3142	41	11	)	)	PUNCT
iajs-3142	41	12	was	be	AUX
iajs-3142	41	13	computed	compute	VERB
iajs-3142	41	14	using	use	VERB
iajs-3142	41	15	the	the	DET
iajs-3142	41	16	formula	formula	NOUN
iajs-3142	41	17	below	below	ADV
iajs-3142	41	18	for	for	ADP
iajs-3142	41	19	calculating	calculate	VERB
iajs-3142	41	20	the	the	DET
iajs-3142	41	21	average	average	ADJ
iajs-3142	41	22	pressure	pressure	NOUN
iajs-3142	41	23	:	:	PUNCT
iajs-3142	41	24	map=	map=	PROPN
iajs-3142	41	25	[	[	X
iajs-3142	41	26	dbp	dbp	PROPN
iajs-3142	41	27	+	+	CCONJ
iajs-3142	41	28	sbp	sbp	PROPN
iajs-3142	41	29	-	-	PUNCT
iajs-3142	41	30	dbp)/3	dbp)/3	PROPN
iajs-3142	41	31	]	]	PUNCT
iajs-3142	42	1	[	[	X
iajs-3142	42	2	14	14	NUM
iajs-3142	42	3	]	]	PUNCT
iajs-3142	42	4	.	.	PUNCT
iajs-3142	43	1	an	an	DET
iajs-3142	43	2	elisa	elisa	NOUN
iajs-3142	43	3	kit	kit	NOUN
iajs-3142	43	4	was	be	AUX
iajs-3142	43	5	used	use	VERB
iajs-3142	43	6	to	to	PART
iajs-3142	43	7	estimate	estimate	VERB
iajs-3142	43	8	the	the	DET
iajs-3142	43	9	adropin	adropin	ADJ
iajs-3142	43	10	level	level	NOUN
iajs-3142	43	11	(	(	PUNCT
iajs-3142	43	12	mybiosource	mybiosource	PROPN
iajs-3142	43	13	,	,	PUNCT
iajs-3142	43	14	america	america	PROPN
iajs-3142	43	15	)	)	PUNCT
iajs-3142	43	16	.	.	PUNCT
iajs-3142	44	1	ihjpas	ihjpas	PROPN
iajs-3142	44	2	.	.	PUNCT
iajs-3142	45	1	37(1)2024	37(1)2024	NUM
iajs-3142	45	2	335	335	NUM
iajs-3142	45	3	2.2	2.2	NUM
iajs-3142	45	4	statistical	statistical	ADJ
iajs-3142	45	5	analysis	analysis	NOUN
iajs-3142	45	6	the	the	DET
iajs-3142	45	7	median	median	NOUN
iajs-3142	45	8	(	(	PUNCT
iajs-3142	45	9	25th	25th	ADJ
iajs-3142	45	10	and	and	CCONJ
iajs-3142	45	11	75th	75th	ADJ
iajs-3142	45	12	percentiles	percentile	NOUN
iajs-3142	45	13	)	)	PUNCT
iajs-3142	45	14	for	for	ADP
iajs-3142	45	15	numerical	numerical	ADJ
iajs-3142	45	16	variables	variable	NOUN
iajs-3142	45	17	with	with	ADP
iajs-3142	45	18	an	an	DET
iajs-3142	45	19	abnormal	abnormal	ADJ
iajs-3142	45	20	distribution	distribution	NOUN
iajs-3142	45	21	is	be	AUX
iajs-3142	45	22	used	use	VERB
iajs-3142	45	23	to	to	PART
iajs-3142	45	24	interpret	interpret	VERB
iajs-3142	45	25	the	the	DET
iajs-3142	45	26	data	datum	NOUN
iajs-3142	45	27	.	.	PUNCT
iajs-3142	46	1	the	the	DET
iajs-3142	46	2	shapiro	shapiro	PROPN
iajs-3142	46	3	-	-	PUNCT
iajs-3142	46	4	wilk	wilk	NOUN
iajs-3142	46	5	test	test	NOUN
iajs-3142	46	6	was	be	AUX
iajs-3142	46	7	applied	apply	VERB
iajs-3142	46	8	to	to	PART
iajs-3142	46	9	check	check	VERB
iajs-3142	46	10	if	if	SCONJ
iajs-3142	46	11	the	the	DET
iajs-3142	46	12	data	datum	NOUN
iajs-3142	46	13	were	be	AUX
iajs-3142	46	14	distributed	distribute	VERB
iajs-3142	46	15	normally	normally	ADV
iajs-3142	46	16	.	.	PUNCT
iajs-3142	47	1	the	the	DET
iajs-3142	47	2	(	(	PUNCT
iajs-3142	47	3	mann	mann	PROPN
iajs-3142	47	4	-	-	PUNCT
iajs-3142	47	5	whitney	whitney	PROPN
iajs-3142	47	6	)	)	PUNCT
iajs-3142	47	7	test	test	NOUN
iajs-3142	47	8	was	be	AUX
iajs-3142	47	9	employed	employ	VERB
iajs-3142	47	10	to	to	PART
iajs-3142	47	11	describe	describe	VERB
iajs-3142	47	12	numerical	numerical	ADJ
iajs-3142	47	13	variables	variable	NOUN
iajs-3142	47	14	that	that	PRON
iajs-3142	47	15	were	be	AUX
iajs-3142	47	16	not	not	PART
iajs-3142	47	17	regularly	regularly	ADV
iajs-3142	47	18	distributed	distribute	VERB
iajs-3142	47	19	.	.	PUNCT
iajs-3142	48	1	the	the	DET
iajs-3142	48	2	significance	significance	NOUN
iajs-3142	48	3	level	level	NOUN
iajs-3142	48	4	was	be	AUX
iajs-3142	48	5	set	set	VERB
iajs-3142	48	6	at	at	ADP
iajs-3142	48	7	a	a	DET
iajs-3142	48	8	p	p	NOUN
iajs-3142	48	9	-	-	PUNCT
iajs-3142	48	10	value	value	NOUN
iajs-3142	48	11	of	of	ADP
iajs-3142	48	12	0.05	0.05	NUM
iajs-3142	48	13	.	.	PUNCT
iajs-3142	49	1	moreover	moreover	ADV
iajs-3142	49	2	,	,	PUNCT
iajs-3142	49	3	receiver	receiver	ADJ
iajs-3142	49	4	operating	operate	VERB
iajs-3142	49	5	characteristic	characteristic	NOUN
iajs-3142	49	6	(	(	PUNCT
iajs-3142	49	7	roc	roc	PROPN
iajs-3142	49	8	)	)	PUNCT
iajs-3142	49	9	was	be	AUX
iajs-3142	49	10	used	use	VERB
iajs-3142	49	11	to	to	PART
iajs-3142	49	12	estimate	estimate	VERB
iajs-3142	49	13	the	the	DET
iajs-3142	49	14	adropin	adropin	NOUN
iajs-3142	49	15	cut	cut	VERB
iajs-3142	49	16	-	-	PUNCT
iajs-3142	49	17	off	off	ADP
iajs-3142	49	18	value	value	NOUN
iajs-3142	49	19	.	.	PUNCT
iajs-3142	50	1	3	3	X
iajs-3142	50	2	.	.	X
iajs-3142	50	3	results	result	VERB
iajs-3142	50	4	the	the	DET
iajs-3142	50	5	median	median	NOUN
iajs-3142	50	6	(	(	PUNCT
iajs-3142	50	7	25th	25th	ADJ
iajs-3142	50	8	and	and	CCONJ
iajs-3142	50	9	75th	75th	ADJ
iajs-3142	50	10	percentiles	percentile	NOUN
iajs-3142	50	11	)	)	PUNCT
iajs-3142	50	12	of	of	ADP
iajs-3142	50	13	age	age	NOUN
iajs-3142	50	14	and	and	CCONJ
iajs-3142	50	15	bmi	bmi	NOUN
iajs-3142	50	16	for	for	ADP
iajs-3142	50	17	mets	met	NOUN
iajs-3142	50	18	,	,	PUNCT
iajs-3142	50	19	t2	t2	NOUN
iajs-3142	50	20	dm	dm	NOUN
iajs-3142	50	21	patients	patient	NOUN
iajs-3142	50	22	,	,	PUNCT
iajs-3142	50	23	and	and	CCONJ
iajs-3142	50	24	control	control	NOUN
iajs-3142	50	25	are	be	AUX
iajs-3142	50	26	listed	list	VERB
iajs-3142	50	27	in	in	ADP
iajs-3142	50	28	table	table	NOUN
iajs-3142	50	29	1	1	NUM
iajs-3142	50	30	.	.	PUNCT
iajs-3142	50	31	age	age	NOUN
iajs-3142	50	32	in	in	ADP
iajs-3142	50	33	patients	patient	NOUN
iajs-3142	50	34	with	with	ADP
iajs-3142	50	35	mets	met	NOUN
iajs-3142	50	36	was	be	AUX
iajs-3142	50	37	49.0	49.0	NUM
iajs-3142	50	38	(	(	PUNCT
iajs-3142	50	39	39.75–53.0	39.75–53.0	NUM
iajs-3142	50	40	)	)	PUNCT
iajs-3142	50	41	,	,	PUNCT
iajs-3142	50	42	in	in	ADP
iajs-3142	50	43	t2	t2	NOUN
iajs-3142	50	44	dm	dm	NUM
iajs-3142	50	45	was	be	AUX
iajs-3142	50	46	48.50	48.50	NUM
iajs-3142	50	47	(	(	PUNCT
iajs-3142	50	48	51.25–60.0	51.25–60.0	NUM
iajs-3142	50	49	)	)	PUNCT
iajs-3142	50	50	,	,	PUNCT
iajs-3142	50	51	and	and	CCONJ
iajs-3142	50	52	in	in	ADP
iajs-3142	50	53	the	the	DET
iajs-3142	50	54	control	control	NOUN
iajs-3142	50	55	group	group	NOUN
iajs-3142	50	56	was	be	AUX
iajs-3142	50	57	46.50	46.50	NUM
iajs-3142	50	58	(	(	PUNCT
iajs-3142	50	59	38.0–52.0	38.0–52.0	NUM
iajs-3142	50	60	)	)	PUNCT
iajs-3142	50	61	.	.	PUNCT
iajs-3142	51	1	the	the	DET
iajs-3142	51	2	bmi	bmi	NOUN
iajs-3142	51	3	distribution	distribution	NOUN
iajs-3142	51	4	of	of	ADP
iajs-3142	51	5	the	the	DET
iajs-3142	51	6	mets	met	NOUN
iajs-3142	51	7	was	be	AUX
iajs-3142	51	8	31.50	31.50	NUM
iajs-3142	51	9	(	(	PUNCT
iajs-3142	51	10	30.0–35.0	30.0–35.0	NUM
iajs-3142	51	11	)	)	PUNCT
iajs-3142	51	12	,	,	PUNCT
iajs-3142	51	13	29.0	29.0	NUM
iajs-3142	51	14	(	(	PUNCT
iajs-3142	51	15	27.0–35.0	27.0–35.0	NUM
iajs-3142	51	16	)	)	PUNCT
iajs-3142	51	17	in	in	ADP
iajs-3142	51	18	t2	t2	NOUN
iajs-3142	51	19	dm	dm	NUM
iajs-3142	51	20	patients	patient	NOUN
iajs-3142	51	21	,	,	PUNCT
iajs-3142	51	22	and	and	CCONJ
iajs-3142	51	23	24.0	24.0	NUM
iajs-3142	51	24	(	(	PUNCT
iajs-3142	51	25	24.0–25.0	24.0–25.0	NUM
iajs-3142	51	26	)	)	PUNCT
iajs-3142	51	27	in	in	ADP
iajs-3142	51	28	the	the	DET
iajs-3142	51	29	healthy	healthy	ADJ
iajs-3142	51	30	subjects	subject	NOUN
iajs-3142	51	31	.	.	PUNCT
iajs-3142	52	1	the	the	DET
iajs-3142	52	2	data	datum	NOUN
iajs-3142	52	3	of	of	ADP
iajs-3142	52	4	the	the	DET
iajs-3142	52	5	whr	whr	PROPN
iajs-3142	52	6	distribution	distribution	NOUN
iajs-3142	52	7	of	of	ADP
iajs-3142	52	8	the	the	DET
iajs-3142	52	9	mets	met	NOUN
iajs-3142	52	10	was	be	AUX
iajs-3142	52	11	0.94	0.94	NUM
iajs-3142	52	12	(	(	PUNCT
iajs-3142	52	13	0.89–1.01	0.89–1.01	ADJ
iajs-3142	52	14	)	)	PUNCT
iajs-3142	52	15	,	,	PUNCT
iajs-3142	52	16	t2	t2	NOUN
iajs-3142	52	17	dm	dm	PROPN
iajs-3142	52	18	patients	patient	NOUN
iajs-3142	52	19	was	be	AUX
iajs-3142	52	20	0.98	0.98	NUM
iajs-3142	52	21	(	(	PUNCT
iajs-3142	52	22	0.94–1.03	0.94–1.03	NUM
iajs-3142	52	23	)	)	PUNCT
iajs-3142	52	24	,	,	PUNCT
iajs-3142	52	25	and	and	CCONJ
iajs-3142	52	26	the	the	DET
iajs-3142	52	27	healthy	healthy	ADJ
iajs-3142	52	28	subjects	subject	NOUN
iajs-3142	52	29	group	group	NOUN
iajs-3142	52	30	was	be	AUX
iajs-3142	52	31	(	(	PUNCT
iajs-3142	52	32	0.83–0.84	0.83–0.84	NUM
iajs-3142	52	33	)	)	PUNCT
iajs-3142	52	34	.	.	PUNCT
iajs-3142	53	1	table	table	NOUN
iajs-3142	53	2	1	1	NUM
iajs-3142	53	3	.	.	PUNCT
iajs-3142	54	1	the	the	DET
iajs-3142	54	2	demographic	demographic	ADJ
iajs-3142	54	3	characteristics	characteristic	NOUN
iajs-3142	54	4	of	of	ADP
iajs-3142	54	5	patients	patient	NOUN
iajs-3142	54	6	and	and	CCONJ
iajs-3142	54	7	control	control	NOUN
iajs-3142	54	8	group	group	NOUN
iajs-3142	54	9	variables	variable	VERB
iajs-3142	54	10	median	median	ADJ
iajs-3142	54	11	mets	met	NOUN
iajs-3142	54	12	(	(	PUNCT
iajs-3142	54	13	n=	n=	ADJ
iajs-3142	54	14	40	40	NUM
iajs-3142	54	15	)	)	PUNCT
iajs-3142	54	16	t2	t2	NOUN
iajs-3142	54	17	dm	dm	PROPN
iajs-3142	54	18	(	(	PUNCT
iajs-3142	54	19	n=	n=	ADJ
iajs-3142	54	20	40	40	NUM
iajs-3142	54	21	)	)	PUNCT
iajs-3142	54	22	control	control	NOUN
iajs-3142	54	23	(	(	PUNCT
iajs-3142	54	24	n=	n=	ADJ
iajs-3142	54	25	40	40	NUM
iajs-3142	54	26	)	)	PUNCT
iajs-3142	54	27	age	age	NOUN
iajs-3142	54	28	(	(	PUNCT
iajs-3142	54	29	years	year	NOUN
iajs-3142	54	30	)	)	PUNCT
iajs-3142	54	31	49.0(39.75	49.0(39.75	PROPN
iajs-3142	54	32	-53.0	-53.0	NUM
iajs-3142	54	33	)	)	PUNCT
iajs-3142	54	34	48.50(51.25	48.50(51.25	NUM
iajs-3142	54	35	-	-	PUNCT
iajs-3142	54	36	60.0)b	60.0)b	NUM
iajs-3142	54	37	46.50	46.50	NUM
iajs-3142	54	38	(	(	PUNCT
iajs-3142	54	39	38.0	38.0	NUM
iajs-3142	54	40	–	–	PUNCT
iajs-3142	54	41	52.0	52.0	NUM
iajs-3142	54	42	)	)	PUNCT
iajs-3142	54	43	bmi	bmi	NOUN
iajs-3142	54	44	31.50	31.50	NUM
iajs-3142	54	45	(	(	PUNCT
iajs-3142	54	46	30.0	30.0	NUM
iajs-3142	54	47	–	–	PUNCT
iajs-3142	54	48	35.0)a	35.0)a	NUM
iajs-3142	54	49	,	,	PUNCT
iajs-3142	54	50	c	c	NOUN
iajs-3142	54	51	29.0(27.0	29.0(27.0	NUM
iajs-3142	54	52	-	-	SYM
iajs-3142	54	53	35.0)b	35.0)b	NUM
iajs-3142	54	54	,	,	PUNCT
iajs-3142	54	55	c	c	PROPN
iajs-3142	54	56	24.0	24.0	NUM
iajs-3142	54	57	(	(	PUNCT
iajs-3142	54	58	23.0	23.0	NUM
iajs-3142	54	59	–	–	PUNCT
iajs-3142	54	60	25.0	25.0	NUM
iajs-3142	54	61	)	)	PUNCT
iajs-3142	54	62	whr	whr	PROPN
iajs-3142	54	63	0.94	0.94	NUM
iajs-3142	54	64	(	(	PUNCT
iajs-3142	54	65	0.89	0.89	NUM
iajs-3142	54	66	–	–	PUNCT
iajs-3142	54	67	1.01	1.01	NUM
iajs-3142	54	68	)	)	PUNCT
iajs-3142	54	69	a	a	PRON
iajs-3142	54	70	,	,	PUNCT
iajs-3142	54	71	c	c	NOUN
iajs-3142	54	72	0.98(0.94	0.98(0.94	NOUN
iajs-3142	54	73	-	-	PUNCT
iajs-3142	54	74	1.03)c	1.03)c	NUM
iajs-3142	54	75	0.83	0.83	NUM
iajs-3142	54	76	(	(	PUNCT
iajs-3142	54	77	0.80	0.80	NUM
iajs-3142	54	78	–	–	PUNCT
iajs-3142	54	79	0.84	0.84	NUM
iajs-3142	54	80	)	)	PUNCT
iajs-3142	54	81	the	the	DET
iajs-3142	54	82	median	median	NOUN
iajs-3142	54	83	(	(	PUNCT
iajs-3142	54	84	25th	25th	ADJ
iajs-3142	54	85	and	and	CCONJ
iajs-3142	54	86	75th	75th	ADJ
iajs-3142	54	87	percentiles	percentile	NOUN
iajs-3142	54	88	)	)	PUNCT
iajs-3142	54	89	of	of	ADP
iajs-3142	54	90	the	the	DET
iajs-3142	54	91	obtained	obtain	VERB
iajs-3142	54	92	data	datum	NOUN
iajs-3142	54	93	were	be	AUX
iajs-3142	54	94	evaluated	evaluate	VERB
iajs-3142	54	95	using	use	VERB
iajs-3142	54	96	the	the	DET
iajs-3142	54	97	mann	mann	PROPN
iajs-3142	54	98	-	-	PUNCT
iajs-3142	54	99	whitney	whitney	PROPN
iajs-3142	54	100	test	test	NOUN
iajs-3142	54	101	at	at	ADP
iajs-3142	54	102	the	the	DET
iajs-3142	54	103	0.05	0.05	NUM
iajs-3142	54	104	threshold	threshold	NOUN
iajs-3142	54	105	;	;	PUNCT
iajs-3142	54	106	there	there	PRON
iajs-3142	54	107	was	be	VERB
iajs-3142	54	108	a	a	DET
iajs-3142	54	109	significant	significant	ADJ
iajs-3142	54	110	difference	difference	NOUN
iajs-3142	54	111	between	between	ADP
iajs-3142	54	112	the	the	DET
iajs-3142	54	113	two	two	NUM
iajs-3142	54	114	independent	independent	ADJ
iajs-3142	54	115	means	mean	NOUN
iajs-3142	54	116	.	.	PUNCT
iajs-3142	55	1	a	a	PRON
iajs-3142	55	2	)	)	PUNCT
iajs-3142	55	3	show	show	VERB
iajs-3142	55	4	how	how	SCONJ
iajs-3142	55	5	mets	met	NOUN
iajs-3142	55	6	group	group	NOUN
iajs-3142	55	7	and	and	CCONJ
iajs-3142	55	8	control	control	NOUN
iajs-3142	55	9	differ	differ	VERB
iajs-3142	55	10	significantly	significantly	ADV
iajs-3142	55	11	from	from	ADP
iajs-3142	55	12	each	each	DET
iajs-3142	55	13	other	other	ADJ
iajs-3142	55	14	.	.	PUNCT
iajs-3142	56	1	b	b	X
iajs-3142	56	2	)	)	PUNCT
iajs-3142	56	3	show	show	VERB
iajs-3142	56	4	that	that	SCONJ
iajs-3142	56	5	the	the	DET
iajs-3142	56	6	t2	t2	NOUN
iajs-3142	56	7	dm	dm	PROPN
iajs-3142	56	8	group	group	NOUN
iajs-3142	56	9	and	and	CCONJ
iajs-3142	56	10	control	control	NOUN
iajs-3142	56	11	have	have	VERB
iajs-3142	56	12	a	a	DET
iajs-3142	56	13	significant	significant	ADJ
iajs-3142	56	14	difference	difference	NOUN
iajs-3142	56	15	.	.	PUNCT
iajs-3142	57	1	c	c	X
iajs-3142	57	2	)	)	PUNCT
iajs-3142	57	3	show	show	VERB
iajs-3142	57	4	that	that	SCONJ
iajs-3142	57	5	the	the	DET
iajs-3142	57	6	mets	mets	PROPN
iajs-3142	57	7	group	group	NOUN
iajs-3142	57	8	and	and	CCONJ
iajs-3142	57	9	the	the	DET
iajs-3142	57	10	t2	t2	NOUN
iajs-3142	57	11	dm	dm	PROPN
iajs-3142	57	12	group	group	NOUN
iajs-3142	57	13	have	have	VERB
iajs-3142	57	14	important	important	ADJ
iajs-3142	57	15	differences	difference	NOUN
iajs-3142	57	16	.	.	PUNCT
iajs-3142	58	1	table	table	NOUN
iajs-3142	58	2	2	2	NUM
iajs-3142	58	3	shows	show	VERB
iajs-3142	58	4	the	the	DET
iajs-3142	58	5	serum	serum	NOUN
iajs-3142	58	6	levels	level	NOUN
iajs-3142	58	7	of	of	ADP
iajs-3142	58	8	serum	serum	NOUN
iajs-3142	58	9	lipid	lipid	NOUN
iajs-3142	58	10	profiles	profile	NOUN
iajs-3142	58	11	in	in	ADP
iajs-3142	58	12	mets	met	NOUN
iajs-3142	58	13	,	,	PUNCT
iajs-3142	58	14	t2	t2	NOUN
iajs-3142	58	15	dm	dm	NOUN
iajs-3142	58	16	patients	patient	NOUN
iajs-3142	58	17	,	,	PUNCT
iajs-3142	58	18	and	and	CCONJ
iajs-3142	58	19	controls	control	NOUN
iajs-3142	58	20	.	.	PUNCT
iajs-3142	59	1	no	no	DET
iajs-3142	59	2	significant	significant	ADJ
iajs-3142	59	3	difference	difference	NOUN
iajs-3142	59	4	appeared	appear	VERB
iajs-3142	59	5	in	in	ADP
iajs-3142	59	6	cholesterol	cholesterol	NOUN
iajs-3142	59	7	,	,	PUNCT
iajs-3142	59	8	t.g	t.g	PROPN
iajs-3142	59	9	.	.	PROPN
iajs-3142	59	10	,	,	PUNCT
iajs-3142	59	11	hdl	hdl	PROPN
iajs-3142	59	12	,	,	PUNCT
iajs-3142	59	13	vldl	vldl	NOUN
iajs-3142	59	14	,	,	PUNCT
iajs-3142	59	15	and	and	CCONJ
iajs-3142	59	16	ldl	ldl	NOUN
iajs-3142	59	17	levels	level	NOUN
iajs-3142	59	18	when	when	SCONJ
iajs-3142	59	19	compared	compare	VERB
iajs-3142	59	20	between	between	ADP
iajs-3142	59	21	mets	met	NOUN
iajs-3142	59	22	and	and	CCONJ
iajs-3142	59	23	t2	t2	NOUN
iajs-3142	59	24	dm	dm	PROPN
iajs-3142	59	25	patients	patient	NOUN
iajs-3142	59	26	and	and	CCONJ
iajs-3142	59	27	the	the	DET
iajs-3142	59	28	control	control	NOUN
iajs-3142	59	29	group	group	NOUN
iajs-3142	59	30	with	with	ADP
iajs-3142	59	31	p>0.05	p>0.05	PROPN
iajs-3142	59	32	as	as	SCONJ
iajs-3142	59	33	shown	show	VERB
iajs-3142	59	34	in	in	ADP
iajs-3142	59	35	table	table	NOUN
iajs-3142	59	36	2	2	NUM
iajs-3142	59	37	.	.	PUNCT
iajs-3142	60	1	much	much	ADJ
iajs-3142	60	2	evidence	evidence	NOUN
iajs-3142	60	3	has	have	AUX
iajs-3142	60	4	linked	link	VERB
iajs-3142	60	5	obesity	obesity	NOUN
iajs-3142	60	6	with	with	ADP
iajs-3142	60	7	sympathetic	sympathetic	ADJ
iajs-3142	60	8	overactivity	overactivity	NOUN
iajs-3142	60	9	(	(	PUNCT
iajs-3142	60	10	increase	increase	VERB
iajs-3142	60	11	in	in	ADP
iajs-3142	60	12	heart	heart	NOUN
iajs-3142	60	13	rate	rate	NOUN
iajs-3142	60	14	,	,	PUNCT
iajs-3142	60	15	blood	blood	NOUN
iajs-3142	60	16	pressure	pressure	NOUN
iajs-3142	60	17	,	,	PUNCT
iajs-3142	60	18	and	and	CCONJ
iajs-3142	60	19	breathing	breathing	NOUN
iajs-3142	60	20	rate	rate	NOUN
iajs-3142	60	21	)	)	PUNCT
iajs-3142	60	22	.	.	PUNCT
iajs-3142	61	1	ihjpas	ihjpas	PROPN
iajs-3142	61	2	.	.	PUNCT
iajs-3142	62	1	37(1)2024	37(1)2024	NUM
iajs-3142	62	2	336	336	NUM
iajs-3142	62	3	table	table	NOUN
iajs-3142	62	4	2	2	NUM
iajs-3142	62	5	.	.	PUNCT
iajs-3142	63	1	the	the	DET
iajs-3142	63	2	serum	serum	NOUN
iajs-3142	63	3	lipid	lipid	NOUN
iajs-3142	63	4	profile	profile	NOUN
iajs-3142	63	5	in	in	ADP
iajs-3142	63	6	mets	met	NOUN
iajs-3142	63	7	,	,	PUNCT
iajs-3142	63	8	t2	t2	NOUN
iajs-3142	63	9	dm	dm	PROPN
iajs-3142	63	10	,	,	PUNCT
iajs-3142	63	11	and	and	CCONJ
iajs-3142	63	12	control	control	NOUN
iajs-3142	63	13	variables	variable	NOUN
iajs-3142	63	14	median	median	ADJ
iajs-3142	63	15	mets	met	NOUN
iajs-3142	63	16	(	(	PUNCT
iajs-3142	63	17	n=	n=	ADJ
iajs-3142	63	18	40	40	NUM
iajs-3142	63	19	)	)	PUNCT
iajs-3142	63	20	t2	t2	NOUN
iajs-3142	63	21	dm	dm	PROPN
iajs-3142	63	22	(	(	PUNCT
iajs-3142	63	23	n=	n=	ADJ
iajs-3142	63	24	40	40	NUM
iajs-3142	63	25	)	)	PUNCT
iajs-3142	63	26	control	control	NOUN
iajs-3142	63	27	(	(	PUNCT
iajs-3142	63	28	n=	n=	ADJ
iajs-3142	63	29	40	40	NUM
iajs-3142	63	30	)	)	PUNCT
iajs-3142	63	31	cholesterol	cholesterol	NOUN
iajs-3142	63	32	(	(	PUNCT
iajs-3142	63	33	mg	mg	PROPN
iajs-3142	63	34	/	/	SYM
iajs-3142	63	35	dl	dl	NOUN
iajs-3142	63	36	)	)	PUNCT
iajs-3142	63	37	203.0(187.0	203.0(187.0	NUM
iajs-3142	63	38	-	-	SYM
iajs-3142	63	39	216.25)a	216.25)a	NUM
iajs-3142	63	40	182.50(151.25217.50)b	182.50(151.25217.50)b	NUM
iajs-3142	63	41	51.30(45.43	51.30(45.43	NUM
iajs-3142	63	42	-	-	SYM
iajs-3142	63	43	142.63	142.63	NUM
iajs-3142	63	44	)	)	PUNCT
iajs-3142	63	45	t.g	t.g	PROPN
iajs-3142	63	46	(	(	PUNCT
iajs-3142	63	47	mg	mg	PROPN
iajs-3142	63	48	/	/	SYM
iajs-3142	63	49	dl	dl	PROPN
iajs-3142	63	50	)	)	PUNCT
iajs-3142	63	51	176.50(134.0	176.50(134.0	NUM
iajs-3142	63	52	-	-	SYM
iajs-3142	63	53	191.50	191.50	NUM
iajs-3142	63	54	)	)	PUNCT
iajs-3142	63	55	197.50(129.50263.0)b	197.50(129.50263.0)b	NUM
iajs-3142	63	56	81.90(62.63	81.90(62.63	NUM
iajs-3142	63	57	-	-	NUM
iajs-3142	63	58	90.40	90.40	NUM
iajs-3142	63	59	)	)	PUNCT
iajs-3142	63	60	hdl	hdl	PROPN
iajs-3142	63	61	-	-	PUNCT
iajs-3142	63	62	c	c	PROPN
iajs-3142	63	63	(	(	PUNCT
iajs-3142	63	64	mg	mg	PROPN
iajs-3142	63	65	/	/	SYM
iajs-3142	63	66	dl	dl	PROPN
iajs-3142	63	67	)	)	PUNCT
iajs-3142	63	68	40.70	40.70	NUM
iajs-3142	63	69	(	(	PUNCT
iajs-3142	63	70	39.05	39.05	NUM
iajs-3142	63	71	-	-	SYM
iajs-3142	63	72	43.83)a	43.83)a	NUM
iajs-3142	63	73	22.60(19.30	22.60(19.30	NUM
iajs-3142	63	74	-	-	SYM
iajs-3142	63	75	45.43	45.43	NUM
iajs-3142	63	76	)	)	PUNCT
iajs-3142	63	77	42.0(36.0	42.0(36.0	NUM
iajs-3142	63	78	-	-	SYM
iajs-3142	63	79	46.0)b	46.0)b	ADJ
iajs-3142	63	80	ldl	ldl	NOUN
iajs-3142	63	81	-	-	PUNCT
iajs-3142	63	82	c	c	NOUN
iajs-3142	63	83	(	(	PUNCT
iajs-3142	63	84	mg	mg	PROPN
iajs-3142	63	85	/	/	SYM
iajs-3142	63	86	dl	dl	PROPN
iajs-3142	63	87	)	)	PUNCT
iajs-3142	63	88	125.60(108.60142.35)a	125.60(108.60142.35)a	NUM
iajs-3142	63	89	109.0(86.0	109.0(86.0	NUM
iajs-3142	63	90	-	-	PUNCT
iajs-3142	63	91	146.50)b	146.50)b	NUM
iajs-3142	63	92	80.40(71.77	80.40(71.77	NUM
iajs-3142	63	93	-	-	SYM
iajs-3142	63	94	88.05	88.05	NUM
iajs-3142	63	95	)	)	PUNCT
iajs-3142	63	96	vldl	vldl	NOUN
iajs-3142	63	97	(	(	PUNCT
iajs-3142	63	98	mg	mg	PROPN
iajs-3142	63	99	/	/	SYM
iajs-3142	63	100	dl	dl	NOUN
iajs-3142	63	101	)	)	PUNCT
iajs-3142	63	102	35.30(26.85	35.30(26.85	PROPN
iajs-3142	63	103	-	-	SYM
iajs-3142	63	104	38.30)a	38.30)a	NUM
iajs-3142	63	105	39.50(25.30	39.50(25.30	NUM
iajs-3142	63	106	-	-	NUM
iajs-3142	63	107	53.0)b	53.0)b	ADJ
iajs-3142	63	108	19.80(15.0	19.80(15.0	PROPN
iajs-3142	63	109	-	-	SYM
iajs-3142	63	110	22.60	22.60	NUM
iajs-3142	63	111	)	)	PUNCT
iajs-3142	63	112	the	the	DET
iajs-3142	63	113	median	median	NOUN
iajs-3142	63	114	(	(	PUNCT
iajs-3142	63	115	25th	25th	ADJ
iajs-3142	63	116	and	and	CCONJ
iajs-3142	63	117	75th	75th	ADJ
iajs-3142	63	118	percentiles	percentile	NOUN
iajs-3142	63	119	)	)	PUNCT
iajs-3142	63	120	of	of	ADP
iajs-3142	63	121	the	the	DET
iajs-3142	63	122	obtained	obtain	VERB
iajs-3142	63	123	data	datum	NOUN
iajs-3142	63	124	were	be	AUX
iajs-3142	63	125	evaluated	evaluate	VERB
iajs-3142	63	126	using	use	VERB
iajs-3142	63	127	the	the	DET
iajs-3142	63	128	mann	mann	PROPN
iajs-3142	63	129	-	-	PUNCT
iajs-3142	63	130	whitney	whitney	PROPN
iajs-3142	63	131	test	test	NOUN
iajs-3142	63	132	at	at	ADP
iajs-3142	63	133	the	the	DET
iajs-3142	63	134	0.05	0.05	NUM
iajs-3142	63	135	threshold	threshold	NOUN
iajs-3142	63	136	;	;	PUNCT
iajs-3142	63	137	there	there	PRON
iajs-3142	63	138	was	be	VERB
iajs-3142	63	139	a	a	DET
iajs-3142	63	140	significant	significant	ADJ
iajs-3142	63	141	difference	difference	NOUN
iajs-3142	63	142	between	between	ADP
iajs-3142	63	143	the	the	DET
iajs-3142	63	144	two	two	NUM
iajs-3142	63	145	independent	independent	ADJ
iajs-3142	63	146	means	mean	NOUN
iajs-3142	63	147	.	.	PUNCT
iajs-3142	64	1	a	a	PRON
iajs-3142	64	2	)	)	PUNCT
iajs-3142	64	3	show	show	VERB
iajs-3142	64	4	how	how	SCONJ
iajs-3142	64	5	mets	met	NOUN
iajs-3142	64	6	group	group	NOUN
iajs-3142	64	7	and	and	CCONJ
iajs-3142	64	8	control	control	NOUN
iajs-3142	64	9	differ	differ	VERB
iajs-3142	64	10	significantly	significantly	ADV
iajs-3142	64	11	from	from	ADP
iajs-3142	64	12	each	each	DET
iajs-3142	64	13	other	other	ADJ
iajs-3142	64	14	.	.	PUNCT
iajs-3142	65	1	b	b	X
iajs-3142	65	2	)	)	PUNCT
iajs-3142	65	3	show	show	VERB
iajs-3142	65	4	that	that	SCONJ
iajs-3142	65	5	the	the	DET
iajs-3142	65	6	t2	t2	NOUN
iajs-3142	65	7	dm	dm	PROPN
iajs-3142	65	8	group	group	NOUN
iajs-3142	65	9	and	and	CCONJ
iajs-3142	65	10	control	control	NOUN
iajs-3142	65	11	have	have	VERB
iajs-3142	65	12	a	a	DET
iajs-3142	65	13	significant	significant	ADJ
iajs-3142	65	14	difference	difference	NOUN
iajs-3142	65	15	.	.	PUNCT
iajs-3142	66	1	c	c	X
iajs-3142	66	2	)	)	PUNCT
iajs-3142	66	3	show	show	VERB
iajs-3142	66	4	that	that	SCONJ
iajs-3142	66	5	the	the	DET
iajs-3142	66	6	mets	mets	PROPN
iajs-3142	66	7	group	group	NOUN
iajs-3142	66	8	and	and	CCONJ
iajs-3142	66	9	the	the	DET
iajs-3142	66	10	t2	t2	NOUN
iajs-3142	66	11	dm	dm	PROPN
iajs-3142	66	12	group	group	NOUN
iajs-3142	66	13	have	have	VERB
iajs-3142	66	14	important	important	ADJ
iajs-3142	66	15	differences	difference	NOUN
iajs-3142	66	16	.	.	PUNCT
iajs-3142	67	1	the	the	DET
iajs-3142	67	2	cholesterol	cholesterol	NOUN
iajs-3142	67	3	levels	level	NOUN
iajs-3142	67	4	increased	increase	VERB
iajs-3142	67	5	significantly	significantly	ADV
iajs-3142	67	6	in	in	ADP
iajs-3142	67	7	mets	met	NOUN
iajs-3142	67	8	and	and	CCONJ
iajs-3142	67	9	t2	t2	NOUN
iajs-3142	67	10	dm	dm	PROPN
iajs-3142	67	11	groups	group	NOUN
iajs-3142	67	12	203.0	203.0	NUM
iajs-3142	67	13	(	(	PUNCT
iajs-3142	67	14	187.0	187.0	NUM
iajs-3142	67	15	-	-	SYM
iajs-3142	67	16	216.25	216.25	NUM
iajs-3142	67	17	)	)	PUNCT
iajs-3142	67	18	and	and	CCONJ
iajs-3142	67	19	182.50	182.50	NUM
iajs-3142	67	20	(	(	PUNCT
iajs-3142	67	21	151.25	151.25	NUM
iajs-3142	67	22	-	-	SYM
iajs-3142	67	23	217.50	217.50	NUM
iajs-3142	67	24	)	)	PUNCT
iajs-3142	67	25	when	when	SCONJ
iajs-3142	67	26	compared	compare	VERB
iajs-3142	67	27	with	with	ADP
iajs-3142	67	28	the	the	DET
iajs-3142	67	29	control	control	NOUN
iajs-3142	67	30	group	group	NOUN
iajs-3142	67	31	51.30	51.30	NUM
iajs-3142	67	32	(	(	PUNCT
iajs-3142	67	33	45.43	45.43	NUM
iajs-3142	67	34	-	-	SYM
iajs-3142	67	35	142.63	142.63	NUM
iajs-3142	67	36	)	)	PUNCT
iajs-3142	67	37	,	,	PUNCT
iajs-3142	67	38	p	p	X
iajs-3142	67	39	>	>	X
iajs-3142	67	40	0.05	0.05	NUM
iajs-3142	67	41	.	.	PUNCT
iajs-3142	68	1	at	at	ADP
iajs-3142	68	2	the	the	DET
iajs-3142	68	3	same	same	ADJ
iajs-3142	68	4	time	time	NOUN
iajs-3142	68	5	,	,	PUNCT
iajs-3142	68	6	there	there	PRON
iajs-3142	68	7	was	be	VERB
iajs-3142	68	8	no	no	DET
iajs-3142	68	9	significant	significant	ADJ
iajs-3142	68	10	difference	difference	NOUN
iajs-3142	68	11	in	in	ADP
iajs-3142	68	12	cholesterol	cholesterol	NOUN
iajs-3142	68	13	compared	compare	VERB
iajs-3142	68	14	with	with	ADP
iajs-3142	68	15	the	the	DET
iajs-3142	68	16	two	two	NUM
iajs-3142	68	17	groups	group	NOUN
iajs-3142	68	18	of	of	ADP
iajs-3142	68	19	patients	patient	NOUN
iajs-3142	68	20	.	.	PUNCT
iajs-3142	69	1	the	the	DET
iajs-3142	69	2	t.g	t.g	PROPN
iajs-3142	69	3	.	.	PROPN
iajs-3142	69	4	and	and	CCONJ
iajs-3142	69	5	vldl	vldl	NOUN
iajs-3142	69	6	levels	level	NOUN
iajs-3142	69	7	increased	increase	VERB
iajs-3142	69	8	significantly	significantly	ADV
iajs-3142	69	9	in	in	ADP
iajs-3142	69	10	patient	patient	ADJ
iajs-3142	69	11	groups	group	NOUN
iajs-3142	69	12	;	;	PUNCT
iajs-3142	69	13	mets	met	NOUN
iajs-3142	69	14	,	,	PUNCT
iajs-3142	69	15	176.50	176.50	NUM
iajs-3142	69	16	(	(	PUNCT
iajs-3142	69	17	134.0	134.0	NUM
iajs-3142	69	18	-	-	SYM
iajs-3142	69	19	191.50	191.50	NUM
iajs-3142	69	20	)	)	PUNCT
iajs-3142	69	21	,	,	PUNCT
iajs-3142	69	22	35.30(26.85	35.30(26.85	PROPN
iajs-3142	69	23	-	-	SYM
iajs-3142	69	24	38.30	38.30	NUM
iajs-3142	69	25	)	)	PUNCT
iajs-3142	69	26	and	and	CCONJ
iajs-3142	69	27	t2	t2	PROPN
iajs-3142	69	28	dm	dm	PROPN
iajs-3142	69	29	,	,	PUNCT
iajs-3142	69	30	197.50	197.50	NUM
iajs-3142	69	31	(	(	PUNCT
iajs-3142	69	32	129.50	129.50	NUM
iajs-3142	69	33	-	-	SYM
iajs-3142	69	34	263.0	263.0	NUM
iajs-3142	69	35	)	)	PUNCT
iajs-3142	69	36	,	,	PUNCT
iajs-3142	69	37	39.50	39.50	NUM
iajs-3142	69	38	(	(	PUNCT
iajs-3142	69	39	25.30–53.0	25.30–53.0	NUM
iajs-3142	69	40	)	)	PUNCT
iajs-3142	69	41	when	when	SCONJ
iajs-3142	69	42	compared	compare	VERB
iajs-3142	69	43	with	with	ADP
iajs-3142	69	44	the	the	DET
iajs-3142	69	45	control	control	NOUN
iajs-3142	69	46	group	group	NOUN
iajs-3142	69	47	81.90	81.90	NUM
iajs-3142	69	48	(	(	PUNCT
iajs-3142	69	49	62.63	62.63	NUM
iajs-3142	69	50	-	-	SYM
iajs-3142	69	51	90.40	90.40	NUM
iajs-3142	69	52	)	)	PUNCT
iajs-3142	69	53	,	,	PUNCT
iajs-3142	69	54	and	and	CCONJ
iajs-3142	69	55	19.80	19.80	NUM
iajs-3142	69	56	(	(	PUNCT
iajs-3142	69	57	15.022.60	15.022.60	NUM
iajs-3142	69	58	)	)	PUNCT
iajs-3142	69	59	,	,	PUNCT
iajs-3142	69	60	p	p	X
iajs-3142	69	61	>	>	X
iajs-3142	69	62	0.05	0.05	NUM
iajs-3142	69	63	.	.	PUNCT
iajs-3142	70	1	at	at	ADP
iajs-3142	70	2	the	the	DET
iajs-3142	70	3	same	same	ADJ
iajs-3142	70	4	time	time	NOUN
iajs-3142	70	5	,	,	PUNCT
iajs-3142	70	6	there	there	PRON
iajs-3142	70	7	was	be	VERB
iajs-3142	70	8	no	no	DET
iajs-3142	70	9	significant	significant	ADJ
iajs-3142	70	10	difference	difference	NOUN
iajs-3142	70	11	in	in	ADP
iajs-3142	70	12	cholesterol	cholesterol	NOUN
iajs-3142	70	13	when	when	SCONJ
iajs-3142	70	14	we	we	PRON
iajs-3142	70	15	compared	compare	VERB
iajs-3142	70	16	the	the	DET
iajs-3142	70	17	mets	met	NOUN
iajs-3142	70	18	and	and	CCONJ
iajs-3142	70	19	t2	t2	NOUN
iajs-3142	70	20	dm	dm	PROPN
iajs-3142	70	21	groups	group	NOUN
iajs-3142	70	22	[	[	X
iajs-3142	70	23	15	15	NUM
iajs-3142	70	24	]	]	PUNCT
iajs-3142	70	25	.	.	PUNCT
iajs-3142	71	1	the	the	DET
iajs-3142	71	2	hdl	hdl	PROPN
iajs-3142	71	3	and	and	CCONJ
iajs-3142	71	4	ldl	ldl	NOUN
iajs-3142	71	5	levels	level	NOUN
iajs-3142	71	6	showed	show	VERB
iajs-3142	71	7	a	a	DET
iajs-3142	71	8	high	high	ADJ
iajs-3142	71	9	significant	significant	ADJ
iajs-3142	71	10	difference	difference	NOUN
iajs-3142	71	11	when	when	SCONJ
iajs-3142	71	12	comparing	compare	VERB
iajs-3142	71	13	patient	patient	ADJ
iajs-3142	71	14	groups	group	NOUN
iajs-3142	71	15	;	;	PUNCT
iajs-3142	71	16	mets	met	NOUN
iajs-3142	71	17	40.70	40.70	NUM
iajs-3142	71	18	(	(	PUNCT
iajs-3142	71	19	39.05	39.05	NUM
iajs-3142	71	20	-	-	SYM
iajs-3142	71	21	43.83	43.83	NUM
iajs-3142	71	22	)	)	PUNCT
iajs-3142	71	23	and	and	CCONJ
iajs-3142	71	24	125.60	125.60	NUM
iajs-3142	71	25	(	(	PUNCT
iajs-3142	71	26	108.60142.35	108.60142.35	NOUN
iajs-3142	71	27	)	)	PUNCT
iajs-3142	71	28	,	,	PUNCT
iajs-3142	71	29	t2	t2	NOUN
iajs-3142	71	30	dm	dm	NUM
iajs-3142	71	31	22.60	22.60	NUM
iajs-3142	71	32	(	(	PUNCT
iajs-3142	71	33	19.30	19.30	NUM
iajs-3142	71	34	-	-	SYM
iajs-3142	71	35	45.43	45.43	NUM
iajs-3142	71	36	)	)	PUNCT
iajs-3142	71	37	,	,	PUNCT
iajs-3142	71	38	109.0	109.0	NUM
iajs-3142	71	39	(	(	PUNCT
iajs-3142	71	40	86.0	86.0	NUM
iajs-3142	71	41	-	-	SYM
iajs-3142	71	42	146.50	146.50	NUM
iajs-3142	71	43	)	)	PUNCT
iajs-3142	71	44	,	,	PUNCT
iajs-3142	71	45	and	and	CCONJ
iajs-3142	71	46	control	control	VERB
iajs-3142	71	47	42.0	42.0	NUM
iajs-3142	71	48	(	(	PUNCT
iajs-3142	71	49	36.0	36.0	NUM
iajs-3142	71	50	-	-	NUM
iajs-3142	71	51	46.0	46.0	NUM
iajs-3142	71	52	)	)	PUNCT
iajs-3142	71	53	,	,	PUNCT
iajs-3142	71	54	and	and	CCONJ
iajs-3142	71	55	80.40	80.40	NUM
iajs-3142	71	56	(	(	PUNCT
iajs-3142	71	57	71.77	71.77	NUM
iajs-3142	71	58	-	-	SYM
iajs-3142	71	59	88.05	88.05	NUM
iajs-3142	71	60	)	)	PUNCT
iajs-3142	71	61	,	,	PUNCT
iajs-3142	71	62	as	as	SCONJ
iajs-3142	71	63	shown	show	VERB
iajs-3142	71	64	in	in	ADP
iajs-3142	71	65	table	table	NOUN
iajs-3142	71	66	2	2	NUM
iajs-3142	71	67	.	.	PUNCT
iajs-3142	72	1	the	the	DET
iajs-3142	72	2	high	high	ADJ
iajs-3142	72	3	visceral	visceral	ADJ
iajs-3142	72	4	fat	fat	ADJ
iajs-3142	72	5	accumulation	accumulation	NOUN
iajs-3142	72	6	characterized	characterize	VERB
iajs-3142	72	7	by	by	ADP
iajs-3142	72	8	obesity	obesity	NOUN
iajs-3142	72	9	is	be	AUX
iajs-3142	72	10	a	a	DET
iajs-3142	72	11	distinct	distinct	ADJ
iajs-3142	72	12	feature	feature	NOUN
iajs-3142	72	13	of	of	ADP
iajs-3142	72	14	mets	met	NOUN
iajs-3142	72	15	[	[	X
iajs-3142	72	16	16	16	NUM
iajs-3142	72	17	]	]	PUNCT
iajs-3142	72	18	.	.	PUNCT
iajs-3142	73	1	patients	patient	NOUN
iajs-3142	73	2	with	with	ADP
iajs-3142	73	3	mets	met	NOUN
iajs-3142	73	4	have	have	VERB
iajs-3142	73	5	low	low	ADJ
iajs-3142	73	6	hdl	hdl	NOUN
iajs-3142	73	7	and	and	CCONJ
iajs-3142	73	8	high	high	ADJ
iajs-3142	73	9	t.g	t.g	PROPN
iajs-3142	73	10	.	.	PROPN
iajs-3142	73	11	levels	level	NOUN
iajs-3142	73	12	due	due	ADP
iajs-3142	73	13	to	to	ADP
iajs-3142	73	14	the	the	DET
iajs-3142	73	15	slower	slow	ADJ
iajs-3142	73	16	clearance	clearance	NOUN
iajs-3142	73	17	of	of	ADP
iajs-3142	73	18	these	these	DET
iajs-3142	73	19	lipoproteins	lipoprotein	NOUN
iajs-3142	73	20	from	from	ADP
iajs-3142	73	21	the	the	DET
iajs-3142	73	22	bloodstream	bloodstream	NOUN
iajs-3142	73	23	[	[	X
iajs-3142	73	24	17,18	17,18	NUM
iajs-3142	73	25	]	]	PUNCT
iajs-3142	73	26	.	.	PUNCT
iajs-3142	74	1	increased	increase	VERB
iajs-3142	74	2	fbg	fbg	NOUN
iajs-3142	74	3	levels	level	NOUN
iajs-3142	74	4	can	can	AUX
iajs-3142	74	5	cause	cause	VERB
iajs-3142	74	6	oxidative	oxidative	ADJ
iajs-3142	74	7	stress	stress	NOUN
iajs-3142	74	8	and	and	CCONJ
iajs-3142	74	9	inflammation	inflammation	NOUN
iajs-3142	74	10	and	and	CCONJ
iajs-3142	74	11	hasten	hasten	VERB
iajs-3142	74	12	the	the	DET
iajs-3142	74	13	development	development	NOUN
iajs-3142	74	14	of	of	ADP
iajs-3142	74	15	dyslipidemia	dyslipidemia	NOUN
iajs-3142	74	16	brought	bring	VERB
iajs-3142	74	17	on	on	ADP
iajs-3142	74	18	by	by	ADP
iajs-3142	74	19	some	some	DET
iajs-3142	74	20	harmful	harmful	ADJ
iajs-3142	74	21	variables	variable	NOUN
iajs-3142	74	22	,	,	PUNCT
iajs-3142	74	23	like	like	ADP
iajs-3142	74	24	air	air	NOUN
iajs-3142	74	25	pollution	pollution	NOUN
iajs-3142	74	26	.	.	PUNCT
iajs-3142	75	1	elevated	elevate	VERB
iajs-3142	75	2	fbg	fbg	NOUN
iajs-3142	75	3	levels	level	NOUN
iajs-3142	75	4	and	and	CCONJ
iajs-3142	75	5	dyslipidemia	dyslipidemia	NOUN
iajs-3142	75	6	have	have	AUX
iajs-3142	75	7	been	be	AUX
iajs-3142	75	8	linked	link	VERB
iajs-3142	75	9	in	in	ADP
iajs-3142	75	10	numerous	numerous	ADJ
iajs-3142	75	11	studies	study	NOUN
iajs-3142	75	12	[	[	X
iajs-3142	75	13	13,19,20	13,19,20	NUM
iajs-3142	75	14	]	]	X
iajs-3142	75	15	,	,	PUNCT
iajs-3142	75	16	and	and	CCONJ
iajs-3142	75	17	in	in	ADP
iajs-3142	75	18	comparison	comparison	NOUN
iajs-3142	75	19	to	to	ADP
iajs-3142	75	20	the	the	DET
iajs-3142	75	21	control	control	NOUN
iajs-3142	75	22	group	group	NOUN
iajs-3142	75	23	,	,	PUNCT
iajs-3142	75	24	the	the	DET
iajs-3142	75	25	dbp	dbp	PROPN
iajs-3142	75	26	,	,	PUNCT
iajs-3142	75	27	sbp	sbp	NOUN
iajs-3142	75	28	,	,	PUNCT
iajs-3142	75	29	and	and	CCONJ
iajs-3142	75	30	fbg	fbg	PROPN
iajs-3142	75	31	significantly	significantly	ADV
iajs-3142	75	32	increased	increase	VERB
iajs-3142	75	33	in	in	ADP
iajs-3142	75	34	the	the	DET
iajs-3142	75	35	mets	met	NOUN
iajs-3142	75	36	and	and	CCONJ
iajs-3142	75	37	t2	t2	NOUN
iajs-3142	75	38	dm	dm	PROPN
iajs-3142	75	39	patient	patient	NOUN
iajs-3142	75	40	groups	group	NOUN
iajs-3142	75	41	(	(	PUNCT
iajs-3142	75	42	p	p	X
iajs-3142	75	43	<	<	X
iajs-3142	75	44	0.05	0.05	NUM
iajs-3142	75	45	,	,	PUNCT
iajs-3142	75	46	p	p	X
iajs-3142	75	47	<	<	X
iajs-3142	75	48	0.001	0.001	NUM
iajs-3142	75	49	)	)	PUNCT
iajs-3142	75	50	.	.	PUNCT
iajs-3142	76	1	when	when	SCONJ
iajs-3142	76	2	comparing	compare	VERB
iajs-3142	76	3	patient	patient	ADJ
iajs-3142	76	4	groups	group	NOUN
iajs-3142	76	5	(	(	PUNCT
iajs-3142	76	6	mets	met	NOUN
iajs-3142	76	7	with	with	ADP
iajs-3142	76	8	t2	t2	PROPN
iajs-3142	76	9	dm	dm	PROPN
iajs-3142	76	10	)	)	PUNCT
iajs-3142	76	11	,	,	PUNCT
iajs-3142	76	12	the	the	DET
iajs-3142	76	13	results	result	NOUN
iajs-3142	76	14	revealed	reveal	VERB
iajs-3142	76	15	a	a	DET
iajs-3142	76	16	significant	significant	ADJ
iajs-3142	76	17	difference	difference	NOUN
iajs-3142	76	18	in	in	ADP
iajs-3142	76	19	diastolic	diastolic	ADJ
iajs-3142	76	20	blood	blood	NOUN
iajs-3142	76	21	pressure	pressure	NOUN
iajs-3142	76	22	,	,	PUNCT
iajs-3142	76	23	sbp	sbp	NOUN
iajs-3142	76	24	,	,	PUNCT
iajs-3142	76	25	and	and	CCONJ
iajs-3142	76	26	fbg	fbg	PROPN
iajs-3142	76	27	(	(	PUNCT
iajs-3142	76	28	p	p	X
iajs-3142	76	29	<	<	X
iajs-3142	76	30	0.05	0.05	NUM
iajs-3142	76	31	,	,	PUNCT
iajs-3142	76	32	p	p	X
iajs-3142	76	33	<	<	X
iajs-3142	76	34	0.00	0.00	NUM
iajs-3142	76	35	)	)	PUNCT
iajs-3142	76	36	.	.	PUNCT
iajs-3142	77	1	the	the	DET
iajs-3142	77	2	result	result	NOUN
iajs-3142	77	3	showed	show	VERB
iajs-3142	77	4	a	a	DET
iajs-3142	77	5	substantial	substantial	ADJ
iajs-3142	77	6	decrease	decrease	NOUN
iajs-3142	77	7	in	in	ADP
iajs-3142	77	8	adropin	adropin	ADJ
iajs-3142	77	9	levels	level	NOUN
iajs-3142	77	10	in	in	ADP
iajs-3142	77	11	the	the	DET
iajs-3142	77	12	mets	met	NOUN
iajs-3142	77	13	and	and	CCONJ
iajs-3142	77	14	t2	t2	NOUN
iajs-3142	77	15	dm	dm	PROPN
iajs-3142	77	16	groups	group	NOUN
iajs-3142	77	17	.	.	PUNCT
iajs-3142	78	1	when	when	SCONJ
iajs-3142	78	2	compared	compare	VERB
iajs-3142	78	3	with	with	ADP
iajs-3142	78	4	the	the	DET
iajs-3142	78	5	control	control	NOUN
iajs-3142	78	6	group	group	NOUN
iajs-3142	78	7	,	,	PUNCT
iajs-3142	78	8	p	p	X
iajs-3142	78	9	<	<	X
iajs-3142	78	10	0.05	0.05	NUM
iajs-3142	78	11	,	,	PUNCT
iajs-3142	78	12	there	there	PRON
iajs-3142	78	13	was	be	VERB
iajs-3142	78	14	no	no	DET
iajs-3142	78	15	significant	significant	ADJ
iajs-3142	78	16	difference	difference	NOUN
iajs-3142	78	17	between	between	ADP
iajs-3142	78	18	the	the	DET
iajs-3142	78	19	patient	patient	ADJ
iajs-3142	78	20	groups	group	NOUN
iajs-3142	78	21	(	(	PUNCT
iajs-3142	78	22	mets	met	NOUN
iajs-3142	78	23	,	,	PUNCT
iajs-3142	78	24	t2	t2	NOUN
iajs-3142	78	25	dm	dm	PROPN
iajs-3142	78	26	)	)	PUNCT
iajs-3142	78	27	and	and	CCONJ
iajs-3142	78	28	the	the	DET
iajs-3142	78	29	control	control	NOUN
iajs-3142	78	30	group	group	NOUN
iajs-3142	78	31	,	,	PUNCT
iajs-3142	78	32	as	as	SCONJ
iajs-3142	78	33	shown	show	VERB
iajs-3142	78	34	in	in	ADP
iajs-3142	78	35	table	table	NOUN
iajs-3142	78	36	3	3	NUM
iajs-3142	78	37	.	.	PUNCT
iajs-3142	78	38	ihjpas	ihjpas	PROPN
iajs-3142	78	39	.	.	PUNCT
iajs-3142	79	1	37(1)2024	37(1)2024	NUM
iajs-3142	79	2	337	337	NUM
iajs-3142	79	3	table	table	NOUN
iajs-3142	79	4	3	3	NUM
iajs-3142	79	5	.	.	PUNCT
iajs-3142	79	6	clinical	clinical	ADJ
iajs-3142	79	7	and	and	CCONJ
iajs-3142	79	8	biochemical	biochemical	ADJ
iajs-3142	79	9	factors	factor	NOUN
iajs-3142	79	10	of	of	ADP
iajs-3142	79	11	patients	patient	NOUN
iajs-3142	79	12	and	and	CCONJ
iajs-3142	79	13	control	control	NOUN
iajs-3142	79	14	group	group	NOUN
iajs-3142	79	15	variables	variable	VERB
iajs-3142	79	16	median	median	ADJ
iajs-3142	79	17	p	p	ADJ
iajs-3142	79	18	-	-	PUNCT
iajs-3142	79	19	value	value	NOUN
iajs-3142	79	20	mets	met	NOUN
iajs-3142	79	21	(	(	PUNCT
iajs-3142	79	22	n=	n=	ADJ
iajs-3142	79	23	40	40	NUM
iajs-3142	79	24	)	)	PUNCT
iajs-3142	79	25	t2	t2	NOUN
iajs-3142	79	26	dm	dm	PROPN
iajs-3142	79	27	(	(	PUNCT
iajs-3142	79	28	n=	n=	ADJ
iajs-3142	79	29	40	40	NUM
iajs-3142	79	30	)	)	PUNCT
iajs-3142	79	31	control	control	NOUN
iajs-3142	79	32	(	(	PUNCT
iajs-3142	79	33	n=	n=	ADJ
iajs-3142	79	34	40	40	NUM
iajs-3142	79	35	)	)	PUNCT
iajs-3142	79	36	dbp	dbp	PROPN
iajs-3142	79	37	(	(	PUNCT
iajs-3142	79	38	mmhg	mmhg	PROPN
iajs-3142	79	39	)	)	PUNCT
iajs-3142	79	40	(	(	PUNCT
iajs-3142	79	41	77.34±25.10)a	77.34±25.10)a	NUM
iajs-3142	79	42	,	,	PUNCT
iajs-3142	79	43	c	c	NOUN
iajs-3142	79	44	(	(	PUNCT
iajs-3142	79	45	78.22±22.10)b	78.22±22.10)b	NUM
iajs-3142	79	46	,	,	PUNCT
iajs-3142	79	47	c	c	NOUN
iajs-3142	79	48	73.4±15.10	73.4±15.10	NOUN
iajs-3142	79	49	0.05	0.05	NUM
iajs-3142	79	50	sbp	sbp	NOUN
iajs-3142	79	51	(	(	PUNCT
iajs-3142	79	52	mmhg	mmhg	PROPN
iajs-3142	79	53	)	)	PUNCT
iajs-3142	79	54	(	(	PUNCT
iajs-3142	79	55	131.03	131.03	NUM
iajs-3142	79	56	±13.05)a	±13.05)a	NUM
iajs-3142	79	57	,	,	PUNCT
iajs-3142	79	58	c	c	NOUN
iajs-3142	79	59	(	(	PUNCT
iajs-3142	79	60	140.03	140.03	NUM
iajs-3142	79	61	±15.05)b	±15.05)b	NOUN
iajs-3142	79	62	,	,	PUNCT
iajs-3142	79	63	c	c	PROPN
iajs-3142	79	64	122.03	122.03	NUM
iajs-3142	79	65	±17.07	±17.07	NOUN
iajs-3142	79	66	0.05	0.05	NUM
iajs-3142	79	67	fbg(mg	fbg(mg	X
iajs-3142	79	68	/	/	SYM
iajs-3142	79	69	dl	dl	NOUN
iajs-3142	79	70	)	)	PUNCT
iajs-3142	79	71	117.50(92.0118.0)a	117.50(92.0118.0)a	NUM
iajs-3142	79	72	,	,	PUNCT
iajs-3142	79	73	c	c	NOUN
iajs-3142	79	74	170.50(142.25236.50)b	170.50(142.25236.50)b	NUM
iajs-3142	79	75	,	,	PUNCT
iajs-3142	79	76	c	c	PROPN
iajs-3142	79	77	112.65(96.0142.63	112.65(96.0142.63	ADJ
iajs-3142	79	78	)	)	PUNCT
iajs-3142	79	79	0.000	0.000	NUM
iajs-3142	80	1	adropin(pg	adropin(pg	PROPN
iajs-3142	80	2	/	/	SYM
iajs-3142	80	3	ml	ml	NOUN
iajs-3142	80	4	)	)	PUNCT
iajs-3142	80	5	100.0(87.18111.50)a	100.0(87.18111.50)a	NUM
iajs-3142	80	6	97.75(87.70106.45)b	97.75(87.70106.45)b	NUM
iajs-3142	80	7	228.65(167.60241.18	228.65(167.60241.18	NUM
iajs-3142	80	8	)	)	PUNCT
iajs-3142	81	1	n.s	n.s	PROPN
iajs-3142	81	2	the	the	DET
iajs-3142	81	3	collected	collect	VERB
iajs-3142	81	4	data	datum	NOUN
iajs-3142	81	5	were	be	AUX
iajs-3142	81	6	analyzed	analyze	VERB
iajs-3142	81	7	by	by	ADP
iajs-3142	81	8	mean	mean	PROPN
iajs-3142	81	9	±	±	NUM
iajs-3142	81	10	stander	stander	NOUN
iajs-3142	81	11	deviation	deviation	NOUN
iajs-3142	81	12	and	and	CCONJ
iajs-3142	81	13	median	median	NOUN
iajs-3142	81	14	(	(	PUNCT
iajs-3142	81	15	25th	25th	ADJ
iajs-3142	81	16	and	and	CCONJ
iajs-3142	81	17	75th	75th	ADJ
iajs-3142	81	18	percentiles	percentile	NOUN
iajs-3142	81	19	)	)	PUNCT
iajs-3142	81	20	of	of	ADP
iajs-3142	81	21	the	the	DET
iajs-3142	81	22	obtained	obtain	VERB
iajs-3142	81	23	data	datum	NOUN
iajs-3142	81	24	were	be	AUX
iajs-3142	81	25	evaluated	evaluate	VERB
iajs-3142	81	26	using	use	VERB
iajs-3142	81	27	the	the	DET
iajs-3142	81	28	mann	mann	PROPN
iajs-3142	81	29	-	-	PUNCT
iajs-3142	81	30	whitney	whitney	PROPN
iajs-3142	81	31	test	test	NOUN
iajs-3142	81	32	at	at	ADP
iajs-3142	81	33	the	the	DET
iajs-3142	81	34	0.05	0.05	NUM
iajs-3142	81	35	threshold	threshold	NOUN
iajs-3142	81	36	;	;	PUNCT
iajs-3142	81	37	there	there	PRON
iajs-3142	81	38	was	be	VERB
iajs-3142	81	39	a	a	DET
iajs-3142	81	40	significant	significant	ADJ
iajs-3142	81	41	difference	difference	NOUN
iajs-3142	81	42	between	between	ADP
iajs-3142	81	43	the	the	DET
iajs-3142	81	44	two	two	NUM
iajs-3142	81	45	independent	independent	ADJ
iajs-3142	81	46	means	mean	NOUN
iajs-3142	81	47	.	.	PUNCT
iajs-3142	82	1	a	a	PRON
iajs-3142	82	2	)	)	PUNCT
iajs-3142	82	3	show	show	VERB
iajs-3142	82	4	how	how	SCONJ
iajs-3142	82	5	mets	met	NOUN
iajs-3142	82	6	group	group	NOUN
iajs-3142	82	7	and	and	CCONJ
iajs-3142	82	8	control	control	NOUN
iajs-3142	82	9	differ	differ	VERB
iajs-3142	82	10	significantly	significantly	ADV
iajs-3142	82	11	from	from	ADP
iajs-3142	82	12	each	each	DET
iajs-3142	82	13	other	other	ADJ
iajs-3142	82	14	.	.	PUNCT
iajs-3142	83	1	b	b	X
iajs-3142	83	2	)	)	PUNCT
iajs-3142	83	3	show	show	VERB
iajs-3142	83	4	that	that	SCONJ
iajs-3142	83	5	the	the	DET
iajs-3142	83	6	t2	t2	NOUN
iajs-3142	83	7	dm	dm	PROPN
iajs-3142	83	8	group	group	NOUN
iajs-3142	83	9	and	and	CCONJ
iajs-3142	83	10	control	control	NOUN
iajs-3142	83	11	have	have	VERB
iajs-3142	83	12	a	a	DET
iajs-3142	83	13	significant	significant	ADJ
iajs-3142	83	14	difference	difference	NOUN
iajs-3142	83	15	.	.	PUNCT
iajs-3142	84	1	c	c	X
iajs-3142	84	2	)	)	PUNCT
iajs-3142	84	3	show	show	VERB
iajs-3142	84	4	that	that	SCONJ
iajs-3142	84	5	the	the	DET
iajs-3142	84	6	mets	mets	PROPN
iajs-3142	84	7	group	group	NOUN
iajs-3142	84	8	and	and	CCONJ
iajs-3142	84	9	the	the	DET
iajs-3142	84	10	t2	t2	NOUN
iajs-3142	84	11	dm	dm	PROPN
iajs-3142	84	12	group	group	NOUN
iajs-3142	84	13	have	have	VERB
iajs-3142	84	14	important	important	ADJ
iajs-3142	84	15	differences	difference	NOUN
iajs-3142	84	16	.	.	PUNCT
iajs-3142	85	1	figure	figure	NOUN
iajs-3142	85	2	1	1	NUM
iajs-3142	85	3	.	.	PUNCT
iajs-3142	86	1	the	the	DET
iajs-3142	86	2	roc	roc	PROPN
iajs-3142	86	3	curve	curve	NOUN
iajs-3142	86	4	analysis	analysis	NOUN
iajs-3142	86	5	of	of	ADP
iajs-3142	86	6	serum	serum	NOUN
iajs-3142	86	7	adropin	adropin	ADJ
iajs-3142	86	8	concentration	concentration	NOUN
iajs-3142	86	9	in	in	ADP
iajs-3142	86	10	mets	met	NOUN
iajs-3142	86	11	patients	patient	NOUN
iajs-3142	86	12	against	against	ADP
iajs-3142	86	13	healthy	healthy	ADJ
iajs-3142	86	14	subjects	subject	NOUN
iajs-3142	86	15	0	0	NUM
iajs-3142	86	16	20	20	NUM
iajs-3142	86	17	40	40	NUM
iajs-3142	86	18	60	60	NUM
iajs-3142	86	19	80	80	NUM
iajs-3142	86	20	100	100	NUM
iajs-3142	86	21	adropin	adropin	NOUN
iajs-3142	86	22	0	0	NUM
iajs-3142	86	23	20	20	NUM
iajs-3142	86	24	40	40	NUM
iajs-3142	86	25	60	60	NUM
iajs-3142	86	26	80	80	NUM
iajs-3142	86	27	100	100	NUM
iajs-3142	86	28	100	100	NUM
iajs-3142	86	29	-	-	PUNCT
iajs-3142	86	30	specificity	specificity	NOUN
iajs-3142	86	31	s	s	PART
iajs-3142	86	32	e	e	NOUN
iajs-3142	86	33	n	n	CCONJ
iajs-3142	86	34	si	si	X
iajs-3142	86	35	ti	ti	X
iajs-3142	86	36	v	v	ADP
iajs-3142	86	37	it	it	PRON
iajs-3142	86	38	y	y	NOUN
iajs-3142	86	39	auc	auc	NOUN
iajs-3142	86	40	=	=	NOUN
iajs-3142	86	41	0.945	0.945	NUM
iajs-3142	86	42	p	p	X
iajs-3142	86	43	<	<	X
iajs-3142	86	44	0.001	0.001	NUM
iajs-3142	86	45	sensitivity	sensitivity	NOUN
iajs-3142	86	46	:	:	PUNCT
iajs-3142	86	47	100.0	100.0	NUM
iajs-3142	86	48	specificity	specificity	NOUN
iajs-3142	86	49	:	:	PUNCT
iajs-3142	86	50	80.0	80.0	NUM
iajs-3142	86	51	criterion	criterion	NOUN
iajs-3142	86	52	:	:	PUNCT
iajs-3142	86	53	≤119	≤119	PROPN
iajs-3142	86	54	ihjpas	ihjpa	VERB
iajs-3142	86	55	.	.	PUNCT
iajs-3142	87	1	37(1)2024	37(1)2024	NUM
iajs-3142	87	2	338	338	NUM
iajs-3142	87	3	table	table	NOUN
iajs-3142	87	4	4	4	NUM
iajs-3142	87	5	.	.	X
iajs-3142	87	6	adropin	adropin	ADV
iajs-3142	87	7	auc	auc	NOUN
iajs-3142	87	8	and	and	CCONJ
iajs-3142	87	9	validity	validity	NOUN
iajs-3142	87	10	in	in	ADP
iajs-3142	87	11	distinguishing	distinguish	VERB
iajs-3142	87	12	between	between	ADP
iajs-3142	87	13	mets	met	NOUN
iajs-3142	87	14	and	and	CCONJ
iajs-3142	87	15	healthy	healthy	ADJ
iajs-3142	87	16	subject	subject	NOUN
iajs-3142	87	17	(	(	PUNCT
iajs-3142	87	18	-ve	-ve	NOUN
iajs-3142	87	19	)	)	PUNCT
iajs-3142	87	20	predictive	predictive	ADJ
iajs-3142	87	21	value	value	NOUN
iajs-3142	87	22	(	(	PUNCT
iajs-3142	87	23	+	+	NOUN
iajs-3142	87	24	ve	ve	NOUN
iajs-3142	87	25	)	)	PUNCT
iajs-3142	87	26	predictive	predictive	ADJ
iajs-3142	87	27	value	value	NOUN
iajs-3142	87	28	accuracy	accuracy	NOUN
iajs-3142	87	29	specificity	specificity	NOUN
iajs-3142	87	30	sensitivity	sensitivity	NOUN
iajs-3142	87	31	cutoff	cutoff	NOUN
iajs-3142	87	32	value	value	NOUN
iajs-3142	87	33	p	p	NOUN
iajs-3142	87	34	-	-	PUNCT
iajs-3142	87	35	value	value	NOUN
iajs-3142	87	36	auc	auc	NOUN
iajs-3142	87	37	variable	variable	NOUN
iajs-3142	87	38	100.0	100.0	NUM
iajs-3142	87	39	83.0	83.0	NUM
iajs-3142	87	40	0.800	0.800	NUM
iajs-3142	87	41	80.0	80.0	NUM
iajs-3142	87	42	100.0	100.0	NUM
iajs-3142	87	43	119	119	NUM
iajs-3142	87	44	0.001	0.001	NUM
iajs-3142	87	45	0.945	0.945	NUM
iajs-3142	87	46	adropin	adropin	NOUN
iajs-3142	87	47	4	4	NUM
iajs-3142	87	48	.	.	PUNCT
iajs-3142	87	49	discussion	discussion	NOUN
iajs-3142	87	50	much	much	ADJ
iajs-3142	87	51	evidence	evidence	NOUN
iajs-3142	87	52	has	have	AUX
iajs-3142	87	53	linked	link	VERB
iajs-3142	87	54	obesity	obesity	NOUN
iajs-3142	87	55	with	with	ADP
iajs-3142	87	56	sympathetic	sympathetic	ADJ
iajs-3142	87	57	overactivity	overactivity	NOUN
iajs-3142	87	58	(	(	PUNCT
iajs-3142	87	59	increased	increase	VERB
iajs-3142	87	60	heart	heart	NOUN
iajs-3142	87	61	rate	rate	NOUN
iajs-3142	87	62	,	,	PUNCT
iajs-3142	87	63	blood	blood	NOUN
iajs-3142	87	64	pressure	pressure	NOUN
iajs-3142	87	65	,	,	PUNCT
iajs-3142	87	66	and	and	CCONJ
iajs-3142	87	67	breathing	breathing	NOUN
iajs-3142	87	68	rate	rate	NOUN
iajs-3142	87	69	)	)	PUNCT
iajs-3142	87	70	.	.	PUNCT
iajs-3142	88	1	numerous	numerous	ADJ
iajs-3142	88	2	studies	study	NOUN
iajs-3142	88	3	have	have	AUX
iajs-3142	88	4	connected	connect	VERB
iajs-3142	88	5	sympathetic	sympathetic	ADJ
iajs-3142	88	6	overactivity	overactivity	NOUN
iajs-3142	88	7	and	and	CCONJ
iajs-3142	88	8	obesity	obesity	NOUN
iajs-3142	88	9	(	(	PUNCT
iajs-3142	88	10	increased	increase	VERB
iajs-3142	88	11	heart	heart	NOUN
iajs-3142	88	12	rate	rate	NOUN
iajs-3142	88	13	,	,	PUNCT
iajs-3142	88	14	blood	blood	NOUN
iajs-3142	88	15	pressure	pressure	NOUN
iajs-3142	88	16	,	,	PUNCT
iajs-3142	88	17	and	and	CCONJ
iajs-3142	88	18	breathing	breathing	NOUN
iajs-3142	88	19	rate	rate	NOUN
iajs-3142	88	20	)	)	PUNCT
iajs-3142	89	1	[	[	X
iajs-3142	89	2	21	21	NUM
iajs-3142	89	3	]	]	PUNCT
iajs-3142	89	4	.	.	PUNCT
iajs-3142	90	1	as	as	SCONJ
iajs-3142	90	2	shown	show	VERB
iajs-3142	90	3	below	below	ADP
iajs-3142	90	4	,	,	PUNCT
iajs-3142	90	5	the	the	DET
iajs-3142	90	6	roc	roc	PROPN
iajs-3142	90	7	was	be	AUX
iajs-3142	90	8	carried	carry	VERB
iajs-3142	90	9	out	out	ADP
iajs-3142	90	10	twice	twice	ADV
iajs-3142	90	11	,	,	PUNCT
iajs-3142	90	12	once	once	ADV
iajs-3142	90	13	for	for	ADP
iajs-3142	90	14	mets	met	NOUN
iajs-3142	90	15	patients	patient	NOUN
iajs-3142	90	16	from	from	ADP
iajs-3142	90	17	healthy	healthy	ADJ
iajs-3142	90	18	subjects	subject	NOUN
iajs-3142	90	19	and	and	CCONJ
iajs-3142	90	20	once	once	ADV
iajs-3142	90	21	for	for	ADP
iajs-3142	90	22	t2	t2	NOUN
iajs-3142	90	23	dm	dm	PROPN
iajs-3142	90	24	patients	patient	NOUN
iajs-3142	90	25	from	from	ADP
iajs-3142	90	26	healthy	healthy	ADJ
iajs-3142	90	27	subjects	subject	NOUN
iajs-3142	90	28	[	[	X
iajs-3142	90	29	22	22	NUM
iajs-3142	90	30	]	]	PUNCT
iajs-3142	90	31	.	.	PUNCT
iajs-3142	91	1	using	use	VERB
iajs-3142	91	2	roc	roc	PROPN
iajs-3142	91	3	curve	curve	NOUN
iajs-3142	91	4	analysis	analysis	NOUN
iajs-3142	91	5	,	,	PUNCT
iajs-3142	91	6	the	the	DET
iajs-3142	91	7	ability	ability	NOUN
iajs-3142	91	8	of	of	ADP
iajs-3142	91	9	serum	serum	NOUN
iajs-3142	91	10	adropin	adropin	PROPN
iajs-3142	91	11	levels	level	NOUN
iajs-3142	91	12	to	to	PART
iajs-3142	91	13	identify	identify	VERB
iajs-3142	91	14	mets	met	NOUN
iajs-3142	91	15	patients	patient	NOUN
iajs-3142	91	16	from	from	ADP
iajs-3142	91	17	healthy	healthy	ADJ
iajs-3142	91	18	individuals	individual	NOUN
iajs-3142	91	19	was	be	AUX
iajs-3142	91	20	examined	examine	VERB
iajs-3142	91	21	table	table	NOUN
iajs-3142	91	22	4	4	NUM
iajs-3142	91	23	and	and	CCONJ
iajs-3142	91	24	figure	figure	VERB
iajs-3142	91	25	1	1	NUM
iajs-3142	91	26	.	.	PUNCT
iajs-3142	92	1	the	the	DET
iajs-3142	92	2	roc	roc	PROPN
iajs-3142	92	3	curve	curve	NOUN
iajs-3142	92	4	was	be	AUX
iajs-3142	92	5	significantly	significantly	ADV
iajs-3142	92	6	lower	low	ADJ
iajs-3142	92	7	than	than	ADP
iajs-3142	92	8	the	the	DET
iajs-3142	92	9	diagnostic	diagnostic	ADJ
iajs-3142	92	10	test	test	NOUN
iajs-3142	92	11	for	for	ADP
iajs-3142	92	12	mets	met	NOUN
iajs-3142	92	13	,	,	PUNCT
iajs-3142	92	14	but	but	CCONJ
iajs-3142	92	15	it	it	PRON
iajs-3142	92	16	had	have	VERB
iajs-3142	92	17	higher	high	ADJ
iajs-3142	92	18	validity	validity	NOUN
iajs-3142	92	19	(	(	PUNCT
iajs-3142	92	20	high	high	ADJ
iajs-3142	92	21	sensitivity	sensitivity	NOUN
iajs-3142	92	22	(	(	PUNCT
iajs-3142	92	23	100.0	100.0	NUM
iajs-3142	92	24	)	)	PUNCT
iajs-3142	92	25	and	and	CCONJ
iajs-3142	92	26	specificity	specificity	NOUN
iajs-3142	92	27	(	(	PUNCT
iajs-3142	92	28	80.0	80.0	NUM
iajs-3142	92	29	)	)	PUNCT
iajs-3142	92	30	.	.	PUNCT
iajs-3142	93	1	the	the	DET
iajs-3142	93	2	area	area	NOUN
iajs-3142	93	3	under	under	ADP
iajs-3142	93	4	the	the	DET
iajs-3142	93	5	curve	curve	NOUN
iajs-3142	93	6	(	(	PUNCT
iajs-3142	93	7	auc	auc	NOUN
iajs-3142	93	8	)	)	PUNCT
iajs-3142	93	9	of	of	ADP
iajs-3142	93	10	the	the	DET
iajs-3142	93	11	receiver	receiver	NOUN
iajs-3142	93	12	operating	operate	VERB
iajs-3142	93	13	characteristic	characteristic	ADJ
iajs-3142	93	14	curve	curve	NOUN
iajs-3142	93	15	for	for	ADP
iajs-3142	93	16	the	the	DET
iajs-3142	93	17	existence	existence	NOUN
iajs-3142	93	18	of	of	ADP
iajs-3142	93	19	a	a	DET
iajs-3142	93	20	mets	met	NOUN
iajs-3142	93	21	diagnosis	diagnosis	NOUN
iajs-3142	93	22	was	be	AUX
iajs-3142	93	23	119	119	NUM
iajs-3142	93	24	(	(	PUNCT
iajs-3142	93	25	p	p	X
iajs-3142	93	26	<	<	X
iajs-3142	93	27	0.001	0.001	NUM
iajs-3142	93	28	)	)	PUNCT
iajs-3142	93	29	,	,	PUNCT
iajs-3142	93	30	which	which	PRON
iajs-3142	93	31	was	be	AUX
iajs-3142	93	32	the	the	DET
iajs-3142	93	33	optimal	optimal	ADJ
iajs-3142	93	34	level	level	NOUN
iajs-3142	93	35	of	of	ADP
iajs-3142	93	36	correct	correct	ADJ
iajs-3142	93	37	mets	met	NOUN
iajs-3142	93	38	prediction	prediction	NOUN
iajs-3142	93	39	[	[	X
iajs-3142	93	40	23	23	NUM
iajs-3142	93	41	]	]	PUNCT
iajs-3142	93	42	.	.	PUNCT
iajs-3142	94	1	diabetes	diabetes	NOUN
iajs-3142	94	2	and	and	CCONJ
iajs-3142	94	3	low	low	ADJ
iajs-3142	94	4	blood	blood	NOUN
iajs-3142	94	5	adropin	adropin	NOUN
iajs-3142	94	6	levels	level	NOUN
iajs-3142	94	7	trigger	trigger	NOUN
iajs-3142	94	8	atherosclerosis	atherosclerosis	NOUN
iajs-3142	94	9	;	;	PUNCT
iajs-3142	94	10	hence	hence	ADV
iajs-3142	94	11	,	,	PUNCT
iajs-3142	94	12	their	their	PRON
iajs-3142	94	13	interaction	interaction	NOUN
iajs-3142	94	14	may	may	AUX
iajs-3142	94	15	result	result	VERB
iajs-3142	94	16	in	in	ADP
iajs-3142	94	17	more	more	ADV
iajs-3142	94	18	severe	severe	ADJ
iajs-3142	94	19	atherosclerosis	atherosclerosis	NOUN
iajs-3142	94	20	.	.	PUNCT
iajs-3142	95	1	additional	additional	ADJ
iajs-3142	95	2	research	research	NOUN
iajs-3142	95	3	is	be	AUX
iajs-3142	95	4	required	require	VERB
iajs-3142	95	5	to	to	PART
iajs-3142	95	6	determine	determine	VERB
iajs-3142	95	7	how	how	SCONJ
iajs-3142	95	8	adropin	adropin	NOUN
iajs-3142	95	9	,	,	PUNCT
iajs-3142	95	10	diabetes	diabetes	NOUN
iajs-3142	95	11	,	,	PUNCT
iajs-3142	95	12	and	and	CCONJ
iajs-3142	95	13	atherosclerosis	atherosclerosis	NOUN
iajs-3142	95	14	are	be	AUX
iajs-3142	95	15	related	relate	VERB
iajs-3142	95	16	causally	causally	ADV
iajs-3142	95	17	[	[	X
iajs-3142	95	18	24,25,26	24,25,26	NUM
iajs-3142	95	19	]	]	X
iajs-3142	95	20	.	.	PUNCT
iajs-3142	96	1	adropin	adropin	NOUN
iajs-3142	96	2	participates	participate	VERB
iajs-3142	96	3	in	in	ADP
iajs-3142	96	4	several	several	ADJ
iajs-3142	96	5	biological	biological	ADJ
iajs-3142	96	6	processes	process	NOUN
iajs-3142	96	7	and	and	CCONJ
iajs-3142	96	8	is	be	AUX
iajs-3142	96	9	controlled	control	VERB
iajs-3142	96	10	by	by	ADP
iajs-3142	96	11	various	various	ADJ
iajs-3142	96	12	nutrients	nutrient	NOUN
iajs-3142	96	13	,	,	PUNCT
iajs-3142	96	14	including	include	VERB
iajs-3142	96	15	lipids	lipid	NOUN
iajs-3142	96	16	and	and	CCONJ
iajs-3142	96	17	carbohydrates	carbohydrate	NOUN
iajs-3142	96	18	[	[	X
iajs-3142	96	19	27	27	NUM
iajs-3142	96	20	]	]	PUNCT
iajs-3142	96	21	.	.	PUNCT
iajs-3142	97	1	adropin	adropin	ADJ
iajs-3142	97	2	treatment	treatment	NOUN
iajs-3142	97	3	can	can	AUX
iajs-3142	97	4	increase	increase	VERB
iajs-3142	97	5	glucose	glucose	NOUN
iajs-3142	97	6	oxidation	oxidation	NOUN
iajs-3142	97	7	and	and	CCONJ
iajs-3142	97	8	decrease	decrease	VERB
iajs-3142	97	9	fatty	fatty	NOUN
iajs-3142	97	10	acid	acid	NOUN
iajs-3142	97	11	oxidation	oxidation	NOUN
iajs-3142	97	12	in	in	ADP
iajs-3142	97	13	skeletal	skeletal	ADJ
iajs-3142	97	14	muscle	muscle	NOUN
iajs-3142	97	15	cells	cell	NOUN
iajs-3142	97	16	[	[	X
iajs-3142	97	17	28	28	NUM
iajs-3142	97	18	]	]	PUNCT
iajs-3142	97	19	.	.	PUNCT
iajs-3142	98	1	a	a	DET
iajs-3142	98	2	drop	drop	NOUN
iajs-3142	98	3	in	in	ADP
iajs-3142	98	4	can	can	AUX
iajs-3142	98	5	lessen	lessen	VERB
iajs-3142	98	6	ir	ir	PROPN
iajs-3142	98	7	and	and	CCONJ
iajs-3142	98	8	delay	delay	VERB
iajs-3142	98	9	the	the	DET
iajs-3142	98	10	onset	onset	NOUN
iajs-3142	98	11	of	of	ADP
iajs-3142	98	12	obesity	obesity	NOUN
iajs-3142	98	13	by	by	ADP
iajs-3142	98	14	improving	improve	VERB
iajs-3142	98	15	lipid	lipid	NOUN
iajs-3142	98	16	catabolism	catabolism	NOUN
iajs-3142	98	17	,	,	PUNCT
iajs-3142	98	18	which	which	PRON
iajs-3142	98	19	has	have	VERB
iajs-3142	98	20	preventive	preventive	ADJ
iajs-3142	98	21	effects	effect	NOUN
iajs-3142	98	22	in	in	ADP
iajs-3142	98	23	t2	t2	NOUN
iajs-3142	98	24	dm	dm	NOUN
iajs-3142	98	25	.	.	PUNCT
iajs-3142	99	1	inhibiting	inhibit	VERB
iajs-3142	99	2	the	the	DET
iajs-3142	99	3	development	development	NOUN
iajs-3142	99	4	of	of	ADP
iajs-3142	99	5	3t3	3t3	PROPN
iajs-3142	99	6	-	-	PUNCT
iajs-3142	99	7	l1	l1	NOUN
iajs-3142	99	8	preadipocytes	preadipocyte	NOUN
iajs-3142	99	9	into	into	ADP
iajs-3142	99	10	mature	mature	ADJ
iajs-3142	99	11	adipocytes	adipocyte	NOUN
iajs-3142	99	12	,	,	PUNCT
iajs-3142	99	13	which	which	PRON
iajs-3142	99	14	reduces	reduce	VERB
iajs-3142	99	15	fat	fat	ADJ
iajs-3142	99	16	accumulation	accumulation	NOUN
iajs-3142	99	17	and	and	CCONJ
iajs-3142	99	18	inflammation	inflammation	NOUN
iajs-3142	99	19	,	,	PUNCT
iajs-3142	99	20	is	be	AUX
iajs-3142	99	21	how	how	SCONJ
iajs-3142	99	22	adropin	adropin	NOUN
iajs-3142	99	23	controls	control	VERB
iajs-3142	99	24	the	the	DET
iajs-3142	99	25	expression	expression	NOUN
iajs-3142	99	26	of	of	ADP
iajs-3142	99	27	peroxisome	peroxisome	VERB
iajs-3142	99	28	proliferator	proliferator	PROPN
iajs-3142	99	29	-	-	PUNCT
iajs-3142	99	30	activated	activate	VERB
iajs-3142	99	31	receptors	receptor	NOUN
iajs-3142	99	32	-	-	PUNCT
iajs-3142	99	33	γ	γ	X
iajs-3142	99	34	.	.	PUNCT
iajs-3142	100	1	another	another	DET
iajs-3142	100	2	study	study	NOUN
iajs-3142	100	3	found	find	VERB
iajs-3142	100	4	that	that	SCONJ
iajs-3142	100	5	patients	patient	NOUN
iajs-3142	100	6	with	with	ADP
iajs-3142	100	7	moderate	moderate	ADJ
iajs-3142	100	8	and	and	CCONJ
iajs-3142	100	9	severe	severe	ADJ
iajs-3142	100	10	obstructive	obstructive	ADJ
iajs-3142	100	11	sleep	sleep	NOUN
iajs-3142	100	12	apnea	apnea	NOUN
iajs-3142	100	13	had	have	AUX
iajs-3142	100	14	decreased	decrease	VERB
iajs-3142	100	15	plasma	plasma	NOUN
iajs-3142	100	16	levels	level	NOUN
iajs-3142	100	17	of	of	ADP
iajs-3142	100	18	adropin	adropin	NOUN
iajs-3142	100	19	and	and	CCONJ
iajs-3142	100	20	higher	high	ADJ
iajs-3142	100	21	levels	level	NOUN
iajs-3142	100	22	of	of	ADP
iajs-3142	100	23	inflammation	inflammation	ADJ
iajs-3142	100	24	markers	marker	NOUN
iajs-3142	100	25	like	like	ADP
iajs-3142	100	26	tumor	tumor	NOUN
iajs-3142	100	27	necrosis	necrosis	NOUN
iajs-3142	100	28	factor	factor	NOUN
iajs-3142	100	29	and	and	CCONJ
iajs-3142	100	30	interleukin-6	interleukin-6	PROPN
iajs-3142	100	31	compared	compare	VERB
iajs-3142	100	32	to	to	ADP
iajs-3142	100	33	healthy	healthy	ADJ
iajs-3142	100	34	people	people	NOUN
iajs-3142	100	35	[	[	X
iajs-3142	100	36	29,30	29,30	NUM
iajs-3142	100	37	]	]	PUNCT
iajs-3142	100	38	.	.	PUNCT
iajs-3142	101	1	the	the	DET
iajs-3142	101	2	auc	auc	NOUN
iajs-3142	101	3	refers	refer	VERB
iajs-3142	101	4	to	to	ADP
iajs-3142	101	5	the	the	DET
iajs-3142	101	6	area	area	NOUN
iajs-3142	101	7	under	under	ADP
iajs-3142	101	8	the	the	DET
iajs-3142	101	9	curve	curve	NOUN
iajs-3142	101	10	.	.	PUNCT
iajs-3142	102	1	while	while	SCONJ
iajs-3142	102	2	the	the	DET
iajs-3142	102	3	negative	negative	ADJ
iajs-3142	102	4	predictive	predictive	ADJ
iajs-3142	102	5	value	value	NOUN
iajs-3142	102	6	and	and	CCONJ
iajs-3142	102	7	positive	positive	ADJ
iajs-3142	102	8	predictive	predictive	ADJ
iajs-3142	102	9	value	value	NOUN
iajs-3142	102	10	,	,	PUNCT
iajs-3142	102	11	respectively	respectively	ADV
iajs-3142	102	12	.	.	PUNCT
iajs-3142	103	1	the	the	DET
iajs-3142	103	2	roc	roc	PROPN
iajs-3142	103	3	curve	curve	NOUN
iajs-3142	103	4	analysis	analysis	NOUN
iajs-3142	103	5	was	be	AUX
iajs-3142	103	6	used	use	VERB
iajs-3142	103	7	to	to	PART
iajs-3142	103	8	see	see	VERB
iajs-3142	103	9	how	how	SCONJ
iajs-3142	103	10	the	the	DET
iajs-3142	103	11	serum	serum	NOUN
iajs-3142	103	12	adropin	adropin	NOUN
iajs-3142	103	13	level	level	NOUN
iajs-3142	103	14	could	could	AUX
iajs-3142	103	15	show	show	VERB
iajs-3142	103	16	the	the	DET
iajs-3142	103	17	difference	difference	NOUN
iajs-3142	103	18	between	between	ADP
iajs-3142	103	19	patients	patient	NOUN
iajs-3142	103	20	with	with	ADP
iajs-3142	103	21	t2	t2	PROPN
iajs-3142	103	22	dm	dm	PROPN
iajs-3142	103	23	and	and	CCONJ
iajs-3142	103	24	healthy	healthy	ADJ
iajs-3142	103	25	subjects	subject	NOUN
iajs-3142	103	26	table	table	VERB
iajs-3142	103	27	5	5	NUM
iajs-3142	103	28	and	and	CCONJ
iajs-3142	103	29	figure	figure	VERB
iajs-3142	103	30	2	2	NUM
iajs-3142	103	31	.	.	PUNCT
iajs-3142	104	1	the	the	DET
iajs-3142	104	2	roc	roc	PROPN
iajs-3142	104	3	curve	curve	NOUN
iajs-3142	104	4	was	be	AUX
iajs-3142	104	5	significantly	significantly	ADV
iajs-3142	104	6	lower	low	ADJ
iajs-3142	104	7	than	than	ADP
iajs-3142	104	8	the	the	DET
iajs-3142	104	9	diagnostic	diagnostic	ADJ
iajs-3142	104	10	test	test	NOUN
iajs-3142	104	11	for	for	ADP
iajs-3142	104	12	t2	t2	PROPN
iajs-3142	104	13	dm	dm	PROPN
iajs-3142	104	14	,	,	PUNCT
iajs-3142	104	15	indicating	indicate	VERB
iajs-3142	104	16	greater	great	ADJ
iajs-3142	104	17	validity	validity	NOUN
iajs-3142	104	18	;	;	PUNCT
iajs-3142	104	19	high	high	ADJ
iajs-3142	104	20	sensitivity	sensitivity	NOUN
iajs-3142	104	21	(	(	PUNCT
iajs-3142	104	22	95.0	95.0	NUM
iajs-3142	104	23	)	)	PUNCT
iajs-3142	104	24	and	and	CCONJ
iajs-3142	104	25	specificity	specificity	NOUN
iajs-3142	104	26	(	(	PUNCT
iajs-3142	104	27	87.5	87.5	NUM
iajs-3142	104	28	)	)	PUNCT
iajs-3142	104	29	.	.	PUNCT
iajs-3142	105	1	the	the	DET
iajs-3142	105	2	auc	auc	NOUN
iajs-3142	105	3	of	of	ADP
iajs-3142	105	4	the	the	DET
iajs-3142	105	5	roc	roc	PROPN
iajs-3142	105	6	curve	curve	NOUN
iajs-3142	105	7	for	for	ADP
iajs-3142	105	8	the	the	DET
iajs-3142	105	9	presence	presence	NOUN
iajs-3142	105	10	of	of	ADP
iajs-3142	105	11	a	a	DET
iajs-3142	105	12	diagnosis	diagnosis	NOUN
iajs-3142	105	13	determined	determine	VERB
iajs-3142	105	14	the	the	DET
iajs-3142	105	15	optimal	optimal	ADJ
iajs-3142	105	16	level	level	NOUN
iajs-3142	105	17	of	of	ADP
iajs-3142	105	18	correct	correct	ADJ
iajs-3142	105	19	t2	t2	NOUN
iajs-3142	105	20	dm	dm	NOUN
iajs-3142	105	21	prediction	prediction	NOUN
iajs-3142	105	22	to	to	PART
iajs-3142	105	23	be	be	AUX
iajs-3142	105	24	0.956	0.956	NUM
iajs-3142	105	25	(	(	PUNCT
iajs-3142	105	26	p=	p=	NOUN
iajs-3142	105	27	0.001	0.001	NUM
iajs-3142	105	28	)	)	PUNCT
iajs-3142	105	29	.	.	PUNCT
iajs-3142	106	1	5	5	X
iajs-3142	106	2	.	.	X
iajs-3142	106	3	conclusion	conclusion	NOUN
iajs-3142	106	4	in	in	ADP
iajs-3142	106	5	conclusion	conclusion	NOUN
iajs-3142	106	6	,	,	PUNCT
iajs-3142	106	7	according	accord	VERB
iajs-3142	106	8	to	to	ADP
iajs-3142	106	9	the	the	DET
iajs-3142	106	10	present	present	ADJ
iajs-3142	106	11	data	datum	NOUN
iajs-3142	106	12	,	,	PUNCT
iajs-3142	106	13	higher	high	ADJ
iajs-3142	106	14	levels	level	NOUN
iajs-3142	106	15	of	of	ADP
iajs-3142	106	16	fbg	fbg	PROPN
iajs-3142	106	17	,	,	PUNCT
iajs-3142	106	18	lipid	lipid	NOUN
iajs-3142	106	19	profile	profile	NOUN
iajs-3142	106	20	,	,	PUNCT
iajs-3142	106	21	and	and	CCONJ
iajs-3142	106	22	increased	increase	VERB
iajs-3142	106	23	bp	bp	PROPN
iajs-3142	106	24	were	be	AUX
iajs-3142	106	25	found	find	VERB
iajs-3142	106	26	in	in	ADP
iajs-3142	106	27	patients	patient	NOUN
iajs-3142	106	28	with	with	ADP
iajs-3142	106	29	mets	met	NOUN
iajs-3142	106	30	and	and	CCONJ
iajs-3142	106	31	t2	t2	NOUN
iajs-3142	106	32	dm	dm	PROPN
iajs-3142	106	33	.	.	PUNCT
iajs-3142	107	1	adropin	adropin	ADJ
iajs-3142	107	2	level	level	NOUN
iajs-3142	107	3	could	could	AUX
iajs-3142	107	4	be	be	AUX
iajs-3142	107	5	considered	consider	VERB
iajs-3142	107	6	a	a	DET
iajs-3142	107	7	novel	novel	ADJ
iajs-3142	107	8	indicator	indicator	NOUN
iajs-3142	107	9	of	of	ADP
iajs-3142	107	10	mets	met	NOUN
iajs-3142	107	11	and	and	CCONJ
iajs-3142	107	12	t2	t2	NOUN
iajs-3142	107	13	dm	dm	PROPN
iajs-3142	107	14	.	.	PUNCT
iajs-3142	107	15	compared	compare	VERB
iajs-3142	107	16	to	to	ADP
iajs-3142	107	17	t2	t2	PROPN
iajs-3142	107	18	dm	dm	PROPN
iajs-3142	107	19	patients	patient	NOUN
iajs-3142	107	20	,	,	PUNCT
iajs-3142	107	21	it	it	PRON
iajs-3142	107	22	is	be	AUX
iajs-3142	107	23	thought	think	VERB
iajs-3142	107	24	that	that	SCONJ
iajs-3142	107	25	adropin	adropin	NOUN
iajs-3142	107	26	levels	level	NOUN
iajs-3142	107	27	have	have	VERB
iajs-3142	107	28	a	a	DET
iajs-3142	107	29	more	more	ADV
iajs-3142	107	30	sensitive	sensitive	ADJ
iajs-3142	107	31	diagnostic	diagnostic	ADJ
iajs-3142	107	32	function	function	NOUN
iajs-3142	107	33	than	than	ADP
iajs-3142	107	34	those	those	PRON
iajs-3142	107	35	with	with	ADP
iajs-3142	107	36	mets	met	NOUN
iajs-3142	107	37	and	and	CCONJ
iajs-3142	107	38	newly	newly	ADV
iajs-3142	107	39	diagnosed	diagnose	VERB
iajs-3142	107	40	dm	dm	PROPN
iajs-3142	107	41	.	.	PUNCT
iajs-3142	107	42	ihjpas	ihjpas	PROPN
iajs-3142	107	43	.	.	PUNCT
iajs-3142	108	1	37(1)2024	37(1)2024	NUM
iajs-3142	108	2	339	339	NUM
iajs-3142	108	3	acknowledgment	acknowledgment	NOUN
iajs-3142	108	4	:	:	PUNCT
iajs-3142	108	5	the	the	DET
iajs-3142	108	6	authors	author	NOUN
iajs-3142	108	7	thank	thank	VERB
iajs-3142	108	8	the	the	DET
iajs-3142	108	9	college	college	NOUN
iajs-3142	108	10	of	of	ADP
iajs-3142	108	11	sciences	science	NOUN
iajs-3142	108	12	for	for	ADP
iajs-3142	108	13	women/	women/	NUM
iajs-3142	108	14	university	university	NOUN
iajs-3142	108	15	of	of	ADP
iajs-3142	108	16	baghdad	baghdad	PROPN
iajs-3142	108	17	staff	staff	NOUN
iajs-3142	108	18	for	for	ADP
iajs-3142	108	19	their	their	PRON
iajs-3142	108	20	assistance	assistance	NOUN
iajs-3142	108	21	in	in	ADP
iajs-3142	108	22	completing	complete	VERB
iajs-3142	108	23	this	this	DET
iajs-3142	108	24	study	study	NOUN
iajs-3142	108	25	.	.	PUNCT
iajs-3142	109	1	conflict	conflict	NOUN
iajs-3142	109	2	of	of	ADP
iajs-3142	109	3	interest	interest	NOUN
iajs-3142	109	4	:	:	PUNCT
iajs-3142	109	5	none	none	NOUN
iajs-3142	109	6	.	.	PUNCT
iajs-3142	110	1	funding	funding	NOUN
iajs-3142	110	2	:	:	PUNCT
iajs-3142	110	3	none	none	NOUN
iajs-3142	110	4	.	.	PUNCT
iajs-3142	111	1	ethical	ethical	ADJ
iajs-3142	111	2	clearance	clearance	NOUN
iajs-3142	111	3	:	:	PUNCT
iajs-3142	111	4	this	this	DET
iajs-3142	111	5	study	study	NOUN
iajs-3142	111	6	was	be	AUX
iajs-3142	111	7	approved	approve	VERB
iajs-3142	111	8	by	by	ADP
iajs-3142	111	9	the	the	DET
iajs-3142	111	10	scientific	scientific	ADJ
iajs-3142	111	11	committee	committee	NOUN
iajs-3142	111	12	in	in	ADP
iajs-3142	111	13	the	the	DET
iajs-3142	111	14	college	college	NOUN
iajs-3142	111	15	of	of	ADP
iajs-3142	111	16	sciences	science	NOUN
iajs-3142	111	17	for	for	ADP
iajs-3142	111	18	women/	women/	NUM
iajs-3142	111	19	university	university	NOUN
iajs-3142	111	20	of	of	ADP
iajs-3142	111	21	baghdad	baghdad	PROPN
iajs-3142	111	22	,	,	PUNCT
iajs-3142	111	23	and	and	CCONJ
iajs-3142	111	24	verbal	verbal	ADJ
iajs-3142	111	25	consent	consent	NOUN
iajs-3142	111	26	was	be	AUX
iajs-3142	111	27	obtained	obtain	VERB
iajs-3142	111	28	from	from	ADP
iajs-3142	111	29	each	each	DET
iajs-3142	111	30	participant	participant	NOUN
iajs-3142	111	31	enrolled	enrol	VERB
iajs-3142	111	32	.	.	PUNCT
iajs-3142	112	1	references	reference	NOUN
iajs-3142	112	2	1	1	NUM
iajs-3142	112	3	.	.	PUNCT
iajs-3142	113	1	schneider	schneider	PROPN
iajs-3142	113	2	,	,	PUNCT
iajs-3142	113	3	j.g	j.g	PROPN
iajs-3142	113	4	.	.	PROPN
iajs-3142	113	5	;	;	PUNCT
iajs-3142	113	6	tompkins	tompkins	PROPN
iajs-3142	113	7	,	,	PUNCT
iajs-3142	113	8	c.	c.	PROPN
iajs-3142	113	9	;	;	PUNCT
iajs-3142	113	10	blumenthal	blumenthal	PROPN
iajs-3142	113	11	,	,	PUNCT
iajs-3142	113	12	r.s	r.s	PROPN
iajs-3142	113	13	.	.	PROPN
iajs-3142	113	14	;	;	PUNCT
iajs-3142	113	15	mora	mora	PROPN
iajs-3142	113	16	,	,	PUNCT
iajs-3142	113	17	s.	s.	PROPN
iajs-3142	113	18	the	the	DET
iajs-3142	113	19	metabolic	metabolic	NOUN
iajs-3142	113	20	syndrome	syndrome	NOUN
iajs-3142	113	21	in	in	ADP
iajs-3142	113	22	women	woman	NOUN
iajs-3142	113	23	.	.	PUNCT
iajs-3142	114	1	cardiol	cardiol	NOUN
iajs-3142	114	2	.	.	PUNCT
iajs-3142	115	1	rev	rev	PROPN
iajs-3142	115	2	.	.	PROPN
iajs-3142	115	3	2006	2006	NUM
iajs-3142	115	4	,	,	PUNCT
iajs-3142	115	5	14(6	14(6	NOUN
iajs-3142	115	6	)	)	PUNCT
iajs-3142	115	7	,	,	PUNCT
iajs-3142	115	8	286–291	286–291	NUM
iajs-3142	115	9	.	.	PUNCT
iajs-3142	116	1	https://doi	https://doi	ADJ
iajs-3142	116	2	:	:	PUNCT
iajs-3142	116	3	10.1097/01.crd.0000233757.15181.67	10.1097/01.crd.0000233757.15181.67	NOUN
iajs-3142	116	4	.	.	NOUN
iajs-3142	117	1	2	2	NUM
iajs-3142	117	2	.	.	X
iajs-3142	117	3	kumar	kumar	PROPN
iajs-3142	117	4	,	,	PUNCT
iajs-3142	117	5	k.g	k.g	PROPN
iajs-3142	117	6	.	.	PROPN
iajs-3142	117	7	;	;	PUNCT
iajs-3142	117	8	trevaskis	trevaskis	PROPN
iajs-3142	117	9	,	,	PUNCT
iajs-3142	117	10	j.l	j.l	PROPN
iajs-3142	117	11	.	.	PROPN
iajs-3142	117	12	;	;	PUNCT
iajs-3142	118	1	lam	lam	PROPN
iajs-3142	118	2	,	,	PUNCT
iajs-3142	118	3	d.d	d.d	PROPN
iajs-3142	118	4	.	.	PROPN
iajs-3142	118	5	;	;	PUNCT
iajs-3142	118	6	sutton	sutton	PROPN
iajs-3142	118	7	,	,	PUNCT
iajs-3142	118	8	g.m	g.m	PROPN
iajs-3142	118	9	.	.	PROPN
iajs-3142	118	10	;	;	PUNCT
iajs-3142	118	11	koza	koza	PROPN
iajs-3142	118	12	,	,	PUNCT
iajs-3142	118	13	r.a	r.a	PROPN
iajs-3142	118	14	.	.	PROPN
iajs-3142	118	15	;	;	PUNCT
iajs-3142	118	16	chouljenko	chouljenko	PROPN
iajs-3142	118	17	,	,	PUNCT
iajs-3142	118	18	v.n	v.n	PROPN
iajs-3142	118	19	.	.	PROPN
iajs-3142	118	20	;	;	PUNCT
iajs-3142	118	21	kousoulas	kousoulas	PROPN
iajs-3142	118	22	,	,	PUNCT
iajs-3142	118	23	k.g	k.g	PROPN
iajs-3142	118	24	.	.	PROPN
iajs-3142	118	25	;	;	PUNCT
iajs-3142	118	26	rogers	roger	NOUN
iajs-3142	118	27	,	,	PUNCT
iajs-3142	118	28	p.m.	p.m.	NOUN
iajs-3142	118	29	;	;	PUNCT
iajs-3142	118	30	kesterson	kesterson	NOUN
iajs-3142	118	31	,	,	PUNCT
iajs-3142	118	32	r.a	r.a	PROPN
iajs-3142	118	33	.	.	PROPN
iajs-3142	118	34	;	;	PUNCT
iajs-3142	118	35	thearle	thearle	NOUN
iajs-3142	118	36	,	,	PUNCT
iajs-3142	118	37	m.	m.	NOUN
iajs-3142	118	38	identification	identification	NOUN
iajs-3142	118	39	of	of	ADP
iajs-3142	118	40	adropin	adropin	NOUN
iajs-3142	118	41	as	as	ADP
iajs-3142	118	42	a	a	DET
iajs-3142	118	43	secreted	secrete	VERB
iajs-3142	118	44	factor	factor	NOUN
iajs-3142	118	45	linking	link	VERB
iajs-3142	118	46	dietary	dietary	ADJ
iajs-3142	118	47	macronutrient	macronutrient	NOUN
iajs-3142	118	48	intake	intake	NOUN
iajs-3142	118	49	with	with	ADP
iajs-3142	118	50	energy	energy	NOUN
iajs-3142	118	51	homeostasis	homeostasis	NOUN
iajs-3142	118	52	and	and	CCONJ
iajs-3142	118	53	lipid	lipid	NOUN
iajs-3142	118	54	metabolism	metabolism	NOUN
iajs-3142	118	55	.	.	PUNCT
iajs-3142	119	1	cell	cell	NOUN
iajs-3142	119	2	metab	metab	NOUN
iajs-3142	119	3	.	.	PUNCT
iajs-3142	120	1	2008	2008	NUM
iajs-3142	120	2	,	,	PUNCT
iajs-3142	120	3	8(6	8(6	NUM
iajs-3142	120	4	)	)	PUNCT
iajs-3142	120	5	,	,	PUNCT
iajs-3142	120	6	468–481	468–481	NUM
iajs-3142	120	7	.	.	PUNCT
iajs-3142	121	1	https://doi	https://doi	ADV
iajs-3142	121	2	:	:	PUNCT
iajs-3142	121	3	10.1016	10.1016	NUM
iajs-3142	121	4	/	/	SYM
iajs-3142	121	5	j.cmet.2008.10.011	j.cmet.2008.10.011	PROPN
iajs-3142	121	6	.	.	PROPN
iajs-3142	122	1	3	3	X
iajs-3142	122	2	.	.	X
iajs-3142	122	3	gao	gao	PROPN
iajs-3142	122	4	,	,	PUNCT
iajs-3142	122	5	s.	s.	PROPN
iajs-3142	122	6	;	;	PUNCT
iajs-3142	122	7	mcmillan	mcmillan	PROPN
iajs-3142	122	8	,	,	PUNCT
iajs-3142	122	9	r.p	r.p	PROPN
iajs-3142	122	10	.	.	PROPN
iajs-3142	122	11	;	;	PUNCT
iajs-3142	122	12	jacas	jacas	PROPN
iajs-3142	122	13	,	,	PUNCT
iajs-3142	122	14	j.	j.	PROPN
iajs-3142	122	15	;	;	PUNCT
iajs-3142	122	16	zhu	zhu	PROPN
iajs-3142	122	17	,	,	PUNCT
iajs-3142	122	18	q.	q.	PROPN
iajs-3142	122	19	;	;	PUNCT
iajs-3142	122	20	li	li	PROPN
iajs-3142	122	21	,	,	PUNCT
iajs-3142	122	22	x.	x.	PROPN
iajs-3142	122	23	;	;	PUNCT
iajs-3142	122	24	kumar	kumar	PROPN
iajs-3142	122	25	,	,	PUNCT
iajs-3142	122	26	g.k	g.k	PROPN
iajs-3142	122	27	.	.	PROPN
iajs-3142	122	28	;	;	PUNCT
iajs-3142	122	29	casals	casal	NOUN
iajs-3142	122	30	,	,	PUNCT
iajs-3142	122	31	n.	n.	NOUN
iajs-3142	122	32	;	;	PUNCT
iajs-3142	122	33	hegardt	hegardt	NOUN
iajs-3142	122	34	,	,	PUNCT
iajs-3142	122	35	f.g	f.g	PROPN
iajs-3142	122	36	.	.	PROPN
iajs-3142	122	37	;	;	PUNCT
iajs-3142	122	38	robbins	robbins	PROPN
iajs-3142	122	39	,	,	PUNCT
iajs-3142	122	40	p.d	p.d	PROPN
iajs-3142	122	41	.	.	PROPN
iajs-3142	122	42	;	;	PUNCT
iajs-3142	122	43	lopaschuk	lopaschuk	NOUN
iajs-3142	122	44	,	,	PUNCT
iajs-3142	122	45	g.d	g.d	PROPN
iajs-3142	122	46	.	.	PROPN
iajs-3142	122	47	regulation	regulation	NOUN
iajs-3142	122	48	of	of	ADP
iajs-3142	122	49	substrate	substrate	NOUN
iajs-3142	122	50	oxidation	oxidation	NOUN
iajs-3142	122	51	preferences	preference	NOUN
iajs-3142	122	52	in	in	ADP
iajs-3142	122	53	muscle	muscle	NOUN
iajs-3142	122	54	by	by	ADP
iajs-3142	122	55	the	the	DET
iajs-3142	122	56	peptide	peptide	ADJ
iajs-3142	122	57	hormone	hormone	NOUN
iajs-3142	122	58	adropin	adropin	NOUN
iajs-3142	122	59	.	.	PUNCT
iajs-3142	123	1	diabetes	diabetes	NOUN
iajs-3142	123	2	2014	2014	NUM
iajs-3142	123	3	,	,	PUNCT
iajs-3142	123	4	63(10	63(10	NOUN
iajs-3142	123	5	)	)	PUNCT
iajs-3142	123	6	,	,	PUNCT
iajs-3142	123	7	3242–3252	3242–3252	NUM
iajs-3142	123	8	.	.	PUNCT
iajs-3142	124	1	https://doi	https://doi	ADJ
iajs-3142	124	2	:	:	PUNCT
iajs-3142	124	3	10.2337	10.2337	NUM
iajs-3142	124	4	/	/	SYM
iajs-3142	124	5	db14	db14	PROPN
iajs-3142	124	6	-	-	PUNCT
iajs-3142	124	7	0388	0388	NUM
iajs-3142	124	8	.	.	PUNCT
iajs-3142	125	1	4	4	X
iajs-3142	125	2	.	.	X
iajs-3142	126	1	hamad	hamad	PROPN
iajs-3142	126	2	,	,	PUNCT
iajs-3142	126	3	h.t	h.t	PROPN
iajs-3142	126	4	;	;	PUNCT
iajs-3142	126	5	mohammed	mohammed	PROPN
iajs-3142	126	6	,	,	PUNCT
iajs-3142	126	7	y.k	y.k	PROPN
iajs-3142	126	8	.	.	PROPN
iajs-3142	126	9	effect	effect	NOUN
iajs-3142	126	10	of	of	ADP
iajs-3142	126	11	clopidogrel	clopidogrel	NOUN
iajs-3142	126	12	on	on	ADP
iajs-3142	126	13	the	the	DET
iajs-3142	126	14	levels	level	NOUN
iajs-3142	126	15	of	of	ADP
iajs-3142	126	16	adropin	adropin	NOUN
iajs-3142	126	17	and	and	CCONJ
iajs-3142	126	18	adiponectin	adiponectin	NOUN
iajs-3142	126	19	in	in	ADP
iajs-3142	126	20	serum	serum	NOUN
iajs-3142	126	21	of	of	ADP
iajs-3142	126	22	female	female	ADJ
iajs-3142	126	23	albino	albino	NOUN
iajs-3142	126	24	rats	rat	NOUN
iajs-3142	126	25	.	.	PUNCT
iajs-3142	127	1	international	international	ADJ
iajs-3142	127	2	research	research	PROPN
iajs-3142	127	3	journal	journal	NOUN
iajs-3142	127	4	of	of	ADP
iajs-3142	127	5	pharmacy	pharmacy	NOUN
iajs-3142	127	6	and	and	CCONJ
iajs-3142	127	7	medical	medical	ADJ
iajs-3142	127	8	sciences	science	NOUN
iajs-3142	127	9	(	(	PUNCT
iajs-3142	127	10	irjpms	irjpms	PROPN
iajs-3142	127	11	)	)	PUNCT
iajs-3142	127	12	,	,	PUNCT
iajs-3142	127	13	2023	2023	NUM
iajs-3142	127	14	,	,	PUNCT
iajs-3142	127	15	6(6),67	6(6),67	NUM
iajs-3142	127	16	-	-	SYM
iajs-3142	127	17	71	71	NUM
iajs-3142	127	18	.	.	PUNCT
iajs-3142	128	1	http://irjpms.com/wpcontent/uploads/2023/10/irjpms-v6n6p115y23.pdf	http://irjpms.com/wpcontent/uploads/2023/10/irjpms-v6n6p115y23.pdf	X
iajs-3142	128	2	.	.	PUNCT
iajs-3142	129	1	5	5	X
iajs-3142	129	2	.	.	X
iajs-3142	129	3	reddy	reddy	PROPN
iajs-3142	129	4	,	,	PUNCT
iajs-3142	129	5	v.s.	v.s.	PROPN
iajs-3142	129	6	;	;	PUNCT
iajs-3142	129	7	reddy	reddy	PROPN
iajs-3142	129	8	,	,	PUNCT
iajs-3142	129	9	e.p	e.p	PROPN
iajs-3142	129	10	.	.	PROPN
iajs-3142	129	11	;	;	PUNCT
iajs-3142	129	12	thangappazham	thangappazham	PROPN
iajs-3142	129	13	,	,	PUNCT
iajs-3142	129	14	b.	b.	PROPN
iajs-3142	129	15	;	;	PUNCT
iajs-3142	129	16	varshney	varshney	NOUN
iajs-3142	129	17	,	,	PUNCT
iajs-3142	129	18	s.	s.	PROPN
iajs-3142	129	19	;	;	PUNCT
iajs-3142	129	20	das	das	PROPN
iajs-3142	129	21	,	,	PUNCT
iajs-3142	129	22	v.l	v.l	PROPN
iajs-3142	129	23	.	.	PROPN
iajs-3142	129	24	;	;	PUNCT
iajs-3142	129	25	munikumar	munikumar	PROPN
iajs-3142	129	26	,	,	PUNCT
iajs-3142	129	27	m.	m.	NOUN
iajs-3142	129	28	adropin	adropin	NOUN
iajs-3142	129	29	levels	level	NOUN
iajs-3142	129	30	and	and	CCONJ
iajs-3142	129	31	its	its	PRON
iajs-3142	129	32	associations	association	NOUN
iajs-3142	129	33	as	as	ADP
iajs-3142	129	34	a	a	DET
iajs-3142	129	35	fat	fat	NOUN
iajs-3142	129	36	-	-	PUNCT
iajs-3142	129	37	burning	burn	VERB
iajs-3142	129	38	hormone	hormone	NOUN
iajs-3142	129	39	in	in	ADP
iajs-3142	129	40	patients	patient	NOUN
iajs-3142	129	41	with	with	ADP
iajs-3142	129	42	polycystic	polycystic	ADJ
iajs-3142	129	43	ovary	ovary	ADJ
iajs-3142	129	44	syndrome	syndrome	NOUN
iajs-3142	129	45	:	:	PUNCT
iajs-3142	130	1	a	a	DET
iajs-3142	130	2	correlational	correlational	ADJ
iajs-3142	130	3	meta	meta	ADJ
iajs-3142	130	4	-	-	PUNCT
iajs-3142	130	5	analysis	analysis	NOUN
iajs-3142	130	6	.	.	PUNCT
iajs-3142	131	1	gynecol	gynecol	ADJ
iajs-3142	131	2	endocrinol	endocrinol	NOUN
iajs-3142	131	3	.	.	PUNCT
iajs-3142	131	4	,	,	PUNCT
iajs-3142	131	5	2021	2021	NUM
iajs-3142	131	6	,	,	PUNCT
iajs-3142	131	7	37(10	37(10	NUM
iajs-3142	131	8	)	)	PUNCT
iajs-3142	131	9	,	,	PUNCT
iajs-3142	131	10	879884	879884	NUM
iajs-3142	131	11	.	.	PUNCT
iajs-3142	132	1	https://doi	https://doi	ADJ
iajs-3142	132	2	:	:	PUNCT
iajs-3142	132	3	10.1080/09513590.2021.1950136	10.1080/09513590.2021.1950136	NUM
iajs-3142	132	4	.	.	NOUN
iajs-3142	133	1	6	6	NUM
iajs-3142	133	2	.	.	X
iajs-3142	133	3	khan	khan	PROPN
iajs-3142	133	4	,	,	PUNCT
iajs-3142	133	5	s.;a	s.;a	PROPN
iajs-3142	133	6	.	.	PUNCT
iajs-3142	133	7	;	;	PUNCT
iajs-3142	133	8	ram	ram	NOUN
iajs-3142	133	9	,	,	PUNCT
iajs-3142	133	10	n.	n.	NOUN
iajs-3142	133	11	;	;	PUNCT
iajs-3142	133	12	masood	masood	PROPN
iajs-3142	133	13	,	,	PUNCT
iajs-3142	133	14	m.q	m.q	PROPN
iajs-3142	133	15	.	.	PROPN
iajs-3142	133	16	patterns	pattern	NOUN
iajs-3142	133	17	of	of	ADP
iajs-3142	133	18	abnormal	abnormal	ADJ
iajs-3142	133	19	glucose	glucose	NOUN
iajs-3142	133	20	metabolism	metabolism	NOUN
iajs-3142	133	21	in	in	ADP
iajs-3142	133	22	acromegaly	acromegaly	NOUN
iajs-3142	133	23	and	and	CCONJ
iajs-3142	133	24	impact	impact	NOUN
iajs-3142	133	25	of	of	ADP
iajs-3142	133	26	treatment	treatment	NOUN
iajs-3142	133	27	modalities	modality	NOUN
iajs-3142	133	28	on	on	ADP
iajs-3142	133	29	glucose	glucose	NOUN
iajs-3142	133	30	metabolism	metabolism	NOUN
iajs-3142	133	31	.	.	PUNCT
iajs-3142	134	1	cureus	cureus	NOUN
iajs-3142	134	2	2021	2021	NUM
iajs-3142	134	3	,	,	PUNCT
iajs-3142	134	4	13(3	13(3	NUM
iajs-3142	134	5	)	)	PUNCT
iajs-3142	134	6	,	,	PUNCT
iajs-3142	134	7	e13852	e13852	NOUN
iajs-3142	134	8	.	.	PUNCT
iajs-3142	135	1	https://doi	https://doi	ADJ
iajs-3142	135	2	:	:	PUNCT
iajs-3142	135	3	10.7759	10.7759	NUM
iajs-3142	135	4	/	/	SYM
iajs-3142	135	5	cureus.13852	cureus.13852	PROPN
iajs-3142	135	6	.	.	NOUN
iajs-3142	135	7	7	7	NUM
iajs-3142	135	8	.	.	X
iajs-3142	135	9	butler	butler	PROPN
iajs-3142	135	10	,	,	PUNCT
iajs-3142	135	11	a.a	a.a	PROPN
iajs-3142	135	12	.	.	PROPN
iajs-3142	135	13	;	;	PUNCT
iajs-3142	135	14	tam	tam	PROPN
iajs-3142	135	15	,	,	PUNCT
iajs-3142	135	16	c.s	c.s	PROPN
iajs-3142	135	17	.	.	PROPN
iajs-3142	135	18	;	;	PUNCT
iajs-3142	135	19	stanhope	stanhope	PROPN
iajs-3142	135	20	,	,	PUNCT
iajs-3142	135	21	k.l	k.l	PROPN
iajs-3142	135	22	.	.	PROPN
iajs-3142	135	23	;	;	PUNCT
iajs-3142	135	24	wolfe	wolfe	PROPN
iajs-3142	135	25	,	,	PUNCT
iajs-3142	135	26	b.m	b.m	PROPN
iajs-3142	135	27	.	.	PROPN
iajs-3142	135	28	;	;	PUNCT
iajs-3142	135	29	ali	ali	PROPN
iajs-3142	135	30	,	,	PUNCT
iajs-3142	135	31	m.r	m.r	PROPN
iajs-3142	135	32	.	.	PROPN
iajs-3142	135	33	;	;	PUNCT
iajs-3142	135	34	o’keeffe	o’keeffe	PROPN
iajs-3142	135	35	,	,	PUNCT
iajs-3142	135	36	m.	m.	NOUN
iajs-3142	135	37	;	;	PUNCT
iajs-3142	135	38	st	st	NOUN
iajs-3142	135	39	-	-	PUNCT
iajs-3142	135	40	onge	onge	ADJ
iajs-3142	135	41	,	,	PUNCT
iajs-3142	135	42	m.-p	m.-p	PROPN
iajs-3142	135	43	.	.	PUNCT
iajs-3142	135	44	;	;	PUNCT
iajs-3142	135	45	ravussin	ravussin	PROPN
iajs-3142	135	46	,	,	PUNCT
iajs-3142	135	47	e.	e.	PROPN
iajs-3142	135	48	;	;	PUNCT
iajs-3142	135	49	havel	havel	PROPN
iajs-3142	135	50	,	,	PUNCT
iajs-3142	135	51	p.j	p.j	PROPN
iajs-3142	135	52	.	.	PROPN
iajs-3142	135	53	low	low	ADJ
iajs-3142	135	54	circulating	circulate	VERB
iajs-3142	135	55	adropin	adropin	NOUN
iajs-3142	135	56	concentrations	concentration	NOUN
iajs-3142	135	57	with	with	ADP
iajs-3142	135	58	obesity	obesity	NOUN
iajs-3142	135	59	and	and	CCONJ
iajs-3142	135	60	aging	aging	NOUN
iajs-3142	135	61	correlate	correlate	VERB
iajs-3142	135	62	with	with	ADP
iajs-3142	135	63	risk	risk	NOUN
iajs-3142	135	64	factors	factor	NOUN
iajs-3142	135	65	for	for	ADP
iajs-3142	135	66	metabolic	metabolic	NOUN
iajs-3142	135	67	disease	disease	NOUN
iajs-3142	135	68	and	and	CCONJ
iajs-3142	135	69	increase	increase	NOUN
iajs-3142	135	70	after	after	ADP
iajs-3142	135	71	gastric	gastric	ADJ
iajs-3142	135	72	bypass	bypass	NOUN
iajs-3142	135	73	surgery	surgery	NOUN
iajs-3142	135	74	in	in	ADP
iajs-3142	135	75	humans	human	NOUN
iajs-3142	135	76	.	.	PUNCT
iajs-3142	136	1	j.	j.	PROPN
iajs-3142	136	2	clin	clin	PROPN
iajs-3142	136	3	.	.	PUNCT
iajs-3142	137	1	endocrinol	endocrinol	NOUN
iajs-3142	137	2	.	.	PUNCT
iajs-3142	138	1	metab	metab	PROPN
iajs-3142	138	2	.	.	PUNCT
iajs-3142	139	1	2012	2012	NUM
iajs-3142	139	2	,	,	PUNCT
iajs-3142	139	3	97(10	97(10	NUM
iajs-3142	139	4	)	)	PUNCT
iajs-3142	139	5	,	,	PUNCT
iajs-3142	139	6	3783–3791	3783–3791	NUM
iajs-3142	139	7	.	.	PUNCT
iajs-3142	140	1	https://doi	https://doi	ADJ
iajs-3142	140	2	:	:	PUNCT
iajs-3142	140	3	10.1210	10.1210	NUM
iajs-3142	140	4	/	/	SYM
iajs-3142	140	5	jc.2012	jc.2012	PROPN
iajs-3142	140	6	-	-	PUNCT
iajs-3142	140	7	2194	2194	NUM
iajs-3142	140	8	.	.	PUNCT
iajs-3142	141	1	8	8	X
iajs-3142	141	2	.	.	PUNCT
iajs-3142	142	1	hamad	hamad	PROPN
iajs-3142	142	2	,	,	PUNCT
iajs-3142	142	3	m.s	m.s	PROPN
iajs-3142	142	4	.	.	PROPN
iajs-3142	142	5	;	;	PUNCT
iajs-3142	142	6	sarhat	sarhat	PROPN
iajs-3142	142	7	,	,	PUNCT
iajs-3142	142	8	e.r	e.r	PROPN
iajs-3142	142	9	.	.	PROPN
iajs-3142	142	10	;	;	PUNCT
iajs-3142	142	11	sarhat	sarhat	PROPN
iajs-3142	142	12	,	,	PUNCT
iajs-3142	142	13	t.r	t.r	PROPN
iajs-3142	142	14	.	.	PROPN
iajs-3142	142	15	;	;	PUNCT
iajs-3142	142	16	abass	abass	PROPN
iajs-3142	142	17	,	,	PUNCT
iajs-3142	142	18	k.s	k.s	PROPN
iajs-3142	142	19	.	.	PROPN
iajs-3142	142	20	impact	impact	NOUN
iajs-3142	142	21	of	of	ADP
iajs-3142	142	22	serum	serum	NOUN
iajs-3142	142	23	adropin	adropin	NOUN
iajs-3142	142	24	and	and	CCONJ
iajs-3142	142	25	irisin	irisin	VERB
iajs-3142	142	26	in	in	ADP
iajs-3142	142	27	iraqi	iraqi	ADJ
iajs-3142	142	28	patients	patient	NOUN
iajs-3142	142	29	with	with	ADP
iajs-3142	142	30	congestive	congestive	ADJ
iajs-3142	142	31	heart	heart	NOUN
iajs-3142	142	32	failure	failure	NOUN
iajs-3142	142	33	.	.	PUNCT
iajs-3142	143	1	pjmh	pjmh	PROPN
iajs-3142	143	2	s	s	PART
iajs-3142	143	3	2021	2021	NUM
iajs-3142	143	4	,	,	PUNCT
iajs-3142	143	5	15(2	15(2	NUM
iajs-3142	143	6	)	)	PUNCT
iajs-3142	143	7	,	,	PUNCT
iajs-3142	143	8	497–499	497–499	NUM
iajs-3142	143	9	.	.	PUNCT
iajs-3142	144	1	https://pjmhsonline.com/2021/feb/497.pdf	https://pjmhsonline.com/2021/feb/497.pdf	PROPN
iajs-3142	144	2	.	.	PUNCT
iajs-3142	145	1	9	9	NUM
iajs-3142	145	2	.	.	X
iajs-3142	145	3	yu	yu	PROPN
iajs-3142	145	4	,	,	PUNCT
iajs-3142	145	5	h.	h.	PROPN
iajs-3142	145	6	;	;	PUNCT
iajs-3142	145	7	zhao	zhao	PROPN
iajs-3142	145	8	,	,	PUNCT
iajs-3142	145	9	p.	p.	PROPN
iajs-3142	145	10	;	;	PUNCT
iajs-3142	145	11	wu	wu	PROPN
iajs-3142	145	12	,	,	PUNCT
iajs-3142	145	13	m.	m.	NOUN
iajs-3142	145	14	;	;	PUNCT
iajs-3142	145	15	liu	liu	PROPN
iajs-3142	145	16	,	,	PUNCT
iajs-3142	145	17	j.	j.	PROPN
iajs-3142	145	18	;	;	PUNCT
iajs-3142	145	19	yin	yin	PROPN
iajs-3142	145	20	,	,	PUNCT
iajs-3142	145	21	w.	w.	PROPN
iajs-3142	145	22	serum	serum	PROPN
iajs-3142	145	23	adropin	adropin	PROPN
iajs-3142	145	24	levels	level	NOUN
iajs-3142	145	25	are	be	AUX
iajs-3142	145	26	decreased	decrease	VERB
iajs-3142	145	27	in	in	ADP
iajs-3142	145	28	patients	patient	NOUN
iajs-3142	145	29	with	with	ADP
iajs-3142	145	30	acute	acute	ADJ
iajs-3142	145	31	myocardial	myocardial	ADJ
iajs-3142	145	32	infarction	infarction	NOUN
iajs-3142	145	33	.	.	PUNCT
iajs-3142	146	1	regul	regul	NOUN
iajs-3142	146	2	.	.	PUNCT
iajs-3142	147	1	pept	pept	PROPN
iajs-3142	147	2	.	.	PROPN
iajs-3142	147	3	,	,	PUNCT
iajs-3142	147	4	2014	2014	NUM
iajs-3142	147	5	,	,	PUNCT
iajs-3142	147	6	190	190	NUM
iajs-3142	147	7	,	,	PUNCT
iajs-3142	147	8	46–49	46–49	NUM
iajs-3142	147	9	.	.	PUNCT
iajs-3142	148	1	https://doi	https://doi	ADV
iajs-3142	148	2	:	:	PUNCT
iajs-3142	148	3	10.1016	10.1016	NUM
iajs-3142	148	4	/	/	SYM
iajs-3142	148	5	j.regpep.2014.04.001	j.regpep.2014.04.001	PROPN
iajs-3142	148	6	.	.	PUNCT
iajs-3142	149	1	ihjpas	ihjpas	PROPN
iajs-3142	149	2	.	.	PUNCT
iajs-3142	150	1	37(1)2024	37(1)2024	NUM
iajs-3142	150	2	340	340	NUM
iajs-3142	150	3	10	10	NUM
iajs-3142	150	4	.	.	PUNCT
iajs-3142	151	1	mustaf	mustaf	PROPN
iajs-3142	151	2	,	,	PUNCT
iajs-3142	151	3	l.a	l.a	PROPN
iajs-3142	151	4	.	.	PROPN
iajs-3142	151	5	adropin	adropin	PROPN
iajs-3142	151	6	levels	level	NOUN
iajs-3142	151	7	in	in	ADP
iajs-3142	151	8	the	the	DET
iajs-3142	151	9	serum	serum	NOUN
iajs-3142	151	10	of	of	ADP
iajs-3142	151	11	obese	obese	ADJ
iajs-3142	151	12	type	type	NOUN
iajs-3142	151	13	2	2	NUM
iajs-3142	151	14	diabetic	diabetic	ADJ
iajs-3142	151	15	patients	patient	NOUN
iajs-3142	151	16	and	and	CCONJ
iajs-3142	151	17	their	their	PRON
iajs-3142	151	18	relationship	relationship	NOUN
iajs-3142	151	19	to	to	PART
iajs-3142	151	20	oxidative	oxidative	VERB
iajs-3142	151	21	stress	stress	NOUN
iajs-3142	151	22	.	.	PUNCT
iajs-3142	152	1	african	african	PROPN
iajs-3142	152	2	j.	j.	PROPN
iajs-3142	152	3	adv	adv	PROPN
iajs-3142	152	4	.	.	PUNCT
iajs-3142	153	1	pure	pure	ADJ
iajs-3142	153	2	appl	appl	PROPN
iajs-3142	153	3	.	.	PUNCT
iajs-3142	154	1	sci	sci	PROPN
iajs-3142	154	2	.	.	PROPN
iajs-3142	154	3	,	,	PUNCT
iajs-3142	154	4	2023	2023	NUM
iajs-3142	154	5	,	,	PUNCT
iajs-3142	154	6	2(2),131–136	2(2),131–136	NUM
iajs-3142	154	7	.	.	PUNCT
iajs-3142	155	1	https://aaasjournals.com/index.php/ajapas/article/view/343	https://aaasjournals.com/index.php/ajapas/article/view/343	INTJ
iajs-3142	155	2	.	.	PUNCT
iajs-3142	156	1	11	11	NUM
iajs-3142	156	2	.	.	X
iajs-3142	157	1	jasaszwili	jasaszwili	NOUN
iajs-3142	157	2	,	,	PUNCT
iajs-3142	157	3	m.	m.	NOUN
iajs-3142	157	4	;	;	PUNCT
iajs-3142	157	5	billert	billert	PROPN
iajs-3142	157	6	,	,	PUNCT
iajs-3142	157	7	m.	m.	NOUN
iajs-3142	157	8	;	;	PUNCT
iajs-3142	157	9	strowski	strowski	PROPN
iajs-3142	157	10	,	,	PUNCT
iajs-3142	157	11	m.z	m.z	PROPN
iajs-3142	157	12	.	.	PROPN
iajs-3142	157	13	;	;	PUNCT
iajs-3142	157	14	nowak	nowak	PROPN
iajs-3142	157	15	,	,	PUNCT
iajs-3142	157	16	k.w	k.w	PROPN
iajs-3142	157	17	.	.	PROPN
iajs-3142	157	18	;	;	PUNCT
iajs-3142	157	19	skrzypski	skrzypski	PROPN
iajs-3142	157	20	,	,	PUNCT
iajs-3142	157	21	m.	m.	NOUN
iajs-3142	157	22	adropin	adropin	NOUN
iajs-3142	157	23	as	as	ADP
iajs-3142	157	24	a	a	DET
iajs-3142	157	25	fatburning	fatburne	VERB
iajs-3142	157	26	hormone	hormone	NOUN
iajs-3142	157	27	with	with	ADP
iajs-3142	157	28	multiple	multiple	ADJ
iajs-3142	157	29	functions	function	NOUN
iajs-3142	157	30	—	—	PUNCT
iajs-3142	157	31	review	review	NOUN
iajs-3142	157	32	of	of	ADP
iajs-3142	157	33	a	a	DET
iajs-3142	157	34	decade	decade	NOUN
iajs-3142	157	35	of	of	ADP
iajs-3142	157	36	research	research	NOUN
iajs-3142	157	37	.	.	PUNCT
iajs-3142	158	1	molecules	molecule	NOUN
iajs-3142	158	2	,	,	PUNCT
iajs-3142	158	3	2020	2020	NUM
iajs-3142	158	4	,	,	PUNCT
iajs-3142	158	5	25(3	25(3	NUM
iajs-3142	158	6	)	)	PUNCT
iajs-3142	158	7	,	,	PUNCT
iajs-3142	158	8	549	549	NUM
iajs-3142	158	9	.	.	PUNCT
iajs-3142	158	10	https://doi.org/10.3390/molecules25030549	https://doi.org/10.3390/molecules25030549	PROPN
iajs-3142	158	11	.	.	PUNCT
iajs-3142	159	1	12	12	NUM
iajs-3142	159	2	.	.	PUNCT
iajs-3142	160	1	elgohary	elgohary	ADJ
iajs-3142	160	2	,	,	PUNCT
iajs-3142	160	3	m.	m.	NOUN
iajs-3142	160	4	;	;	PUNCT
iajs-3142	160	5	el	el	PROPN
iajs-3142	160	6	maghawry	maghawry	PROPN
iajs-3142	160	7	,	,	PUNCT
iajs-3142	160	8	m.a	m.a	PROPN
iajs-3142	160	9	.	.	PROPN
iajs-3142	160	10	;	;	PUNCT
iajs-3142	160	11	mostafa	mostafa	PROPN
iajs-3142	160	12	,	,	PUNCT
iajs-3142	160	13	d.	d.	PROPN
iajs-3142	160	14	;	;	PUNCT
iajs-3142	160	15	abd	abd	PROPN
iajs-3142	160	16	el	el	PROPN
iajs-3142	160	17	-	-	PUNCT
iajs-3142	160	18	sattar	sattar	PROPN
iajs-3142	160	19	,	,	PUNCT
iajs-3142	160	20	e.m	e.m	PROPN
iajs-3142	160	21	.	.	PROPN
iajs-3142	160	22	;	;	PUNCT
iajs-3142	160	23	el	el	PROPN
iajs-3142	160	24	tahir	tahir	PROPN
iajs-3142	160	25	,	,	PUNCT
iajs-3142	160	26	f.	f.	PROPN
iajs-3142	161	1	the	the	DET
iajs-3142	161	2	association	association	NOUN
iajs-3142	161	3	between	between	ADP
iajs-3142	161	4	serum	serum	NOUN
iajs-3142	161	5	adropin	adropin	ADJ
iajs-3142	161	6	level	level	NOUN
iajs-3142	161	7	and	and	CCONJ
iajs-3142	161	8	metabolic	metabolic	NOUN
iajs-3142	161	9	complications	complication	NOUN
iajs-3142	161	10	of	of	ADP
iajs-3142	161	11	type	type	NOUN
iajs-3142	161	12	2	2	NUM
iajs-3142	161	13	diabetes	diabetes	NOUN
iajs-3142	161	14	mellitus	mellitus	NOUN
iajs-3142	161	15	.	.	PUNCT
iajs-3142	162	1	egypt	egypt	PROPN
iajs-3142	162	2	.	.	PUNCT
iajs-3142	163	1	j.	j.	PROPN
iajs-3142	163	2	hosp	hosp	PROPN
iajs-3142	163	3	.	.	PUNCT
iajs-3142	164	1	med	med	PROPN
iajs-3142	164	2	.	.	PROPN
iajs-3142	164	3	,	,	PUNCT
iajs-3142	164	4	2023	2023	NUM
iajs-3142	164	5	,	,	PUNCT
iajs-3142	164	6	93	93	NUM
iajs-3142	164	7	,	,	PUNCT
iajs-3142	164	8	7323–7328	7323–7328	NUM
iajs-3142	164	9	.	.	PUNCT
iajs-3142	165	1	https://doi.org/10.1186%2fs13098022-00796-y	https://doi.org/10.1186%2fs13098022-00796-y	PROPN
iajs-3142	165	2	.	.	PUNCT
iajs-3142	166	1	13	13	NUM
iajs-3142	166	2	.	.	PUNCT
iajs-3142	167	1	farhan	farhan	PROPN
iajs-3142	167	2	,	,	PUNCT
iajs-3142	167	3	l.o	l.o	PROPN
iajs-3142	167	4	.	.	PROPN
iajs-3142	167	5	study	study	NOUN
iajs-3142	167	6	of	of	ADP
iajs-3142	167	7	partially	partially	ADV
iajs-3142	167	8	purification	purification	NOUN
iajs-3142	167	9	ast	ast	NOUN
iajs-3142	167	10	activity	activity	NOUN
iajs-3142	167	11	in	in	ADP
iajs-3142	167	12	sera	sera	NOUN
iajs-3142	167	13	of	of	ADP
iajs-3142	167	14	iraqi	iraqi	ADJ
iajs-3142	167	15	patients	patient	NOUN
iajs-3142	167	16	with	with	ADP
iajs-3142	167	17	diabetic	diabetic	ADJ
iajs-3142	167	18	nephropathy	nephropathy	NOUN
iajs-3142	167	19	.	.	PUNCT
iajs-3142	168	1	atherosclerosis	atherosclerosis	NOUN
iajs-3142	168	2	,	,	PUNCT
iajs-3142	168	3	2014	2014	NUM
iajs-3142	168	4	,	,	PUNCT
iajs-3142	168	5	14(9	14(9	NUM
iajs-3142	168	6	)	)	PUNCT
iajs-3142	168	7	,	,	PUNCT
iajs-3142	168	8	12	12	NUM
iajs-3142	168	9	.	.	PUNCT
iajs-3142	169	1	https://www.tsijournals.com/articles/study-of-partially-purification-ast-activity-in-sera-ofiraqi-patients-with-diabetic-nephropathy.pdf	https://www.tsijournals.com/articles/study-of-partially-purification-ast-activity-in-sera-ofiraqi-patients-with-diabetic-nephropathy.pdf	PROPN
iajs-3142	169	2	.	.	PUNCT
iajs-3142	170	1	14	14	NUM
iajs-3142	170	2	.	.	PUNCT
iajs-3142	171	1	demers	demers	PROPN
iajs-3142	171	2	,	,	PUNCT
iajs-3142	171	3	d.	d.	PROPN
iajs-3142	171	4	;	;	PUNCT
iajs-3142	171	5	wachs	wachs	PROPN
iajs-3142	171	6	,	,	PUNCT
iajs-3142	171	7	d.	d.	NOUN
iajs-3142	171	8	physiology	physiology	NOUN
iajs-3142	171	9	,	,	PUNCT
iajs-3142	171	10	mean	mean	VERB
iajs-3142	171	11	arterial	arterial	ADJ
iajs-3142	171	12	pressure	pressure	NOUN
iajs-3142	171	13	.	.	PUNCT
iajs-3142	172	1	statpearls	statpearls	PROPN
iajs-3142	172	2	publishing	publishing	NOUN
iajs-3142	172	3	,	,	PUNCT
iajs-3142	172	4	2021	2021	NUM
iajs-3142	172	5	.	.	PUNCT
iajs-3142	173	1	https://www.ncbi.nlm.nih.gov/books/nbk538226	https://www.ncbi.nlm.nih.gov/books/nbk538226	NOUN
iajs-3142	173	2	.	.	PUNCT
iajs-3142	174	1	15	15	NUM
iajs-3142	174	2	.	.	X
iajs-3142	175	1	huang	huang	PROPN
iajs-3142	175	2	,	,	PUNCT
iajs-3142	175	3	j.-k	j.-k	PROPN
iajs-3142	175	4	.	.	PUNCT
iajs-3142	175	5	;	;	PUNCT
iajs-3142	175	6	lee	lee	PROPN
iajs-3142	175	7	,	,	PUNCT
iajs-3142	175	8	h.-c	h.-c	PROPN
iajs-3142	175	9	.	.	PUNCT
iajs-3142	176	1	emerging	emerge	VERB
iajs-3142	176	2	evidence	evidence	NOUN
iajs-3142	176	3	of	of	ADP
iajs-3142	176	4	pathological	pathological	ADJ
iajs-3142	176	5	roles	role	NOUN
iajs-3142	176	6	of	of	ADP
iajs-3142	176	7	very	very	ADV
iajs-3142	176	8	-	-	PUNCT
iajs-3142	176	9	low	low	ADJ
iajs-3142	176	10	-	-	PUNCT
iajs-3142	176	11	density	density	NOUN
iajs-3142	176	12	lipoprotein	lipoprotein	ADJ
iajs-3142	176	13	(	(	PUNCT
iajs-3142	176	14	vldl	vldl	NOUN
iajs-3142	176	15	)	)	PUNCT
iajs-3142	176	16	.	.	PUNCT
iajs-3142	177	1	int	int	NOUN
iajs-3142	177	2	.	.	PUNCT
iajs-3142	178	1	j.	j.	PROPN
iajs-3142	178	2	mol	mol	PROPN
iajs-3142	178	3	.	.	PUNCT
iajs-3142	179	1	sci	sci	PROPN
iajs-3142	179	2	.	.	PROPN
iajs-3142	179	3	,	,	PUNCT
iajs-3142	179	4	2022	2022	NUM
iajs-3142	179	5	,	,	PUNCT
iajs-3142	179	6	23(8	23(8	NUM
iajs-3142	179	7	)	)	PUNCT
iajs-3142	179	8	,	,	PUNCT
iajs-3142	179	9	4300	4300	NUM
iajs-3142	179	10	.	.	PUNCT
iajs-3142	180	1	https://doi	https://doi	ADJ
iajs-3142	180	2	:	:	PUNCT
iajs-3142	180	3	10.3390	10.3390	NUM
iajs-3142	180	4	/	/	SYM
iajs-3142	180	5	ijms23084300	ijms23084300	PROPN
iajs-3142	180	6	.	.	PUNCT
iajs-3142	181	1	16	16	NUM
iajs-3142	181	2	.	.	PUNCT
iajs-3142	182	1	bailey	bailey	PROPN
iajs-3142	182	2	,	,	PUNCT
iajs-3142	182	3	a.	a.	NOUN
iajs-3142	182	4	;	;	PUNCT
iajs-3142	182	5	mohiuddin	mohiuddin	NOUN
iajs-3142	182	6	,	,	PUNCT
iajs-3142	182	7	s.s	s.s	PROPN
iajs-3142	182	8	.	.	PROPN
iajs-3142	182	9	biochemistry	biochemistry	PROPN
iajs-3142	182	10	,	,	PUNCT
iajs-3142	182	11	high	high	ADJ
iajs-3142	182	12	density	density	NOUN
iajs-3142	182	13	lipoprotein	lipoprotein	ADJ
iajs-3142	182	14	.	.	PUNCT
iajs-3142	183	1	statpearls	statpearls	PROPN
iajs-3142	183	2	publishing	publishing	NOUN
iajs-3142	183	3	,	,	PUNCT
iajs-3142	183	4	2022	2022	NUM
iajs-3142	183	5	.	.	PUNCT
iajs-3142	184	1	https://www.ncbi.nlm.nih.gov/books/nbk549802	https://www.ncbi.nlm.nih.gov/books/nbk549802	NOUN
iajs-3142	184	2	.	.	PUNCT
iajs-3142	185	1	17	17	NUM
iajs-3142	185	2	.	.	PUNCT
iajs-3142	186	1	haile	haile	PROPN
iajs-3142	186	2	,	,	PUNCT
iajs-3142	186	3	k.	k.	PROPN
iajs-3142	186	4	;	;	PUNCT
iajs-3142	186	5	haile	haile	PROPN
iajs-3142	186	6	,	,	PUNCT
iajs-3142	186	7	a.	a.	NOUN
iajs-3142	186	8	;	;	PUNCT
iajs-3142	186	9	timerga	timerga	PROPN
iajs-3142	186	10	,	,	PUNCT
iajs-3142	186	11	a.	a.	NOUN
iajs-3142	186	12	predictors	predictor	NOUN
iajs-3142	186	13	of	of	ADP
iajs-3142	186	14	lipid	lipid	NOUN
iajs-3142	186	15	profile	profile	NOUN
iajs-3142	186	16	abnormalities	abnormality	NOUN
iajs-3142	186	17	among	among	ADP
iajs-3142	186	18	patients	patient	NOUN
iajs-3142	186	19	with	with	ADP
iajs-3142	186	20	metabolic	metabolic	NOUN
iajs-3142	186	21	syndrome	syndrome	NOUN
iajs-3142	186	22	in	in	ADP
iajs-3142	186	23	southwest	southwest	ADJ
iajs-3142	186	24	ethiopia	ethiopia	PROPN
iajs-3142	186	25	:	:	PUNCT
iajs-3142	186	26	a	a	DET
iajs-3142	186	27	cross	cross	ADJ
iajs-3142	186	28	-	-	ADJ
iajs-3142	186	29	sectional	sectional	ADJ
iajs-3142	186	30	study	study	NOUN
iajs-3142	186	31	.	.	PUNCT
iajs-3142	187	1	vasc	vasc	PROPN
iajs-3142	187	2	.	.	PROPN
iajs-3142	188	1	health	health	NOUN
iajs-3142	188	2	risk	risk	NOUN
iajs-3142	188	3	manag	manag	NOUN
iajs-3142	188	4	.	.	PUNCT
iajs-3142	188	5	,	,	PUNCT
iajs-3142	188	6	2021	2021	NUM
iajs-3142	188	7	,	,	PUNCT
iajs-3142	188	8	17	17	NUM
iajs-3142	188	9	,	,	PUNCT
iajs-3142	188	10	461	461	NUM
iajs-3142	188	11	.	.	PUNCT
iajs-3142	189	1	https://doi.org/10.2147%2fvhrm.s319161	https://doi.org/10.2147%2fvhrm.s319161	PROPN
iajs-3142	189	2	.	.	PUNCT
iajs-3142	190	1	18	18	NUM
iajs-3142	190	2	.	.	NUM
iajs-3142	190	3	abed	abe	VERB
iajs-3142	190	4	,	,	PUNCT
iajs-3142	190	5	b.a	b.a	PROPN
iajs-3142	190	6	.	.	PROPN
iajs-3142	190	7	;	;	PUNCT
iajs-3142	191	1	al	al	PROPN
iajs-3142	191	2	-	-	PUNCT
iajs-3142	191	3	aaraji	aaraji	PROPN
iajs-3142	191	4	,	,	PUNCT
iajs-3142	191	5	s.b	s.b	PROPN
iajs-3142	191	6	.	.	PROPN
iajs-3142	191	7	;	;	PUNCT
iajs-3142	191	8	salman	salman	PROPN
iajs-3142	191	9	,	,	PUNCT
iajs-3142	191	10	i.n	i.n	PROPN
iajs-3142	191	11	.	.	PROPN
iajs-3142	191	12	estimation	estimation	NOUN
iajs-3142	191	13	of	of	ADP
iajs-3142	191	14	apelin	apelin	PROPN
iajs-3142	191	15	levels	level	NOUN
iajs-3142	191	16	in	in	ADP
iajs-3142	191	17	iraqi	iraqi	ADJ
iajs-3142	191	18	patients	patient	NOUN
iajs-3142	191	19	with	with	ADP
iajs-3142	191	20	type	type	NOUN
iajs-3142	191	21	ii	ii	PROPN
iajs-3142	191	22	diabetic	diabetic	ADJ
iajs-3142	191	23	peripheral	peripheral	ADJ
iajs-3142	191	24	neuropathy	neuropathy	ADJ
iajs-3142	191	25	,	,	PUNCT
iajs-3142	191	26	baghdad	baghdad	PROPN
iajs-3142	191	27	science	science	PROPN
iajs-3142	191	28	journal	journal	PROPN
iajs-3142	191	29	,	,	PUNCT
iajs-3142	191	30	2023	2023	NUM
iajs-3142	191	31	,	,	PUNCT
iajs-3142	191	32	20(5	20(5	NUM
iajs-3142	191	33	)	)	PUNCT
iajs-3142	191	34	,	,	PUNCT
iajs-3142	191	35	1684	1684	NUM
iajs-3142	191	36	-	-	SYM
iajs-3142	191	37	1691	1691	NUM
iajs-3142	191	38	.	.	PUNCT
iajs-3142	192	1	https://doi.org/10.21123/bsj.2023.7566	https://doi.org/10.21123/bsj.2023.7566	PROPN
iajs-3142	192	2	.	.	PROPN
iajs-3142	193	1	19	19	NUM
iajs-3142	193	2	.	.	PUNCT
iajs-3142	193	3	shi	shi	PROPN
iajs-3142	193	4	,	,	PUNCT
iajs-3142	193	5	j.	j.	PROPN
iajs-3142	193	6	;	;	PUNCT
iajs-3142	193	7	he	he	PRON
iajs-3142	193	8	,	,	PUNCT
iajs-3142	193	9	l.	l.	PROPN
iajs-3142	193	10	;	;	PUNCT
iajs-3142	193	11	yu	yu	PROPN
iajs-3142	193	12	,	,	PUNCT
iajs-3142	193	13	d.	d.	PROPN
iajs-3142	193	14	;	;	PUNCT
iajs-3142	193	15	ju	ju	PROPN
iajs-3142	193	16	,	,	PUNCT
iajs-3142	193	17	l.	l.	PROPN
iajs-3142	193	18	;	;	PUNCT
iajs-3142	193	19	guo	guo	PROPN
iajs-3142	193	20	,	,	PUNCT
iajs-3142	193	21	q.	q.	PROPN
iajs-3142	193	22	;	;	PUNCT
iajs-3142	193	23	piao	piao	NOUN
iajs-3142	193	24	,	,	PUNCT
iajs-3142	193	25	w.	w.	PROPN
iajs-3142	193	26	;	;	PUNCT
iajs-3142	193	27	xu	xu	PROPN
iajs-3142	193	28	,	,	PUNCT
iajs-3142	193	29	x.	x.	PROPN
iajs-3142	193	30	;	;	PUNCT
iajs-3142	193	31	zhao	zhao	PROPN
iajs-3142	193	32	,	,	PUNCT
iajs-3142	193	33	l.	l.	PROPN
iajs-3142	193	34	;	;	PUNCT
iajs-3142	193	35	yuan	yuan	PROPN
iajs-3142	193	36	,	,	PUNCT
iajs-3142	193	37	x.	x.	PROPN
iajs-3142	193	38	;	;	PUNCT
iajs-3142	193	39	cao	cao	PROPN
iajs-3142	193	40	,	,	PUNCT
iajs-3142	193	41	q.	q.	NOUN
iajs-3142	193	42	prevalence	prevalence	NOUN
iajs-3142	193	43	and	and	CCONJ
iajs-3142	193	44	correlates	correlate	VERB
iajs-3142	193	45	of	of	ADP
iajs-3142	193	46	metabolic	metabolic	NOUN
iajs-3142	193	47	syndrome	syndrome	NOUN
iajs-3142	193	48	and	and	CCONJ
iajs-3142	193	49	its	its	PRON
iajs-3142	193	50	components	component	NOUN
iajs-3142	193	51	in	in	ADP
iajs-3142	193	52	chinese	chinese	ADJ
iajs-3142	193	53	children	child	NOUN
iajs-3142	193	54	and	and	CCONJ
iajs-3142	193	55	adolescents	adolescent	NOUN
iajs-3142	193	56	aged	aged	ADJ
iajs-3142	193	57	7–17	7–17	NOUN
iajs-3142	193	58	:	:	PUNCT
iajs-3142	193	59	the	the	DET
iajs-3142	193	60	china	china	PROPN
iajs-3142	193	61	national	national	PROPN
iajs-3142	193	62	nutrition	nutrition	PROPN
iajs-3142	193	63	and	and	CCONJ
iajs-3142	193	64	health	health	NOUN
iajs-3142	193	65	survey	survey	NOUN
iajs-3142	193	66	of	of	ADP
iajs-3142	193	67	children	child	NOUN
iajs-3142	193	68	and	and	CCONJ
iajs-3142	193	69	lactating	lactate	VERB
iajs-3142	193	70	mothers	mother	NOUN
iajs-3142	193	71	from	from	ADP
iajs-3142	193	72	2016–2017	2016–2017	NUM
iajs-3142	193	73	.	.	PUNCT
iajs-3142	194	1	nutrients	nutrient	NOUN
iajs-3142	194	2	2022	2022	NUM
iajs-3142	194	3	,	,	PUNCT
iajs-3142	194	4	14(16	14(16	NUM
iajs-3142	194	5	)	)	PUNCT
iajs-3142	194	6	,	,	PUNCT
iajs-3142	194	7	3348	3348	NUM
iajs-3142	194	8	.	.	PUNCT
iajs-3142	195	1	https://doi.org/10.3390%2fnu14163348	https://doi.org/10.3390%2fnu14163348	PROPN
iajs-3142	195	2	.	.	PROPN
iajs-3142	196	1	20	20	NUM
iajs-3142	196	2	.	.	X
iajs-3142	196	3	khaleel	khaleel	PROPN
iajs-3142	196	4	,	,	PUNCT
iajs-3142	196	5	f.	f.	PROPN
iajs-3142	196	6	;	;	PUNCT
iajs-3142	196	7	n	n	CCONJ
iajs-3142	196	8	-	-	PUNCT
iajs-3142	196	9	oda	oda	NOUN
iajs-3142	196	10	,	,	PUNCT
iajs-3142	196	11	n.	n.	NOUN
iajs-3142	196	12	;	;	PUNCT
iajs-3142	196	13	abed	abe	VERB
iajs-3142	196	14	,	,	PUNCT
iajs-3142	196	15	b.a	b.a	PROPN
iajs-3142	196	16	.	.	PROPN
iajs-3142	196	17	disturbance	disturbance	NOUN
iajs-3142	196	18	of	of	ADP
iajs-3142	196	19	arginase	arginase	ADJ
iajs-3142	196	20	activity	activity	NOUN
iajs-3142	196	21	and	and	CCONJ
iajs-3142	196	22	nitric	nitric	ADJ
iajs-3142	196	23	oxide	oxide	NOUN
iajs-3142	196	24	levels	level	NOUN
iajs-3142	196	25	in	in	ADP
iajs-3142	196	26	iraqi	iraqi	ADJ
iajs-3142	196	27	type	type	NOUN
iajs-3142	196	28	2	2	NUM
iajs-3142	196	29	diabetes	diabetes	NOUN
iajs-3142	196	30	mellitus	mellitus	NOUN
iajs-3142	196	31	.	.	PUNCT
iajs-3142	197	1	baghdad	baghdad	PROPN
iajs-3142	197	2	sci	sci	PROPN
iajs-3142	197	3	.	.	PUNCT
iajs-3142	198	1	j.	j.	PROPN
iajs-3142	198	2	,	,	PUNCT
iajs-3142	198	3	2018	2018	NUM
iajs-3142	198	4	,	,	PUNCT
iajs-3142	198	5	15(2),189	15(2),189	NUM
iajs-3142	198	6	-	-	SYM
iajs-3142	198	7	191	191	NUM
iajs-3142	198	8	.	.	PUNCT
iajs-3142	199	1	https://doi.org/10.21123/bsj.2018.15.2.0189	https://doi.org/10.21123/bsj.2018.15.2.0189	PROPN
iajs-3142	199	2	.	.	PUNCT
iajs-3142	200	1	21	21	NUM
iajs-3142	200	2	.	.	PUNCT
iajs-3142	201	1	krishnamoorthy	krishnamoorthy	ADJ
iajs-3142	201	2	,	,	PUNCT
iajs-3142	201	3	y.	y.	PROPN
iajs-3142	201	4	;	;	PUNCT
iajs-3142	201	5	rajaa	rajaa	PROPN
iajs-3142	201	6	,	,	PUNCT
iajs-3142	201	7	s.	s.	PROPN
iajs-3142	201	8	;	;	PUNCT
iajs-3142	201	9	murali	murali	PROPN
iajs-3142	201	10	,	,	PUNCT
iajs-3142	201	11	s.	s.	PROPN
iajs-3142	201	12	;	;	PUNCT
iajs-3142	201	13	sahoo	sahoo	PROPN
iajs-3142	201	14	,	,	PUNCT
iajs-3142	201	15	j.	j.	PROPN
iajs-3142	201	16	;	;	PUNCT
iajs-3142	201	17	kar	kar	PROPN
iajs-3142	201	18	,	,	PUNCT
iajs-3142	201	19	s.s	s.s	PROPN
iajs-3142	201	20	.	.	PROPN
iajs-3142	201	21	association	association	NOUN
iajs-3142	201	22	between	between	ADP
iajs-3142	201	23	anthropometric	anthropometric	ADJ
iajs-3142	201	24	risk	risk	NOUN
iajs-3142	201	25	factors	factor	NOUN
iajs-3142	201	26	and	and	CCONJ
iajs-3142	201	27	metabolic	metabolic	NOUN
iajs-3142	201	28	syndrome	syndrome	NOUN
iajs-3142	201	29	among	among	ADP
iajs-3142	201	30	adults	adult	NOUN
iajs-3142	201	31	in	in	ADP
iajs-3142	201	32	india	india	PROPN
iajs-3142	201	33	:	:	PUNCT
iajs-3142	201	34	a	a	DET
iajs-3142	201	35	systematic	systematic	ADJ
iajs-3142	201	36	review	review	NOUN
iajs-3142	201	37	and	and	CCONJ
iajs-3142	201	38	meta	meta	ADJ
iajs-3142	201	39	-	-	PUNCT
iajs-3142	201	40	analysis	analysis	NOUN
iajs-3142	201	41	of	of	ADP
iajs-3142	201	42	observational	observational	ADJ
iajs-3142	201	43	studies	study	NOUN
iajs-3142	201	44	.	.	PUNCT
iajs-3142	202	1	prev	prev	X
iajs-3142	202	2	.	.	PUNCT
iajs-3142	203	1	chronic	chronic	PROPN
iajs-3142	203	2	dis	dis	PROPN
iajs-3142	203	3	.	.	PROPN
iajs-3142	203	4	,	,	PUNCT
iajs-3142	203	5	2022	2022	NUM
iajs-3142	203	6	,	,	PUNCT
iajs-3142	203	7	19	19	NUM
iajs-3142	203	8	,	,	PUNCT
iajs-3142	203	9	e24	e24	NOUN
iajs-3142	203	10	.	.	PUNCT
iajs-3142	204	1	https://doi	https://doi	ADJ
iajs-3142	204	2	:	:	PUNCT
iajs-3142	204	3	10.5888	10.5888	NUM
iajs-3142	204	4	/	/	SYM
iajs-3142	204	5	pcd19.210231	pcd19.210231	ADJ
iajs-3142	204	6	.	.	PUNCT
iajs-3142	205	1	22	22	NUM
iajs-3142	205	2	.	.	X
iajs-3142	205	3	vladu	vladu	NOUN
iajs-3142	205	4	,	,	PUNCT
iajs-3142	205	5	i.m	i.m	PROPN
iajs-3142	205	6	.	.	PROPN
iajs-3142	205	7	;	;	PUNCT
iajs-3142	205	8	forțofoiu	forțofoiu	PROPN
iajs-3142	205	9	,	,	PUNCT
iajs-3142	205	10	m.	m.	NOUN
iajs-3142	205	11	;	;	PUNCT
iajs-3142	205	12	clenciu	clenciu	PROPN
iajs-3142	205	13	,	,	PUNCT
iajs-3142	205	14	d.	d.	PROPN
iajs-3142	205	15	;	;	PUNCT
iajs-3142	205	16	forțofoiu	forțofoiu	PROPN
iajs-3142	205	17	,	,	PUNCT
iajs-3142	205	18	m.-c	m.-c	NOUN
iajs-3142	205	19	.	.	PUNCT
iajs-3142	205	20	;	;	PUNCT
iajs-3142	205	21	pădureanu	pădureanu	NOUN
iajs-3142	205	22	,	,	PUNCT
iajs-3142	205	23	r.	r.	PROPN
iajs-3142	205	24	;	;	PUNCT
iajs-3142	205	25	radu	radu	PROPN
iajs-3142	205	26	,	,	PUNCT
iajs-3142	205	27	l.	l.	PROPN
iajs-3142	205	28	;	;	PUNCT
iajs-3142	205	29	cojan	cojan	PROPN
iajs-3142	205	30	,	,	PUNCT
iajs-3142	205	31	ștefăniță	ștefăniță	PROPN
iajs-3142	205	32	t.	t.	PROPN
iajs-3142	205	33	țenea	țenea	PROPN
iajs-3142	205	34	;	;	PUNCT
iajs-3142	205	35	rădulescu	rădulescu	PROPN
iajs-3142	205	36	,	,	PUNCT
iajs-3142	205	37	p.m.	p.m.	NOUN
iajs-3142	205	38	;	;	PUNCT
iajs-3142	205	39	pădureanu	pădureanu	NOUN
iajs-3142	205	40	,	,	PUNCT
iajs-3142	205	41	v.	v.	ADP
iajs-3142	205	42	insulin	insulin	NOUN
iajs-3142	205	43	resistance	resistance	NOUN
iajs-3142	205	44	quantified	quantify	VERB
iajs-3142	205	45	by	by	ADP
iajs-3142	205	46	the	the	DET
iajs-3142	205	47	value	value	NOUN
iajs-3142	205	48	of	of	ADP
iajs-3142	205	49	homa‑ir	homa‑ir	PROPN
iajs-3142	205	50	and	and	CCONJ
iajs-3142	205	51	cardiovascular	cardiovascular	ADJ
iajs-3142	205	52	risk	risk	NOUN
iajs-3142	205	53	in	in	ADP
iajs-3142	205	54	patients	patient	NOUN
iajs-3142	205	55	with	with	ADP
iajs-3142	205	56	type	type	NOUN
iajs-3142	205	57	2	2	NUM
iajs-3142	205	58	diabetes	diabetes	NOUN
iajs-3142	205	59	.	.	PUNCT
iajs-3142	206	1	exp	exp	X
iajs-3142	206	2	.	.	PUNCT
iajs-3142	207	1	ther	ther	PROPN
iajs-3142	207	2	.	.	PUNCT
iajs-3142	208	1	med	med	PROPN
iajs-3142	208	2	.	.	PUNCT
iajs-3142	208	3	2022	2022	NUM
iajs-3142	208	4	,	,	PUNCT
iajs-3142	208	5	23(1),73	23(1),73	NUM
iajs-3142	208	6	.	.	PUNCT
iajs-3142	209	1	https://doi	https://doi	ADJ
iajs-3142	209	2	:	:	PUNCT
iajs-3142	209	3	10.3892	10.3892	NUM
iajs-3142	209	4	/	/	SYM
iajs-3142	209	5	etm.2021.10996	etm.2021.10996	PROPN
iajs-3142	209	6	.	.	PUNCT
iajs-3142	210	1	e.	e.	PROPN
iajs-3142	210	2	23	23	NUM
iajs-3142	210	3	.	.	PUNCT
iajs-3142	211	1	xia	xia	PROPN
iajs-3142	211	2	,	,	PUNCT
iajs-3142	211	3	s.-j	s.-j	PROPN
iajs-3142	211	4	.	.	PUNCT
iajs-3142	211	5	;	;	PUNCT
iajs-3142	211	6	gao	gao	PROPN
iajs-3142	211	7	,	,	PUNCT
iajs-3142	211	8	b.-z	b.-z	PROPN
iajs-3142	211	9	.	.	PUNCT
iajs-3142	211	10	;	;	PUNCT
iajs-3142	211	11	wang	wang	PROPN
iajs-3142	211	12	,	,	PUNCT
iajs-3142	211	13	s.-h	s.-h	NOUN
iajs-3142	211	14	.	.	PUNCT
iajs-3142	211	15	;	;	PUNCT
iajs-3142	211	16	guttery	guttery	NOUN
iajs-3142	211	17	,	,	PUNCT
iajs-3142	211	18	d.s	d.s	PROPN
iajs-3142	211	19	.	.	PROPN
iajs-3142	211	20	;	;	PUNCT
iajs-3142	211	21	li	li	PROPN
iajs-3142	211	22	,	,	PUNCT
iajs-3142	211	23	c.-d	c.-d	PROPN
iajs-3142	211	24	.	.	PUNCT
iajs-3142	211	25	;	;	PUNCT
iajs-3142	211	26	zhang	zhang	PROPN
iajs-3142	211	27	,	,	PUNCT
iajs-3142	211	28	y.-d	y.-d	PROPN
iajs-3142	211	29	.	.	PUNCT
iajs-3142	212	1	modeling	modeling	NOUN
iajs-3142	212	2	of	of	ADP
iajs-3142	212	3	diagnosis	diagnosis	NOUN
iajs-3142	212	4	for	for	ADP
iajs-3142	212	5	metabolic	metabolic	NOUN
iajs-3142	212	6	syndrome	syndrome	NOUN
iajs-3142	212	7	by	by	ADP
iajs-3142	212	8	integrating	integrate	VERB
iajs-3142	212	9	symptoms	symptom	NOUN
iajs-3142	212	10	into	into	ADP
iajs-3142	212	11	physiochemical	physiochemical	ADJ
iajs-3142	212	12	indexes	index	NOUN
iajs-3142	212	13	.	.	PUNCT
iajs-3142	212	14	biomed	biome	VERB
iajs-3142	212	15	.	.	PUNCT
iajs-3142	213	1	pharmacother	pharmacother	PROPN
iajs-3142	213	2	.	.	PUNCT
iajs-3142	213	3	,	,	PUNCT
iajs-3142	213	4	2021	2021	NUM
iajs-3142	213	5	,	,	PUNCT
iajs-3142	213	6	137	137	NUM
iajs-3142	213	7	,	,	PUNCT
iajs-3142	213	8	111367	111367	NUM
iajs-3142	213	9	.	.	PUNCT
iajs-3142	214	1	https://doi	https://doi	ADV
iajs-3142	214	2	:	:	PUNCT
iajs-3142	214	3	10.1016	10.1016	NUM
iajs-3142	214	4	/	/	SYM
iajs-3142	214	5	j.biopha.2021.111367	j.biopha.2021.111367	PROPN
iajs-3142	214	6	..	..	PUNCT
iajs-3142	214	7	ihjpas	ihjpas	PROPN
iajs-3142	214	8	.	.	PUNCT
iajs-3142	215	1	37(1)2024	37(1)2024	NUM
iajs-3142	215	2	341	341	NUM
iajs-3142	215	3	24	24	NUM
iajs-3142	215	4	.	.	PUNCT
iajs-3142	215	5	grigorescu	grigorescu	PROPN
iajs-3142	215	6	,	,	PUNCT
iajs-3142	215	7	e.-d	e.-d	NOUN
iajs-3142	215	8	.	.	PUNCT
iajs-3142	215	9	;	;	PUNCT
iajs-3142	216	1	lăcătușu	lăcătușu	PROPN
iajs-3142	216	2	,	,	PUNCT
iajs-3142	216	3	c.-m	c.-m	NOUN
iajs-3142	216	4	.	.	PUNCT
iajs-3142	216	5	;	;	PUNCT
iajs-3142	217	1	crețu	crețu	PROPN
iajs-3142	217	2	,	,	PUNCT
iajs-3142	217	3	i.	i.	PROPN
iajs-3142	217	4	;	;	PUNCT
iajs-3142	217	5	floria	floria	PROPN
iajs-3142	217	6	,	,	PUNCT
iajs-3142	217	7	m.	m.	NOUN
iajs-3142	217	8	;	;	PUNCT
iajs-3142	217	9	onofriescu	onofriescu	NUM
iajs-3142	217	10	,	,	PUNCT
iajs-3142	217	11	a.	a.	NOUN
iajs-3142	217	12	;	;	PUNCT
iajs-3142	217	13	ceasovschih	ceasovschih	NOUN
iajs-3142	217	14	,	,	PUNCT
iajs-3142	217	15	a.	a.	PROPN
iajs-3142	217	16	;	;	PUNCT
iajs-3142	217	17	mihai	mihai	PROPN
iajs-3142	217	18	,	,	PUNCT
iajs-3142	217	19	b.-m	b.-m	PROPN
iajs-3142	217	20	.	.	PUNCT
iajs-3142	217	21	;	;	PUNCT
iajs-3142	217	22	șorodoc	șorodoc	PROPN
iajs-3142	217	23	,	,	PUNCT
iajs-3142	217	24	l.	l.	PROPN
iajs-3142	217	25	self	self	NOUN
iajs-3142	217	26	-	-	PUNCT
iajs-3142	217	27	reported	report	VERB
iajs-3142	217	28	satisfaction	satisfaction	NOUN
iajs-3142	217	29	to	to	ADP
iajs-3142	217	30	treatment	treatment	NOUN
iajs-3142	217	31	,	,	PUNCT
iajs-3142	217	32	quality	quality	NOUN
iajs-3142	217	33	of	of	ADP
iajs-3142	217	34	life	life	NOUN
iajs-3142	217	35	and	and	CCONJ
iajs-3142	217	36	general	general	ADJ
iajs-3142	217	37	health	health	NOUN
iajs-3142	217	38	of	of	ADP
iajs-3142	217	39	type	type	NOUN
iajs-3142	217	40	2	2	NUM
iajs-3142	217	41	diabetes	diabetes	NOUN
iajs-3142	217	42	patients	patient	NOUN
iajs-3142	217	43	with	with	ADP
iajs-3142	217	44	inadequate	inadequate	ADJ
iajs-3142	217	45	glycemic	glycemic	ADJ
iajs-3142	217	46	control	control	NOUN
iajs-3142	217	47	from	from	ADP
iajs-3142	217	48	north	north	NOUN
iajs-3142	217	49	-	-	PUNCT
iajs-3142	217	50	eastern	eastern	ADJ
iajs-3142	217	51	romania	romania	PROPN
iajs-3142	217	52	.	.	PUNCT
iajs-3142	218	1	int	int	NOUN
iajs-3142	218	2	.	.	PUNCT
iajs-3142	219	1	j.	j.	PROPN
iajs-3142	219	2	environ	environ	PROPN
iajs-3142	219	3	.	.	PUNCT
iajs-3142	220	1	res	re	NOUN
iajs-3142	220	2	.	.	PROPN
iajs-3142	220	3	,	,	PUNCT
iajs-3142	220	4	public	public	ADJ
iajs-3142	220	5	health	health	NOUN
iajs-3142	220	6	2021	2021	NUM
iajs-3142	220	7	,	,	PUNCT
iajs-3142	220	8	18(6),3249	18(6),3249	NUM
iajs-3142	220	9	.	.	PUNCT
iajs-3142	221	1	https://doi	https://doi	ADJ
iajs-3142	221	2	:	:	PUNCT
iajs-3142	221	3	10.3390	10.3390	NUM
iajs-3142	221	4	/	/	SYM
iajs-3142	221	5	ijerph18063249	ijerph18063249	PROPN
iajs-3142	221	6	.	.	PUNCT
iajs-3142	222	1	25	25	NUM
iajs-3142	222	2	.	.	PUNCT
iajs-3142	223	1	farhan	farhan	PROPN
iajs-3142	223	2	,	,	PUNCT
iajs-3142	223	3	l.o	l.o	PROPN
iajs-3142	223	4	.	.	PROPN
iajs-3142	223	5	;	;	PUNCT
iajs-3142	223	6	taha	taha	PROPN
iajs-3142	223	7	,	,	PUNCT
iajs-3142	223	8	e.m	e.m	PROPN
iajs-3142	223	9	.	.	PROPN
iajs-3142	223	10	;	;	PUNCT
iajs-3142	223	11	farhan	farhan	PROPN
iajs-3142	223	12	,	,	PUNCT
iajs-3142	223	13	a.m.	a.m.	NOUN
iajs-3142	224	1	a	a	DET
iajs-3142	224	2	case	case	NOUN
iajs-3142	224	3	control	control	NOUN
iajs-3142	224	4	study	study	NOUN
iajs-3142	224	5	to	to	PART
iajs-3142	224	6	determine	determine	VERB
iajs-3142	224	7	macrophage	macrophage	ADJ
iajs-3142	224	8	migration	migration	NOUN
iajs-3142	224	9	inhibitor	inhibitor	NOUN
iajs-3142	224	10	,	,	PUNCT
iajs-3142	224	11	and	and	CCONJ
iajs-3142	224	12	n	n	CCONJ
iajs-3142	224	13	-	-	PUNCT
iajs-3142	224	14	telopeptides	telopeptide	NOUN
iajs-3142	224	15	of	of	ADP
iajs-3142	224	16	type	type	NOUN
iajs-3142	224	17	i	i	PRON
iajs-3142	224	18	bone	bone	NOUN
iajs-3142	224	19	collagen	collagen	NOUN
iajs-3142	224	20	levels	level	NOUN
iajs-3142	224	21	in	in	ADP
iajs-3142	224	22	the	the	DET
iajs-3142	224	23	sera	sera	NOUN
iajs-3142	224	24	of	of	ADP
iajs-3142	224	25	osteoporosis	osteoporosis	NOUN
iajs-3142	224	26	patients	patient	NOUN
iajs-3142	224	27	.	.	PUNCT
iajs-3142	225	1	baghdad	baghdad	PROPN
iajs-3142	225	2	sci	sci	PROPN
iajs-3142	225	3	.	.	PUNCT
iajs-3142	226	1	j.	j.	PROPN
iajs-3142	226	2	,	,	PUNCT
iajs-3142	226	3	2022	2022	NUM
iajs-3142	226	4	,	,	PUNCT
iajs-3142	226	5	19(4	19(4	NUM
iajs-3142	226	6	)	)	PUNCT
iajs-3142	226	7	,	,	PUNCT
iajs-3142	226	8	848	848	NUM
iajs-3142	226	9	-	-	SYM
iajs-3142	226	10	854	854	NUM
iajs-3142	226	11	.	.	PUNCT
iajs-3142	226	12	https://doi.org/10.21123/bsj.2022.19.4.0848	https://doi.org/10.21123/bsj.2022.19.4.0848	PROPN
iajs-3142	226	13	.	.	PUNCT
iajs-3142	227	1	26	26	NUM
iajs-3142	227	2	.	.	PUNCT
iajs-3142	228	1	wei	wei	PROPN
iajs-3142	228	2	,	,	PUNCT
iajs-3142	228	3	w.	w.	PROPN
iajs-3142	228	4	;	;	PUNCT
iajs-3142	228	5	liu	liu	PROPN
iajs-3142	228	6	,	,	PUNCT
iajs-3142	228	7	h.	h.	PROPN
iajs-3142	228	8	;	;	PUNCT
iajs-3142	228	9	qiu	qiu	PROPN
iajs-3142	228	10	,	,	PUNCT
iajs-3142	228	11	x.	x.	PROPN
iajs-3142	228	12	;	;	PUNCT
iajs-3142	228	13	zhang	zhang	PROPN
iajs-3142	228	14	,	,	PUNCT
iajs-3142	228	15	j.	j.	PROPN
iajs-3142	228	16	;	;	PUNCT
iajs-3142	228	17	huang	huang	PROPN
iajs-3142	228	18	,	,	PUNCT
iajs-3142	228	19	j.	j.	PROPN
iajs-3142	228	20	;	;	PUNCT
iajs-3142	228	21	chen	chen	PROPN
iajs-3142	228	22	,	,	PUNCT
iajs-3142	228	23	h.	h.	PROPN
iajs-3142	228	24	;	;	PUNCT
iajs-3142	228	25	qiu	qiu	PROPN
iajs-3142	228	26	,	,	PUNCT
iajs-3142	228	27	s.	s.	PROPN
iajs-3142	228	28	;	;	PUNCT
iajs-3142	228	29	lin	lin	PROPN
iajs-3142	228	30	,	,	PUNCT
iajs-3142	228	31	r.	r.	PROPN
iajs-3142	228	32	;	;	PUNCT
iajs-3142	228	33	li	li	PROPN
iajs-3142	228	34	,	,	PUNCT
iajs-3142	228	35	s.	s.	PROPN
iajs-3142	228	36	;	;	PUNCT
iajs-3142	228	37	tu	tu	PROPN
iajs-3142	228	38	,	,	PUNCT
iajs-3142	228	39	m.	m.	NOUN
iajs-3142	228	40	the	the	DET
iajs-3142	228	41	association	association	NOUN
iajs-3142	228	42	between	between	ADP
iajs-3142	228	43	serum	serum	NOUN
iajs-3142	228	44	adropin	adropin	NOUN
iajs-3142	228	45	and	and	CCONJ
iajs-3142	228	46	carotid	carotid	VERB
iajs-3142	228	47	atherosclerosis	atherosclerosis	NOUN
iajs-3142	228	48	in	in	ADP
iajs-3142	228	49	patients	patient	NOUN
iajs-3142	228	50	with	with	ADP
iajs-3142	228	51	type	type	NOUN
iajs-3142	228	52	2	2	NUM
iajs-3142	228	53	diabetes	diabetes	NOUN
iajs-3142	228	54	mellitus	mellitus	NOUN
iajs-3142	228	55	:	:	PUNCT
iajs-3142	228	56	a	a	DET
iajs-3142	228	57	cross	cross	ADJ
iajs-3142	228	58	-	-	ADJ
iajs-3142	228	59	sectional	sectional	ADJ
iajs-3142	228	60	study	study	NOUN
iajs-3142	228	61	.	.	PUNCT
iajs-3142	229	1	diabetol	diabetol	ADJ
iajs-3142	229	2	.	.	PUNCT
iajs-3142	230	1	metab	metab	NOUN
iajs-3142	230	2	.	.	PUNCT
iajs-3142	231	1	syndr	syndr	PROPN
iajs-3142	231	2	.	.	PUNCT
iajs-3142	231	3	,	,	PUNCT
iajs-3142	231	4	2022	2022	NUM
iajs-3142	231	5	,	,	PUNCT
iajs-3142	231	6	14	14	NUM
iajs-3142	231	7	,	,	PUNCT
iajs-3142	231	8	1–8	1–8	NUM
iajs-3142	231	9	.	.	PUNCT
iajs-3142	232	1	https://doi.org/10.1186%2fs13098-022-00796-y	https://doi.org/10.1186%2fs13098-022-00796-y	PROPN
iajs-3142	232	2	.	.	PROPN
iajs-3142	233	1	27	27	NUM
iajs-3142	233	2	.	.	X
iajs-3142	234	1	zhang	zhang	PROPN
iajs-3142	234	2	,	,	PUNCT
iajs-3142	234	3	h.	h.	PROPN
iajs-3142	234	4	;	;	PUNCT
iajs-3142	234	5	chen	chen	PROPN
iajs-3142	234	6	,	,	PUNCT
iajs-3142	234	7	n.	n.	PROPN
iajs-3142	234	8	adropin	adropin	NOUN
iajs-3142	234	9	as	as	ADP
iajs-3142	234	10	an	an	DET
iajs-3142	234	11	indicator	indicator	NOUN
iajs-3142	234	12	of	of	ADP
iajs-3142	234	13	t2	t2	NOUN
iajs-3142	234	14	dm	dm	PROPN
iajs-3142	234	15	and	and	CCONJ
iajs-3142	234	16	its	its	PRON
iajs-3142	234	17	complications	complication	NOUN
iajs-3142	234	18	.	.	PUNCT
iajs-3142	235	1	food	food	PROPN
iajs-3142	235	2	sci	sci	PROPN
iajs-3142	235	3	.	.	PUNCT
iajs-3142	235	4	hum	hum	PROPN
iajs-3142	235	5	.	.	PUNCT
iajs-3142	236	1	wellness	wellness	NOUN
iajs-3142	236	2	,	,	PUNCT
iajs-3142	236	3	2022	2022	NUM
iajs-3142	236	4	,	,	PUNCT
iajs-3142	236	5	11(6	11(6	NUM
iajs-3142	236	6	)	)	PUNCT
iajs-3142	236	7	,	,	PUNCT
iajs-3142	236	8	1455	1455	NUM
iajs-3142	236	9	-	-	SYM
iajs-3142	236	10	1463	1463	NUM
iajs-3142	236	11	.	.	PUNCT
iajs-3142	237	1	https://doi.org/10.1016/j.fshw.2022.06.00228	https://doi.org/10.1016/j.fshw.2022.06.00228	PROPN
iajs-3142	237	2	.	.	PUNCT
iajs-3142	238	1	28	28	NUM
iajs-3142	238	2	.	.	PUNCT
iajs-3142	239	1	gao	gao	PROPN
iajs-3142	239	2	,	,	PUNCT
iajs-3142	239	3	s.	s.	PROPN
iajs-3142	239	4	;	;	PUNCT
iajs-3142	239	5	mcmillan	mcmillan	PROPN
iajs-3142	239	6	,	,	PUNCT
iajs-3142	239	7	r.p	r.p	PROPN
iajs-3142	239	8	.	.	PROPN
iajs-3142	239	9	;	;	PUNCT
iajs-3142	239	10	zhu	zhu	PROPN
iajs-3142	239	11	,	,	PUNCT
iajs-3142	239	12	q.	q.	PROPN
iajs-3142	239	13	;	;	PUNCT
iajs-3142	239	14	lopaschuk	lopaschuk	NOUN
iajs-3142	239	15	,	,	PUNCT
iajs-3142	239	16	g.d	g.d	PROPN
iajs-3142	239	17	.	.	PROPN
iajs-3142	239	18	;	;	PUNCT
iajs-3142	239	19	hulver	hulver	ADV
iajs-3142	239	20	,	,	PUNCT
iajs-3142	239	21	m.w	m.w	PROPN
iajs-3142	239	22	.	.	PROPN
iajs-3142	239	23	;	;	PUNCT
iajs-3142	239	24	butler	butler	PROPN
iajs-3142	239	25	,	,	PUNCT
iajs-3142	239	26	a.a	a.a	PROPN
iajs-3142	239	27	.	.	PROPN
iajs-3142	239	28	therapeutic	therapeutic	ADJ
iajs-3142	239	29	effects	effect	NOUN
iajs-3142	239	30	of	of	ADP
iajs-3142	239	31	adropin	adropin	NOUN
iajs-3142	239	32	on	on	ADP
iajs-3142	239	33	glucose	glucose	NOUN
iajs-3142	239	34	tolerance	tolerance	NOUN
iajs-3142	239	35	and	and	CCONJ
iajs-3142	239	36	substrate	substrate	NOUN
iajs-3142	239	37	utilization	utilization	NOUN
iajs-3142	239	38	in	in	ADP
iajs-3142	239	39	diet	diet	NOUN
iajs-3142	239	40	-	-	PUNCT
iajs-3142	239	41	induced	induce	VERB
iajs-3142	239	42	obese	obese	ADJ
iajs-3142	239	43	mice	mouse	NOUN
iajs-3142	239	44	with	with	ADP
iajs-3142	239	45	insulin	insulin	NOUN
iajs-3142	239	46	resistance	resistance	NOUN
iajs-3142	239	47	.	.	PUNCT
iajs-3142	240	1	mol	mol	PROPN
iajs-3142	240	2	.	.	PUNCT
iajs-3142	240	3	metab	metab	PROPN
iajs-3142	240	4	.	.	PUNCT
iajs-3142	240	5	,	,	PUNCT
iajs-3142	240	6	2015	2015	NUM
iajs-3142	240	7	,	,	PUNCT
iajs-3142	240	8	4(4):310	4(4):310	NUM
iajs-3142	240	9	-	-	SYM
iajs-3142	240	10	24	24	NUM
iajs-3142	240	11	.	.	PUNCT
iajs-3142	241	1	https://doi	https://doi	ADV
iajs-3142	241	2	:	:	PUNCT
iajs-3142	241	3	10.1016	10.1016	NUM
iajs-3142	241	4	/	/	SYM
iajs-3142	241	5	j.molmet.2015.01.005	j.molmet.2015.01.005	PROPN
iajs-3142	241	6	.	.	PUNCT
iajs-3142	242	1	29	29	NUM
iajs-3142	242	2	.	.	X
iajs-3142	242	3	ali	ali	PROPN
iajs-3142	242	4	,	,	PUNCT
iajs-3142	242	5	i.i	i.i	PROPN
iajs-3142	242	6	.	.	PROPN
iajs-3142	242	7	;	;	PUNCT
iajs-3142	242	8	d’souza	d’souza	PROPN
iajs-3142	242	9	,	,	PUNCT
iajs-3142	242	10	c.	c.	NOUN
iajs-3142	242	11	;	;	PUNCT
iajs-3142	242	12	singh	singh	PROPN
iajs-3142	242	13	,	,	PUNCT
iajs-3142	242	14	j.	j.	PROPN
iajs-3142	242	15	;	;	PUNCT
iajs-3142	242	16	adeghate	adeghate	VERB
iajs-3142	242	17	,	,	PUNCT
iajs-3142	243	1	e.	e.	PROPN
iajs-3142	243	2	adropin	adropin	PROPN
iajs-3142	243	3	’s	’s	PART
iajs-3142	243	4	role	role	NOUN
iajs-3142	243	5	in	in	ADP
iajs-3142	243	6	energy	energy	NOUN
iajs-3142	243	7	homeostasis	homeostasis	NOUN
iajs-3142	243	8	and	and	CCONJ
iajs-3142	243	9	metabolic	metabolic	NOUN
iajs-3142	243	10	disorders	disorder	NOUN
iajs-3142	243	11	.	.	PUNCT
iajs-3142	244	1	int	int	NOUN
iajs-3142	244	2	.	.	PUNCT
iajs-3142	245	1	j.	j.	PROPN
iajs-3142	245	2	mol	mol	PROPN
iajs-3142	245	3	.	.	PUNCT
iajs-3142	246	1	sci	sci	PROPN
iajs-3142	246	2	.	.	PROPN
iajs-3142	246	3	,	,	PUNCT
iajs-3142	246	4	2022	2022	NUM
iajs-3142	246	5	,	,	PUNCT
iajs-3142	246	6	23(15):8318	23(15):8318	NUM
iajs-3142	246	7	.	.	PUNCT
iajs-3142	247	1	https://doi	https://doi	ADJ
iajs-3142	247	2	:	:	PUNCT
iajs-3142	247	3	10.3390	10.3390	NUM
iajs-3142	247	4	/	/	SYM
iajs-3142	247	5	ijms23158318	ijms23158318	PROPN
iajs-3142	247	6	.	.	PUNCT
iajs-3142	248	1	30	30	NUM
iajs-3142	248	2	.	.	PUNCT
iajs-3142	249	1	layla	layla	PROPN
iajs-3142	249	2	,	,	PUNCT
iajs-3142	249	3	o.f	o.f	PROPN
iajs-3142	249	4	.	.	PROPN
iajs-3142	249	5	;	;	PUNCT
iajs-3142	249	6	baydaa	baydaa	PROPN
iajs-3142	249	7	,	,	PUNCT
iajs-3142	249	8	a.a	a.a	PROPN
iajs-3142	249	9	.	.	PROPN
iajs-3142	249	10	;	;	PUNCT
iajs-3142	249	11	aufaira	aufaira	PROPN
iajs-3142	249	12	,	,	PUNCT
iajs-3142	249	13	s.n	s.n	PROPN
iajs-3142	249	14	.	.	PROPN
iajs-3142	249	15	;	;	PUNCT
iajs-3142	249	16	wesen	wesen	PROPN
iajs-3142	249	17	,	,	PUNCT
iajs-3142	249	18	a.m.	a.m.	PROPN
iajs-3142	249	19	total	total	ADJ
iajs-3142	249	20	antioxidant	antioxidant	ADJ
iajs-3142	249	21	capacity	capacity	NOUN
iajs-3142	249	22	and	and	CCONJ
iajs-3142	249	23	malondialdehyde	malondialdehyde	NOUN
iajs-3142	249	24	as	as	ADP
iajs-3142	249	25	a	a	DET
iajs-3142	249	26	markers	marker	NOUN
iajs-3142	249	27	of	of	ADP
iajs-3142	249	28	oxidative	oxidative	ADJ
iajs-3142	249	29	stress	stress	NOUN
iajs-3142	249	30	in	in	ADP
iajs-3142	249	31	women	woman	NOUN
iajs-3142	249	32	with	with	ADP
iajs-3142	249	33	diabetic	diabetic	ADJ
iajs-3142	249	34	and	and	CCONJ
iajs-3142	249	35	disorder	disorder	NOUN
iajs-3142	249	36	hormones	hormone	NOUN
iajs-3142	249	37	.	.	PUNCT
iajs-3142	250	1	adv	adv	PROPN
iajs-3142	250	2	.	.	PUNCT
iajs-3142	251	1	environ	environ	PROPN
iajs-3142	251	2	.	.	PUNCT
iajs-3142	252	1	biol	biol	PROPN
iajs-3142	252	2	.	.	PUNCT
iajs-3142	252	3	,	,	PUNCT
iajs-3142	252	4	2016	2016	NUM
iajs-3142	252	5	,	,	PUNCT
iajs-3142	252	6	10(5	10(5	NUM
iajs-3142	252	7	)	)	PUNCT
iajs-3142	252	8	,	,	PUNCT
iajs-3142	252	9	172	172	NUM
iajs-3142	252	10	-	-	SYM
iajs-3142	252	11	176	176	NUM
iajs-3142	252	12	.	.	PUNCT
iajs-3142	252	13	https://doi.org/10.1155%2f2013%2f150693	https://doi.org/10.1155%2f2013%2f150693	PROPN
iajs-3142	252	14	.	.	PUNCT